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I N TRODU C T I 0 K
These studies on ovarian tumours were largely based on the
collection of gynaecological pathology material in the Department of
Obstetrics and Gynaecology of the University of Edinburgh. All
ovarian tumour cases examined during a period of 10 years, 1954-1963
were reviewed. These amounted to a total of 1734 cases. For the
purpose of some studies, the review was extended beyond the 10 year
period.
The studies included in this thesis fall into three parts.
In part I, biostatistical and general aspects of the ovarian tumour
series are presented. Part II deals with histopathological studies.
In part III, the application of cytogenetic techniques to the study
of some problems of ovarian tumours is presented and discussed.
BIOSTATISTICAL AND GENERAL ASPECTS
F A.R T I
BIOSTATISTICAL AND GSHEBAL ASPECTS
1
INCIDENCE
It is difficult to arrive at exact figures to describe the
incidence of ovarian tumours in the general population. However, an
idea about their relative incidence may be obtained from review of
the routine gynaecological pathology material. During a period of
10 years, 1954 - 1963* the total number of cases received in the
pathology laboratory of the Department of Obstetrics and Gynaecology
of the University of Edinburgh was 63*938. Of these, 113b were cases
of ovarian tumours, a relative incidence of 2*7 per cent.
The general Incidence of ovarian tumours, expressed as a
percentage of the total number of admissions in a gynaecologic clinic,
varied widely in various reports from 1*2+ to 9*9 per cent (Selye
1946). This is certainly due to the different standards according to
which patients are admitted in the various clinics. Obviously, the
incidence of ovarian tumours will be comparatively low in those
hospitals in which women are admitted for minor ailments requiring no
operative intervention. Based on a collected series from the
literature of 160,324 cases of hospital admissions, Selye (1946)
calculated the incidence of ovarian tumours to be 2*8 per cent in the
average gynaecological clinic. This figure is remarkably similar to
our own figure for the frequency of ovarian tumours in gynaecological
pathology material.
AGE DISTRIBUTION
The age of the patients in our series of ovarian tumours ranged
from 10 to 92 years. Table I shows the age distribution in 1721
patients with benign and malignant ovarian tumours. In the remaining
13 cases in the series, the age of the patients was not stated.
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Table I
Age distribution in patients with ovarian tumours
range -20 -30 -1+0 -50 -60 60+ total
Benign 10 - 92 29 197 213 261+ 235 303 121+1
Malignant 11+ - 85 7 11+ 31+ 95 150 180 1+80
Total 10 - 92 36 211 21+7 359 385 1+83 1721
The rising number of both the benign and malignant ovarian
tumours with age can be noted. This is also clearly demonstrated in
the accompanying graph (.Figure I). Ovarian tumours can occur, though
very rarely, in patients below the age of 10 years. However, these
are usually dealt with by the pediatric surgeon and not the gynaecologist,
Comparison of the age distribution of benign and malignant
ovarian tumours can also be seen in Figure I. In the case of benign
tumours, after a steep rise in the number of cases in the 3rd decade,
the increase in the number of cases with age is not marked. In the
case of the malignant tumours, on the other hand, the increase in the
number of cases with age is more marked and a steep rise occurs in
the 5th decade. It is also interesting to note that the 7 malignant
tumours below the age of 20 years were all of rare type: 1 malignant
teratoma, 1 disgerminoma, 2 mesoblastomas and 3 arrhenoblastomas.
The youngest patient with the common ovarian adenocarcinoma in this
series was 22 years old and the tumour was a mucinous adenocarcinoma.
From a clinical point of view, it is interesting to correlate
the frequency of malignancy in ovarian tumours with the age of the
patients. Figure 2 shows the percentage of malignant tumours among
the total number of ovarian tumours in each decade. In spite of the
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higher age incidence of malignant tumours, the frequency of the
benign tumours is such that at no age period was the chance of an
ovarian tumour to be malignant more than or equal to its chance of
being benign. The percentage of malignant tumours was quite high
below the age of 20 years (due to the rarity of benign tumours, not
to the frequency of malignant tumours)• The percentage fell in the
next two decades (due to the frequency of benign tumours and also the
relative rarity of malignant tumours). After the bth decade, the
percentage of malignant tumours rose again (due to the rather steady
number of benign tumours and the rapidly increasing number of
malignant tumours). Application of the x test to the figures in
Table 1 shows that the differences in age distribution between the
benign and malignant cases is statistically significant (p < 0*01)
BILATSRALITY IN OVARIAN TUMOURS
Ovarian tumours show a decided tendency to involve both ovaries.
This applies not only to malignant tumours but to benign tumours as
well. The implications of this observation are threefold:
pathogenetic, diagnostic and surgical. The pathogenetic implication
in a bilateral tumour is that a general rather than an isolated local
factor is probably underlying the development of the tumour. The
diagnostic importance stems from the difference in the tendency to
bilaterality among the various types of ovarian tumours and especially
between benign and malignant tumours. From the surgical point of
view, this tendency to bilaterality is an argument for the excision
of the contra-lateral grossly normal ovary.
In attempting to assess the clinical diagnostic value of
bilaterality, we excluded from the study tumours encountered in grossly
h
normal ovaries. Thus, we were left with 161+9 tumours. Of these,
195 were bilateral, an incidence of about 12 per cent. The
distribution of these cases is shown in Tables II and III. Although
primary malignant tumours were nearly three times as commonly
bilateral as benign tumours, the chance of a primary bilateral tumour
being benign was about as equal to its chance of being malignant.
This is due to the more relative frequency of benign tumours.
Table II
Bilaterality in ovarian tumours
Bilateral Total
Adenocarcinoma 85 357
Serous cystadenoma 31 292
Secondary 23 60








Note: Tumours detected in clinically normal ovaries are not
included.
Table III












TOTAL 1178 1+71 161+9
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The relation of tumour "bilateral!t.v to the age of the patients
The incidence of bilaterality in ovarian tumours, "benign and
malignant, in the various age groups is shown in Table IV. The
incidence of bilaterality, in general, is nearly doubled after the
age of 1+0 years. In the benign tumours, however, an increase in
incidence of bilaterality was marked only after the 6th decade.
Table IV
Bilaterality in ovarian tumours in the different age groups
1
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total 21+5 21+3 319 366 1+53 1626
The ratio of malignant tumours in the bilateral ovarian tumours in the
various age groups is shorn in Figure 3. A bilateral ovarian
tumour was more commonly malignant in the i+th and 5th decade only.
Earlier, bilateral tumours were more commonly benign. Later, the
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chance was almost equal. Application of the x test to the figures
in this analysis shows that the differences between benign and
malignant tumours in the aspect of bilaterality were statistically
significant (p < 0*01).
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Heterogenous bilaterality
It should be remembered, in the case of bilateral tumours of the
ovary, that the tumours may be of different types. We encountered
several examples of these associated tumours. A benign cystic
teratoma on one side with a mucinous cystadenoma on the opposite
side was encountered in 3 cases. A benign serous cystadenoma on
one side with a malignant serous cystadenocarcinoma in the opposite
side was also encountered in several cases. The simultaneous
occurrence of two primary ovarian adenocarcinomas of different
types in both ovaries is more difficult to prove. In two cases
in this series, the presence of a well differentiated adenocarcinoma
in one ovary and a completely undifferentiated adenocarcinoma in the
opposite ovary suggested this possibility. However, the possibility
of a metastatic origin for the undifferentiated tumour cannot be
definitely excluded. We have also encountered two examples of a
mesenchymoma in one ovary and a primary adenocarcinoma in the
opposite ovary.
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PRi^UENCY Off THE VARIOUS TYPES OP OVARIAN TUKOURS
It is not the. intention here to add another elaborate
classification to the already numerous ones for ovarian tumours.
The types of ovarian tumours in this consecutive series of 173U
cases, are arranged in the order of their frequency in Table V,
According to their relative frequency, ovarian tumours may be
placed into b groups: common, uncommon, rare and very rare tumours.
1. Common ovarian tumours: This group includes the common benign
neoplastic cysts (the mucinous cystadenoma, the serous cystadenoma
and the benign cystic teratoma) ana the ovarian adenocarcinoma.
Each of these types accounts for more than 10 per cent of all
ovarian tumours. Grouped together, these types accounted for
78 per cent of all the ovarian tumours in our series.
2. Uncommon ovarian tumours: This group includes the mesenchymal
ovarian tumours (granulosa cell tumour, thecoma, Brenner tumour,
adenofibroma and fibroma), the struma ovarii and secondary ovarian
tumours (excluding the Krifkenberg tumour). Each of the tumour
types included accounts for 1-10 per cent of all ovarian tumours.
Grouped together, these tumours accounted for 20 per cent of all
ovarian tumours in our series.
3» Rare ovarian tumours: The tumour types included under this heading
are the disgerminoma, arrhenoblastoma, lipoid cell tumour,
Krvikenberg tumour and malignant transformation in benign cystic
teratoma. Each of these tumours accounts for less than 1 per cent
but more than 1 in 1000 of the total ovarian tumours. Grouped
together, these tumours accounted for 1*5 per cent of all ovarian
tumours in our series.
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U. Very rare ovarian tumours; Under this heading are included the
rarest types of ovarian tumours. In this group, our series
included 2 mesodermal mixed tumours, 2 mesoblastomas (Teilum),
a malignant Brenner tumour, a malignant adenofibroma and a solid
malignant teratoma. This group accounted for less than 0*5 per
cent of the total number of ovarian tumours in our series.
To put the relative frequency of these groups of ovarian tumours in
a rough and approximate way -
Ten ovarian tumours are needed to get examples of all the
types of the common ovarian tumours.
One hundred ovarian tumours are needed to get examples of all
the types of the uncommon ovarian tumours.
One thousand ovarian tumours are needed to get examples of all
the types of the rare ovarian tumours.
More than one thousand ovarian tumours are needed to get examples
of all the types of the very rare ovarian tumours.
A brief comment on the various types of ovarian tumours will
he given. This will also include an orientation to studies which
will follow in other chapters.
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COMMON EPITHELIAL TUMOURS OF THE OVARY
This group includes the most frequent types of ovarian tumours.
In our series, 1113 out of the total of 173b tumours were in this
group.
Recently the cancer committee of the International Federation
of Gynaecology and Obstetrics has set out to standardize the
classification of malignant ovarian neoplasms so that therapeutic
reports throughout the world may be more accurately compared. For
this purpose, a conference was convened at the Radiumhemmet in
Stockholm in August 1961. The conference, whose members were
distinguished gynaecological pathologists, considered in detail only
the classification of the common epithelial tumours of the ovary,
those generally considered to arise from the ovarian peritoneal
epithelium. The histological classification recommended by the
conference was subsequently adopted by the General Assembly of the
International Federation of Gynaecology and Obstetrics, at a meeting
in Mar del Plata, in September 196iw This classification was as
follows:
Histologic classification of the common primary epithelial tumours
of the ovary
1. Serous cystomas:
a. Serous benign cystadenomaS
b. Serous cystadenomas with proliferative activity of the epithelial
cells and nuclear abnormalities but with no infiltrative




a. Mucinous benign eystadenomas
b. Mucinous cystadenomaswith proliferative activity of the
epithelial cells and nuclear abnormalities but with no
infiltrative destructive growth (low potential malignancy).
c. Mucinous cystadenocarcinomas.
3. Endometrioid tumours (similar to adenocarcinomas in the endometrium):
a. Endometrioid benign cysts
b. Endometrioid tumours with proliferative activity of the
epithelial cells and nuclear abnormalities but with no
infiltrative destructive growth (low potential malignancy)
c. Endometrioid adenocarcinomas.
1+. Concomitant carcinoma, unclassified carcinoma (tumours which cannot
be allotted to one of the groups 1, 2 or 3).
(Examples of these tumour types are shown in figures 1+ - 12)
The two main features in this classification are the
introduction of a borderline group between frankly benign and frankly
malignant cases and the introduction of the endometrioid group of
tumours•
The introduction of a borderline group in this classification
is of much help. Malignancy is to be considered as a quality
variably present, rather than as an entity (Taylor 1959). No valid
comparison between different results of treatment can be made without
segregation of this group of borderline cases. A warning, however,
must be stated. This group should not be used too frequently to
avoid deciding either way. A pathologist is safe with a borderline
diagnosis! It is important to remember that examination of other
areas of the tumour in these cases may well push a borderline case
into the definitely malignant class. The diagnosis of a borderline
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or potentially malignant lesion should only "be made after a careful
and thorough examination of several representative areas of the tumour.
The introduction of the endometrioid group meets the realization
of pathologists that many cases of ovarian carcinoma show a
histological similarity to endometrial carcinomas (Kottmeier 1952,
Santesson 1961, Long and Taylor 196h). Whether benign endometrial
lesions in the ovary should he classified as neoplasms, as suggested
in the classification, is, however, debatable. The relationship of
endometrioid carcinoma of the ovary to benign endometriosis raises
the question of the possibility and frequency of malignant
transformation in ovarian endometriosis. A special study of this
problem will be presented in another part of this thesis.
It should also be noted that mixed pictures do occasionally
occur in these epithelial tumours. A serous cystadenoma may show
mucinous areas (Figure 13)• It is not uncommon for an ovarian
carcinoma to show serous, mucinous as well as endometrioid areas
(Figures 115)* The predominant pattern should be taken as the
type of the tumour in these cases.
Completely undifferentiated ovarian carcinomas are rare.
.Examination of other parts of the tumour often shows other more
differentiated areas (Figures 16, 17). It is mostly in cases where
only a biopsy of the tumour is available for examination that difficulty
in classifying the tumour ma^ not be overcome.
We have reclassified our tumours according to the FIGO
classification. The result is shown in Table VI.
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Table VI
Classification of the common epithelial tumours of the ovary-
Serous Mucinous Endometrioid Unclassified ! Total
Benign 292 kSk (592) - 756
Borderline 2k Ik 2 - ho I
f
Malignant 223 31 k& 15 317
TOTAL 539 509 50 15 1113
Attention may he drawn to the relatively small number of cases
in the borderline and the unclassified groups. Careful examination
will commonly help to place these cases in other appropriate groups.
Due to their potential of malignancy, we have included the borderline
cases in the group of ovarian adenocarcinoma in the general tabulation
of ovarian tumours.
Analysis of our figures suggests that the three groups of serous,
mucinous and endometrioid tumours (including endometrioid benign
cysts) occur with about equal frequency. If it is accepted that all
the three types generally arise from the surface epithelium of the
ovary, which retains its capacity to differentiate along Mitllerian
lines, then it is probable that this differentiation proceeds equally
to a tubal, endometrial or cervical pattern. The potential of
malignancy, however, differs markedly in the three groups. Most of
the mucinous and endometrioid growths are benign whereas almost half
the serous tumours are malignant.
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OVARIM TERATOMA
The following classification is suggested for the cases of
ovarian teratoma. It is modified from the classification outlined
by Peterson (1957).
1. "Benign cystic teratoma": This is a benign cyst containing
derivatives of two or three germ layers with differentiation and
maturity of tissue elements.
2. "Malignant transformation in a benign cystic teratoma": In this
type anaplastic changes are confined to a specific tissue element
or portion of that element, with the remaining tissue in the tumour
continuing to exhibit benign properties. This type should be
sharply distinguished from the next type, the solid malignant
teratoma.
3. "Malignant teratoma": This term should be restricted to the solid
tumour composed of derivatives of all three gem layers. Its
tissue elements show a varying degree of immaturity and lack of
differentiation. The so-called "solid histologically benign
teratoma" should be considered as a well-differentiated solid
malignant teratoma.
i+. "Teratoma with one-sided development": The well-knovm example of
tumours in this group is the teratomatous Struma Ovarii. Other
examples are debatable.
The frequency of the four types of the ovarian teratoma may be
described according to our previously outlined tabulation as follows.
The benign cystic teratoma is one of the common tumours of the ovary.
The struma ovarii is one of the uncommon tumours of the ovary. The
benign cystic teratoma with malignant transformation is one of the rare
tumours of the ovary. The malignant teratoma is one of the very rare
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tumours of the ovary. The frequency of these cases In our series
has already "been shown in Tahle V.
Benign cystic teratoma:
The benign cystic teratoma accounted in our series for 11+ per
cent of all ovarian tumours. It also accounted for 21+ per cent of
all benign neoplastic cysts. Below the age of 50 years, the benign
cystic teratoma accounted for about one third of all benign
neoplastic cysts. Table VII compares the age distribution in the
three types of benign neoplastic cysts of the ovary. The predilection
of the benign cystic teratoma to the childbearing period of age can
be seen.
Table VII
Age distribution of benign neoplastic cysts of the ovary
.
range 0CM1 -30 -1*0 -50 -60 60+ Total
1
! Serous
! cystadenoma 10-81 10 1+8 58 1+9 59 67 291
Mucinous
cystadenoma 16-92 6 70 70 98 102 116 1+62
IBenign cystic
teratoma 15-76 10 69 66 62 13 13 233
,
j TOTAL 10-92 26 187 191+ 209 171+ 196 986
The association of benign cystic teratoma of the ovary with pregnancy
is relatively not infrequent. Figure 18 shows such an example, with
pregnancy decidual reaction in the ovarian wall of the cyst.
Striking examples of the phenomenon of tissue correlation are
often seen in the benign teratoma. The well-known appearance of
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stratified squamous epithelium with sebacious glands, hair
follicles, sweat glands and adipose tissue is an example.
Respiratory epithelium is often associated with salivary mucous and
serous glands, cartilage and sometimes thyroid acini (Figure 19).
The development of bone marrow tissue in between the trabeculae of
bone may also be observed (Figure 20). The association of brain
tissue with choroid plexus structure and ependyma is not infrequent
(Figure 21). These tissue correlations may be looked upon as
abortive attempts towards organ formation. The foetiform nature
of teratomas has been the subject of controversy, in old times and
also recently. A discussion of this problem in the light of the
recently introduced methods of cytogenetic study will be presented
in another chapter in this thesis.
malignant transformation in a benign cystic teratoma:
Five examples of malignant transformation in a benign cystic
teratoma were encountered in this study. During the same period,
239 benign cysts were encountered, and the total number of malignant
ovarian tumours was 1+82. In the review of Peterson (1957)» the
overall incidence of malignant degeneration in a benign cystic
teratoma was 1*8 per cent. According to the same author, the
consensus of the literature £>laces the incidence in the neighbourhood
of 1*5 per cent of all ovarian malignancies. According to Matz
(1961), the vast majority of the reported cases were epidermoid
carcinomas (80 per cent); less commonly the tumour was an adeno¬
carcinoma, sarcoma (gliosarcoma, osteogenic sarcoma, melanosarcoma),
carcinoid, chorionepithelioma or malignant struma ovarii. Of our 5
cases, two were squamous cell carcinomas (Figure 22), two were
mucinous adenocarcinomas arising in gut epithelium (Figures 23, 21+)
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and one was an adenocarcinoma of doubtful origin. More recently,
I have encountered an example of the rare carcinoid tumour or
argentaffin carcinoma (Figures 25, 26), in relation to a benign
cystic teratoma.
It is worth remembering that the presence of a malignant tumour
in the same ovary as a benign cystic teratoma does not necessarily
mean the origin of this tumour in the tissues of the teratoma. If
the origin of the tumour from the teratoma is not demonstrable, and
the histological picture of the tumour is different from that of
primary malignant ovarian tumours, the possibility of secondary
tumours should be considered. I have recently seen an example of
secondary bronchial carcinoma in the ovary, in association with a
benign cystic teratoma. In another case, a disgerminoma was present
in association with a benign cystic teratoma. The latter
association and its possible significance will be referred to in
discussing the disgerrninoma.
The age incidence in our 5 cases of malignant transformation
in benign cystic teratoma ranged from 1+8 to 63 years. According to
the review of Peterson (1957), 63 per cent of reported cases were
over 1+0 years when the disease was discovered. This high age
incidence is in contrast to the commonly young age of the patients
with the malignant solid teratomas and emphasizes further the
distinction between the two groups.
Carcinoid tumours of the ovary are rare. In 1939, the first two
recorded cases of an argentaffin carcinoma occurring in the wall of
ovarian teratoma were reported by Stewart et al. (1939).
Occasional cases have been reported since then. Doucette and Estes
(1965) mentioned 16 reported cases of primary ovarian carcinoid tumours,
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13 of which have been associated with benign cystic teratomas.
The two authors presented a 14th case. The apparent teratomatous
tissue of origin of the carcinoid component, when recognized, was
gastro-intestinal in 6, respiratory in 5» and unspecified entodermal
in 1, An interesting aspect of these rare tumours is the possibility
of functioning activity leading to the well-known carcinoid syndrome.
The first report of flushing and cutaneous manifestations of
functioning argentaffin elements found solely in an ovarian tumour
was probably that of Kierland et al. (1958). It is worth
remembering functioning carcinoid tissue as another cause of vasomotor
symptoms in women. The presence of a palpable ovarian tumour co¬
incident with abnormal vaso-motor activity should arouse suspicion
concerning serotinin producing structures. The utilization of the
simple urinary test for 5-Hydroxy Indole Acetic Acid (5-HIAA) can be
of diagnostic help. In our carcinoid tumour, there was no definite
evidence that the tumour was functioning.
Solid malignant teratoma:
Malignant teratomas of the ovary are tumours composed of a
mixture of tissue forms, both mesenchymal and epithelial, of a
variable degree of differentiation and resembling the tissues of the
embryo. According to Murray and Hofmeister (1961), 5k cases have
been reported in the world literature. Bren and Neubecker (1963)*
reported another 17 cases. In our series, the solid malignant
teratoma was one of the very rare ovarian tumours. Only one case was
encountered. The teratomatous elements in this tumour were apparently
mature and of adult type. However, the recurrence of the tumour
proved its potential of malignancy. For its rarity and for its
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interesting features, this case will he discussed in detail under
the heading of very rare ovarian tumours, in another chapter of this
thesis.
More recently, I have seen two other cases of solid malignant
teratoma in the ovary. One was removed from a girl aged 10 years.
Most of the tissues of the tumour were poorly differentiated.
However, the picture was variable in different parts of the tumour.
Figure 27 for example shows mature epidermal tissue. Figure 28
from another part shows an extremely anaplastic pattern, with a
superficial resemblance to malignant trophoblast. Figure 29 from a
third part of the tumour may suggest the picture of disgerminoma,
another possibly germ cell tumour (Bren and Neubeeker 1963)* '-Che
other tumour, removed from a patient aged 39 years, showed well
differentiated teratomatous elements. The tumour was partly solid
and partly cystic (Figure 30). The cystic part, however, was lined
not by squamous epithelium but by neural tissue (Figure 31)
(Unfortunately, the composition of the fluid content of this cystic
part was not analysed). Figures 32-3U show tissues from the solid
part of the tumour. Figure 32 shows mature skin elements.
Figure 33 shows salivary glands and respiratory epithelium. Figure 3h
shows nerve ganglion from the muscle wall of a gut-like structure.
Struma Ovarii
The presence of thyroid tissue in a benign cystic teratoma is
not uncommon (in 19 per cent of cases according to EmgeJ19i|0). How¬
ever, the predominance of this tissue in the teratoma is uncommon.
Five cases in our series showed this picture of teratomatous struma
ovarii. In 13 other cases, no other teratomatous elements were seen
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in the available sections from the tumour. These cases may he
labelled "pure" struma ovarii, though admittedly a more thorough
examination may have probably revealed other teratomatous structures
in at least some of these cases.
It is not known why the thyroid tissue should occasionally
overgrow other elements in the teratoma of the ovary. The patterns
of age distribution do not appear to be the same in the struma ovarii
and the teratoma. In our series, all the cases of benign cystic
teratoma with the exception of 36 cases (out of 233) were encountered
between the ages of 20 and 50 years. Of the 18 cases of struma
ovarii, only 8 cases were encountered between the ages of 20 and 50
years. Nieminen et al. (1963) found the average age of their 19 cases
of struma ovarii to be 12 years higher than that expected for the
benign cystic teratoma. Another point that may be worthy of note
is that none of our cases of struma ovarii was bilateral. This was
also the experience of Nieminen et al. (1963)* The tendency of the
benign cystic teratoma to be bilateral is well-known.
Thyroid tissue in the ovary is liable to the same functional and
pathologic changes as thyroid tissue in the neck (Novak and Woodruff
1962). In one of our cases, the structure of the thyroid tissue
closely resembled that of the thyroid foetal adenoma (Figure 35).
One-sided development in the ovarian teratoma:
The predominance of one type of tissue in the benign cystic
teratoma is referred to as one-sided development. The predominance
of cutaneous tissue elements in the well-known dermoid cyst can
actually he regarded as an example of this phenomenon. The struma
ovarii is another well-known example. The solid sehacious gland
tumour of the ovary reported by Strauss and Gates (I96h) is probably
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another but unusual example. The very rare examples of non-
gestational choriocarcinoma of the ovary are also in this category.
The origin of other tumour types in the ovary as one-sided
development in teratomas is more debatable, and the concept has been
rather abused to explain the obscure origin of some ovarian tumours.
It is interesting to mention here only two tumour types: the
mucinous cystadenoma and the mesonephroma of Schiller. It has been
maintained that mucinous cystadenomas represent teratomas in which a
tall, columnar entodermic epithelium has overridden and blotted away
other tissues in the teratoma (Novak and Woodruff 1962). ?/illis
(I960), on the other hand, rejects this hypothesis. We have
encountered 9 examples of the association of mucinous cysts and
benign cystic teratomas, of which 7 were on the same side. The tumours
varied from a dermoid cyst with large mucinous locules to mucinous
cystadenomas with the dermoid cyst forming a small part of the tumour.
With the exception of these 9 cases, there was no suggestion, in our
U6i+ cases, of a teratomatous origin. It may be that a teratomatous
origin accounts for some of the cases of mucinous tumours in the
ovary. However, in the great majority of cases, evidence for such
an origin is not apparent. Demonstration of argentaffin or
argyrophil cells in some of these cases has been suggested as an
evidence for an enteroid origin (Pox et al. 1961+) #
The interpretation by Teilum of certain tumours,described as
mesonephromasby Schiller (1939),as extraembryonic mesoblastomas is
interesting. Teilum compares the structure of the tumour to the
extraembryonic mesoderm, with the epithelial spaces interpreted as
vitelline in character (Iviesoblastoma vitellinura, Teilum 1965). The
possibility that a tumour (apparently of teratomatous origin) may
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develop only the structure of extraembryonic mesoderm is worthy of
consideration. Teratomas, especially in the testis, may develop
mainly the structure of extra-embryonic ectoderm or trophoblast (the
chorionepithelioma). The interpretation of the mesonephroma of
Schiller will be referred to again in the chapter about the very
rare tumours.
BMNE3 TUMOUR
Our poor understanding of the nature of the Brenner tumour is
easily evident from the fact that it is the only primary ovarian
tumour that has no pathological designation, other than its eponymic
title. The interesting story behind this eponymic title was
revealed by Speert (1956). Dr. Fritz Brenner, who emigrated to
Africa before the first world war, was no more aware in 1956 than
his fellow general practitioners in Johannesburg, that his own name
was inseparably attached to the tumour he described long back in 19071
Brenner's original concept was that the tumour arose from the ovarian
follicular tissue: "Das oophoroma folliculare" (Brenner 1907).
Meyer (1932), in his classical paper on this tumour, sharply
differentiated it from the granulosa cell tumours, emphasized its
lack of endocrine activity, noted its association with the mucinous
cystadenoma, attributed its origin to Walthard nests and also
popularized the eponymic title of Brenner tumour. Since then, several
series and studies discussing this tumour and agreeing or diverging
from Meyer's concept have appeared in the literature. It is of
interest, at least historically, to note the recent trend of going
back to Brenner's original concept. Teoh (1953)» for example, states
his belief that Brenner's opinion, implied in his term "Oophoroma
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folliculare", that this tumour came from ovarian follicular tissue,
v?as correct and that the histo-genesis of the Brenner tumour is the
same as that of the granulosa-theca cell series of tumours and that
its "typical" structure which makes it appear to he distinct from
the "typical" granulosa cell tumours, is the result only of a change
in form with metaplasia of the epithelial cells.
In our series of 173U ovarian tumours, 31+ Brenner tupours were
encountered, an incidence of about 2 per cent. A notable feature,
however, was that in 18 of the 3k cases the ovary was not or only
slightly enlarged (Pigs. 36, 37). In one more case, it was an
accidental finding in the wall of a tubovarian abseess. The true
incidence of the Brenner tumour may possibly be more than these
figures indicate. Many of the small tumours can pass undetected.
Small tumours in the walls of large mucinous cystadenomas may also
be missed. A Brenner tumour with marked overgrowth of the
fibromatous tissue may also be reported as a simple ovarian fibroma.
The age of the patients ranged from 22 to 80 years with an
average of 1+6 years. Only two patients were below the age of i+O
years. The fact that these tumours are slowly growing and produce
symptoms mainly by their bulk can partly account for the late age of
clinical presentation. The age distribution in the small tumours
was not significantly different from that of the large tumours and
it appears that the difference between the two groups is a difference
in the rate or capacity of growth and not in the duration of the
tumour before discovery. Brenner tumours in association with
mucinous cystadenomas also showed the same high age incidence.
Only one tumour was bilateral in our series. This striking
tendency to unilaterality has also been the experience of other
2h
authors. Idelson (1963) could gather only a total of 33 bilateral
cases from the literature.
The gross appearance of the tumours varied. As already
mentioned, the tumour was an incidental pathological finding in a
more or less normal ovary in 18 cases. In 6 cases, the tumour was
an incidental finding in the wall of a mucinous cystadenoma. In
one case, the tumour was an incidental finding in the wall of a
tubovarian abscess. Thus, in only 9 cases was the tumour the
presenting feature of the case. In 6 of these, the tumour was
solid and fibroma-like on gross appearance while in the 3 remaining
cases the tumour was partly cystic.
The sites of the small Brenner tumours in the ovary are of
histogenetic significance. Figure 38 shows a small Brenner tumour
in the ovarian cortex near the surface of the ovary. An origin
from rete structures as suggested by Schiller (193U) is certainly
not applicable for this tumour. Figure 39, on the other hand, shows
a Brenner tumour in the hilum of the ovary, A diverse origin for the
Brenner tumour, as suggested by Greene (1952) may explain these
findings•
The malignant Brenner tumour is very rare. I made this
diagnosis in only one case. This will be considered together with
other very rare types of ovarian tumours in another part of this
thesis.
TH2 ADENOF IBROMA AN J CYriTADHNOF1320ka
Data about this group of tumours have been rather scanty in the
literature. Scott (19^2) could collect from the literature a total of
17 tumours of this distinct group (including the case of Wolfe 1927,
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as the only case previously reported in the English literature) and
added 11+ other cases. The study of Scott emphasized that these
tumours are of germinal epithelial origin with a close relationship
to serous cystadenomas and papillary fibromas and he suggested that
these tumours are to "be classified as a special type of epithelial
tumours of the ovary under the subhead of serous cystadenoma. With
the reports of McNulty (1959) and Rothman and Blumenthal (1959)* the
total number of reported cases was brought up to 68.
In our series of ovarian tumours, 50 cases of adenofibroma and
cystadenofibroma were encountered, an incidence of 2*8 per cent. It
should be noted, however, that 15 of the cases were encountered in
grossly normal ovaries.
The age of the patients ranged from 26 to 82 years with an
average of 1+9*3 years. This high age incidence is in agreement with
that reported by other authors. In the review of Scott (191+2),
93*5 per* cent of the patients were 1+0 years or over, and 61+*5 per
cent were 50 years of age or over. In the review of Rothman and
Blumenthal (1959)* 30 of the 1+3 coses were 50 years of age or over.
It is interesting to compare the age distribution of the adeno and
cystadenofibroma with that of the two related tumours, the serous
cystadenoma and the fibroma. This is shown in Table VIII. The
adenofibroma is more related in its age distribution to the fibroma.
Indeed, such high age incidence is usual for all fibromatous tumours
of the ovary as we have observed in the case of the Brenner tumour.
The gross appearance of the tumours varied. As already
mentioned, in 15 cases the tumours were incidental findings, producing
little or no ovarian enlargement (Figures i»Q, Ul). In 13 cases, the
tumour showed the gross picture of cystadenofibroma (at least one
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Table VIII
Age distribution of the serous cystadenoma, adeno- and cystadeno¬
fibroma and the ovarian fibroma








Cystadenofibroma 26-82 U9-3 88% 62%
Fibroma 20-81 88*1$ 71*5% j
fourth of the tumour mass was solid)# In 3 of these, the cysts
were also papuliferous. In the remaining 22 cases, the tumour
presented a fibroma-like appearance.
Microscopically, the tumours showed a variable quantitative
relationship of epithelial elements and fibromatous tissue. The
epithelial lining ranged from a flat type to a cubical or columnar,
sometimes tubal, type. Less commonly, however, the epithelium
showed endometrioid or mucinous areas. Calcified psammoma bodies
may also be noted.
Malignancy in the ovarian adeno- and cystadenofibroma has been
rarely reported. The original report of Scott (1942) included no
example of clinical or microscopical malignancy but he suggested
that the potentiality in this respect would appear to be as great as
in the serous cystadenoma and the fibroma. Minkowitz and Cohen
(1966) could collect from the literature only 9 instances of this
type of malignant transformation and in only two of these was the case
completely reported. They added to these one case of their own. Our
own observations in this aspect lead us to make a distinction between
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the potential of malignancy in the cystic part of the
cystadenofibroma and the potential of malignancy in the solid
fibroadenomatous part.
1. Malignant transformation in the eystadenofibroma, involving the
serous cyst, takes the form of the common papillary serous
cystadenocarcinoma and is usually not distinguishable from it*
When the growth is fairly advanced, its relation to the benign
cystadenofibroma may be lost. Figures U2 and 1+2+ illustrate two
examples in our series in which such a change was detected at an
early stage. Figure 1+2 shows a borderline papillary lesion in
benign cystadenofibroma. Figure 1+1+ shows an early polypoid
adenocarcinoma in one of the locules of a benign cystadenof'ibroma.
2. Malignant transformation in the solid adenofibromatous part may,
on theoretical grounds, implicate either the fibromatous or the
epithelial elements. Sarcomatous transformation in the ovarian
adenofibroma has not to our knowledge been reported, though it is
known in the analogous fibroadenoma of the breast.
In one of our cases, the stromal elements of the tumour showed
evidence of active proliferation, though not amounting to the degree
of sarcomatous change (Figure 1+3) • In this tumour thecal transformation
was marked in the stroma and the cystic part of the tumour showed a
borderline papillary lesion (Figure 1+2).
Squamous cell metaplasia and proliferation in the ovarian
adenofibroma have been described (Novak and Woodruff 1962). It is
quite possible, however, that these cases really represent endo-
metriomas with an inactive epithelium and a lacking stroma, especially
when they are encountered in patients past the menopause. Figures
2+5 ~ 1+8 illustrate two Interesting examples in our series. In
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Figures 45 and 2+6 the tumour was encountered as a localized nodule
in the wall of a mucinous cystadenoma. In Figures 47 and 48 the
tumour was encountered as a fibromatous area in association with a
serous papillary cystadenocarcinoma. These two examples may
illustrate the multiple MtfLlerian potentialities of the surface
epithelium of the ovary.
Apart from these cases of adenoacanthoma the epithelial elements
of the adenofibroma may undergo a frank carcinomatous change. This
change should be a very rare event. We have encountered only one
case in this series. More recently, we have diagnosed another case.
The histological picture is also rather distinctive, and it is this
type of tumour which deserves the designation as malignant adenofibroma.
In view of its extreme rarity, a more detailed description of this
type of tumour will be given together with the other very rare types
of ovarian tumours in another part of this thesis.
Till) OVARIAN FIBROMA
The relative frequency of the ovarian fibroma is not generally
realized. In our series, 135 cases were fibromas, an incidence of
7*7 per cent. Of these, however, 29 were encountered in normal-
sized ovaries (Figures 49, 50).
Clinically, solid ovarian tumours are regarded as suspicious of
malignancy. In our consecutive series, however, solid benign
ovarian tumours were not uncommon. If we exclude tumours detected
in clinically normal ovaries (as these have no diagnostic clinical
significance), the total number of cases of fibroma, adenofibroma,
Brenner tumour and thecoma was 165• The total number of primary
malignant ovarian tumours during the same period was 412. Of these,
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probably the majority were cystic (Novak and Woodruff 1962), The
solid benign tumours share the same high age incidence as the
malignant tumours, as we have shown in previous discussions. It may
be noted, however, that bilaterality is not as common in these benign
solid tumours as in the malignant tumours (Table II). Bilateral
solid tumours are more commonly malignant.
GRANULOSA AND THNCA CELL TUMOURS
In our material, the 58 cases of granulosa and theca cell
tumours accounted for 3*2 per cent of all ovarian tumours. Forty-one
of the cases were granulosa cell tumours and 17 were theca cell
tumours. Included in the granulosa cell tumours, however, are cases
showing prominent thecomatous tissue as well as the granulosal
elements. It should also be noted that it is sometimes difficult to
differentiate with certainty a granulosa cell tumour from a thecoma.
These are the cases in which the granulosa cells are diffusely
arranged with no definite structural pattern, follicular or trabecular.
Again, it should also be mentioned that the distinction between a
thecoma and a fibroma is not always sharp and perhaps a more thorough
examination of cases of fibroma may disclose more tumours with
thecomatous areas.
A comparison of the age distribution of the cases of granulosa
cell tumours and the theca cell tumours is shown in Table IX.
The later age incidence of thecomas is apparent in this table.
With the exception of one case of bilateral theca cell tumour,
all the tumours were unilateral.
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Table IX









Granulosa cell tumours 27-78 2 3 8 10 18 hi
Theca cell tumours 51-80 mm - mm 6 11 17
An interesting feature in this series was that in 16 of the
cases, the tumour was detected after operation in a clinically
normal ovary. These small tumours present several interesting
features. These will be the subject of a special study in another
chapter.
ARHHKN OBLASTOfcA
The arrhenoblastoma is one of the rare types of ovarian tumours.
Only 5 cases in our series were classified as arrhenoblastomas.
It has been customary to regard the arrhenoblastoma and the
granulosa cell tumours, as tumour types which are sharply distinct
in their morphology, histogenesis as well as in their endocrine
potential. This distinction does not seem now to be so exact. As
regards the endocrine potential, it has been suggested that both
types contain feminizing and masculinizing cells and so are potentially
bisexual. Thus, Teilum (19h9) recognizes the Sertoli cell as
feminizing and the Leydig cell as masculinizing. Shippel (1955)
recognizes the granulosa cell as feminizing and the theca cell as
masculinizing. As regards the histological distinction, most
gynaecological pathologists would admit that this is not easy in many
of the cases, Haines and Taylor (1962) recommend the term gonadal
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stromal tumour for the type of case in which differentiation is not
possible. Novak and Long (1965), after reviewing about 100
arrhenoblastomas from the ovarian tumour registry, have adopted a more
defeatist attitude and recommended the term gonadal stromal tumour
for all tumours of both groups, since morphological differentiation
seems futile. The old distinction in histogenesis also does not
seem to hold, since tumours showing mixed patterns are more frequent
than what was originally recognized. Mackinlay (1957) described
the presence of male cells in granulosa-theea cell tumours and
recommended the deletion of the term arrhenoblastoma. Warner et al.
(i960), on the other hand, recommended the generic title of
gynandroblastoma for both tumour types.
We have seen examples of tumours of apparently granulosa cell
type which show in areas a picture comparable to that of the
arrhenoblastoma (Figures 51 and 52). We have also seen examples of
tumours in which neither the histological picture nor the endocrine
potential could decide whether the tumour was a granulosa cell tumour
or an arrhenoblastoma and the diagnosis was really anybody's guess
(Figures 53» 5h)• Granulosa cell tumours, however, may show a
distinctive folliculoid pattern that is not present in an
arrheaoblastoma. It may be concluded that the arrhenoblastoma and
the granulosa cell tumour are better regarded as examples of
divergent differentiation of the tumour of the gonadal stroma, rather
than as separate tumour entities.
Attempts to correlate the histological structure with the
endocrine potential are certainly futile. It is not necessary for
an ovarian tumour to reproduce the structure of the testis in order
to secrete androgens. In fact, it is not the testicular parenchyma
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"but the interstital tissue which is responsible for hormone
production. The "masculinizing" arrhenoblastomas really hardly
resemble the testicular structure (Figure 55). It was only by a
stretch of imagination and by including cases of testicular tubular
adenoma that Robert Meyer could elaborate his hypothesis (Meyer,
1931b). The status of the testicular tubular adenoma as an
ovarian tumour has been recently questioned in the light of recent
knowledge of intersex states. The presence of testicular-like
tissue in the gonad may have as its basis an underlying intersex
state and not abnormal tumour differentiation of the ovary. These
cytogenetic aspects of the arrhenoblastoma will be dealt with in
further detail in another part of this thesis.
DlSOmi INOMA
The disgerminoma is one of the rare ovarian tumours. Only
3 cases are included in this series.
One of the cases showed abnormally high gonadotrophin titres.
This case has been reported in full by Hobson and Baird (1966). In
another case, the tumour was encountered in association with a benign
cystic teratoma in the same ovary. This association is rare, as
evidenced by the review of Mueller et al. (1950) who found only 3
examples of the association in 1+27 cases of disgerminoma in the
literature. In the testis, the coexistence of seminoma and
teratoma is not uncommon. ¥lillis (i960) believes that the association
cannot be regarded as fortuitious in the testis but does not believe
in a common origin for the two tumours and he suggests that mal-
development of the testis predisposes to both neoplasms. Other
authors consider such associations as an evidence for the germ cell
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origin of "both tumour types (Bren and Neubecker 1963).
The relationship of the disgerminoma to intersex states will
be discussed fully in another chapter of this thesis.
LIPOID CELL TUMOURS
The generic title, lipoid cell tumours, is used to refer to
certain types of ovarian tumours with a high lipoid content
(Haines and Taylor, 1962). These tumours are generally composed of
large, rounded or polyhedral cells that resemble Leydig, lutein and
adreno-cortical cells. It is doubtful, however, whether a
histological distinction can be made with any certainty between these
types of cells. It is also doubtful vdiether adrenal rests give rise
to ovarian tumours (Hughesdon, 5-966).
Lipoid cell tumours of the ovary are rare. Hughesdon (1966)
could collect from the literature only 109 cases. We have
encountered 3 examples of these tumours in our series. We inter¬
preted two of these as hilus cell tumours and the third as a
luteinized thecoma. It is interesting to note that our two cases of
hilus cell tumours presented with postmenopausal bleeding and
endometrial hyperplasia and showed no evidence of masculinization
(Figures 56-59). Novak and Mattingly (i960) observed that a
hyperplastic endometrial pattern was present in all the cases of
hilus cell tumours included in their review, whenever the endometrium
had been available for examination. In the third example of lipoid
cell tumours in our series, the tumour was encountered in the ovarian
cortex as a small nodule, detected only when the ovary was sectioned
after operation (Figures 60-62). The endometrium showed post¬
menopausal atrophy in this case. These 3 cases illustrate the lack
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of correlation between the histological pattern and the endocrine
potential in these types of ovarian tumours.
3 ovarian tulours
In clinical material, secondary ovarian tumours are uncommon.
In fact the cases that are liable to be encountered fall mostly in
one of the following two groups:
1. Cases of genital malignancy in which the ovaries are removed as
part of the operation. Cases of breast carcinoma with oophorectomy
carried out as a line of treatment also fall in this group.
2. Secondary tumours presenting as ovarian tumours with the primary
lesion not evident clinically. In these cases, the nature of the
tumour may be revealed during the operation or more commonly after
pathological examination. This group includes, among others, the
famous KriJkenberg tumours. Rarely, cases of carcinoma of the body
of the uterus may present with large ovarian tumours when the primary
endometrial lesion is still small and localized. In these cases,
however, it may be difficult to decide whether the ovarian tumour Is
primary or secondary. Primary malignant ovarian tumours of
endometrioid character are not uncommon. In h of our U1 cases of
ovarian secondary endometrial carcinoma, the endometrial growth was
early and with no definite evidence or with only minimal evidence of
invasion. In one of these h cases, the adenocarcinoma was present
in the curettings only and the removed uterus showed no further
evidence of the tumour.
The distribution of the cases of secondary ovarian tumours in
our series was as follows:
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A Biostatistical and General Survey of a consecutive series
of 173^4- ovarian tumours is presented.
1. The incidence of ovarian tumours in routine gynaecological
pathology material was 2*7 per cent.
2. The age of the patients ranged from 10 to 92 years. The number
of cases increased with age. The behaviour of benign and
malignant tumours was, however, different. After a steep rise in
the number of cases in the third decade, the increase in the
number of benign tumours with age was not marked. In the case of
malignant tumours, on the other hand, the increase in the number
of cases with age was more marked and a steep rise occurred in the
5th decade. The percentage of malignant tumours was relatively
high below the age of 20 years (due to the rarity of benign tumours,
not to the frequency of malignant tumours). The percentage fell
in the next two decades (due to the frequency of benign tumours
and also the relative rarity of malignant tumours). After the
Uth decade, the percentage of malignant tumours rose again (due
to the rather steady number of benign tumours and the rapidly
increasing number of malignant tumours).
3. The overall incidence of bilaterality in our series was 12 per cent.
Although primary malignant tumours were nearly three times as
commonly bilateral as benign tumours, the chance of a primary
bilateral tumour being benign was about as equal to its chance of
being malignant, due to the much more relative frequency of benign
tumours. The incidence of bilaterality in ovarian tumours was
nearly doubled after the age of I4O years. In benign tumours, the
increase in incidence of bilaterality was marked only after the
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sixth decade. A bilateral ovarian tumour was more commonly
malignant in the 4th and 5th decades only. Sarlier, bilateral
tumours were more commonly benign. Later, the chance was almost
equal. Cases of heterogenous bllaterality were also encountered.
4. According to their relative frequency, ovarian tumours were
tabulated into four groups: common, uncommon, rare and very rare
tumours.
5. General observations on the various types of ovarian tumours






THE ORIGIN OF MALIG8JAKT OVARIM TUMOURS IN ENDOMETRIOSIS
It is now 1+0 years since Sampson (1921*, 1925) first pointed
out the possibility of malignant transformation in ovarian
endometriosis. However, its frequency and clinical and pathological
characteristics remain widely unrecognised. Pew studies have been
made on this problem and most of the literature on the subject has
been limited to the reporting of isolated cases.
Recent interest in the problem has been aroused by the more
general realization among pathologists of the frequency with which
endometrial-like adenocarcinoma is encountered among cases of
primary ovarian carcinoma (Long and Taylor, 1961+). The introduction
of a new group, termed "endometrioid", into the histological
classification of the common primary epithelial tumours of the ovary
has already been discussed in the previous chapter. The frequency
of tumours so designated was considered to warrant the status of a
separate group.
As Sampson (1925) rightly pointed out, there are two methods for
attacking the problem of the development of malignant transformation
in ovarian endometriosis: either to study cases of benign
endometriosis in an endeavour to find early malignant changes in them
or to study cases of ovarian carcinoma to ascertain whether or not
the carcinoma could have arisen in misplaced endometrial tissue.
In our study of this problem, we decided to follow both lines of
approach.
Material
This study is based on the histological material in the
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laboratory during a period of 10 years, 195*+ - 1963 ♦ Apart from
a critical examination of the 1+18 primary malignant tumours
encountered during this period for evidence of a possible or
definite origin in endometriosis, we also reviewed all the cases
of ovarian endometriosis during the same period. Among the total
of 62,938 cases reported on during this period, there were 637 cases
of ovarian endometriosis. In 1+5 of these, however, the diagnosis
was only presumptive, due to the absence of well-defined endometrial
elements. In the remaining 592 cases the slides were reviewed for
evidence of pre-malignant or early malignant changes.
Results
Ovarian endometriosis
Atypical epithelinm was encountered in four endometrial cysts,
but without definite evidence of malignancy with stromal invasion.
Heaping up in layers, cellular pleomorphism, variations in the size
of the nuclei, nuclear hyperchromatism and mitotic figures were
noted to variable degrees in these cases (Figure 63)• The ages of
the four patients were 1+5» 1+8, 55 and 66 years and two of them were
six and ten years postmenopausal.
Another interesting observation was the presence of postmeno¬
pausal benign hyperplasia in two cases of ovarian endometriosis
associated with the presence of a granulosa-theea cell tumour in the
opposite ovary. The two patients were 12 and 15 years postmenopausal.
The association of endometriosis with an ovarian tumour in the
same and/or the opposite ovary was observed in 52 cases. In 21 of
these, the tumour was malignant and of these, seven cases showed both
the endometriosis and the malignant tumour in the same ovary. The
1+0
malignant tumours in these seven cases were two adenoacanthomas,
four endometrioid adenocarcinomas and one mesodermal mixed tumour.
Definite evidence for the origin of the tumour in endometriosis
could be established for the two adenoacanthomas and for two
endometrioid carcinomas. These cases will be considered further in
the next section.
Primary malignant ovarian tumours
In the survey of 1+18 primary malignant ovarian tumours, we
classified 52 cases as having a histological appearance similar to
that of malignant tumours of the uterine endometrium. Of these,
12 were adenoacanthomas, 38 were adenocarcinomas and two were
mesodermal mixed tumours. These malignant "endometrioid" tumours
thus accounted for about 12 per cent of all primary malignant tumours
of the ovary in our series. However,unfortunately the uterus was
not available for examination in 17 of these cases - three
adenoacanthomas and 11+ adenocarcinomas. In these cases, the
possibility of a metastatic spread from a primary uterine tumour
cannot be excluded on histological review,
Adenoacanthoma:
Of the 12 cases, two were shown to develop in endometrial cysts.
Endometriosis was present in the opposite ovary in two other cases but
could not be demonstrated in the same ovary. In four cases, the
opposite ovary was not available for examination. In two instances,
the adenoacanthoma was encountered as an accidental pathological
finding. The first was encountered as a localized nodule in the wall
of a benign mucinous cystadenoma (Pigs. 1+5,1+$. An additional
interesting feature in this case was the presence of a few areas of
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squamous metaplasia in the benign proliferative uterine endometrium
(Figure 7U). The second case occurred as a fibrous area in the
wall of a serous papillary cystadenocarcinoma (Figures U7» h8). In
both cases, no definite evidence of benign endometriosis with
endometrial stroma could be demonstrated, and the cases were classified
as adenoacanthoma developing in adenofibroma. A brief report of the
two cases of definite malignant transformation in endometrial cysts
will now be given#
Case reports
Case 1: (Serial number E 913» F 990) Mrs. H.D., aged 51 years,
nulliparous and two years postmenopausal, was operated upon with
the diagnosis of uterine fibromyomata and ovarian endometriosis.
A total hysterectomy with bilateral salpingo-oophorectomy was
performed. Eighteen months later the patient returned with abdominal
pain, a lump and urinary frequency. Laparotomy was carried out and
a bilocular completely encapsulated cyst about 10 cm. in diameter
was removed from the site of the right broad ligament. During
removal, one loculus ruptured with escape of chocolate brown fluid.
Review of the previous sections from the ovary one and a half years
before revealed the presence of an early endometrial carcinoma in an
endometrial cyst (Figures 6kt 65). Gross pathological examination
of the second specimen showed the presence of intracystic papillae
and suggested the appearance of an endometrial cyst. Sections from
the tumour, on review, were diagnosed as showing adenoacanthoma.
An interesting feature was the apparent malignant nature of both the
glandular and squamous elements in this tumour (Figure 67). No
definitely benign endometrial tissue was encountered in the sections
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available from this second tumour, but the cyst was partly lined
by a broad zone of pseudo-xanthoma cells (Figure 66) and old
haemorrhages were abundant in the stroma. One may be inclined,
however, to interpret the second tumour in this case as representing
malignant transformation in an endometriotic lesion left from the
previous operation, rather than a recurrence of the first localized
growth.
Case 2: (serial No. F 9700) Mrs. W.B., aged li7 years, was
operated upon for an asymptomatic abdominal mass. An adherent
right ovarian cyst was found as well as an anterior wall fibroid.
The cyst ruptured during removal with the escape of brownish
stained fluid and pieces of friable tissue. Subtotal hysterectomy
with bilateral salpingo-oophorectomy was carried out and the patient
received a post-operative course of deep X-ray therapy. Three years
later, when the patient was last seen, there was no evidence of any
recurrence. Pathological examination of the cyst showed a
localized papillary adenoacanthoma (Figure 68). The rest of the
cyst wall showed some atrophic endometrial glands but the lining
epithelium was largely replaced by a broad zone of pseudo-xanthoma
cells. The other ovary contained a small blood cyst.
Endometrioid adenocarcinoma:
The histopathological characteristic of endometrioid carcinoma
of the ovary, as distinct from the more common serous cystadeno-
carcinoma, have been outlined by Long and Taylor (196U) as follows:
1. Glandular type of cellular arrangement.
2. A more blunt appearance of papillary extensions. The papillary
serous cystadenocarcinoma is characterized by fine branching
papillae•
1+3
3. The "border of the multi-layered endometrial growth has a less
uneven appearance than that seen in the serous type in which the
margin projects in a more papillary pattern.
1+. Presence of squamous metaplasia or acanthosis.
Evidence of "benign endometriosis was demonstrable in the same
ovary in four of our cases of endometrioid carcinoma. In two of
these, the carcinoma could be clearly shown to be arising from the
endometriosis. In the other two cases, the relation was highly
suggestive but not definite. Endometriosis was encountered in the
opposite ovary but not on the side of the tumour in four other cases.
In one of these, the endometriosis showed pronounced cystic hyperplasia.
The opposite ovary was available for examination in 15 cases. A
brief report of the two cases of definite malignant transformation in
endometrial cysts will now be given.
Case reports
! Case 3: {serial no. F 2839) Miss J.L., aged 1+6 years, presented
with acute abdominal pain and a tender pelvi-abdominal mass.
Laparotomy showed that the peritoneal cavity was filled with a light
brovm opaque fluid, having its source from a ruptured left ovarian
cyst. The cyst was thick walled, adherent and still distended to
about the size of a grapefruit by some brown thick fluid.
Pathological examination of the removed cyst showed that it was an
endometrial cyst with areas of endometrial cystic hyperplasia and
areas of papillary adenocarcinoma (Figure 69).
Case 1+: (serial no. G 2361+) Miss B.S., aged 37 years,
presented with recurrent attacks of hypogastric pain and an enlarging
abdominal lump. A left ovarian cyst, together with the uterus and
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the right ovary were removed. The cyst was about 15 cm. in
diameter and contained copious amounts of dark fluid. Multiple
small papillomata were seen to fill almost half the cyst cavity.
Microscopical study showed a papillary endometrioid adenocarcinoma
arising into and continuous with the benign epithelial lining of an
endometrial cyst (Figures 70, 71). The opposite ovary was the
seat of endometriosis.
Mesodermal mixed tumours
Primary mesodermal mixed tumours of the ovary are extremely
rare. Two cases in our series were so diagnosed, on re-evaluation
of the pathological sections of the tumours. The fact that these
tumours are usually uterine justifies their classification as one
type of endometrioid tumours of the ovary. A detailed report of
the two cases will be given in another chapter, under the heading of
very rare ovarian tumours. It may be mentioned here, however, that
in one of the two cases one part of the tumour showed the picture
of a benign adenomyoma. Unfortunately, however, in the absence of
the original specimen, we could not demonstrate to our satisfaction
a transition between the benign and malignant areas.
DISCUSSION
Sampson has the credit of first pointing out the possibility of
malignant transformation in ovarian endometriosis (Sampson 1921+).
He noted the similarity of some cases of primary ovarian carcinoma
to endometrial carcinoma, and suggested that these may have arisen
in ovarian endometriosis. In 1925, Sampson tried to prove his
thesis by presenting 7 cases of primary ovarian carcinoma in which he
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thought such an origin was possible. He also pointed out the
difficulties of proving beyond doubt the origin of an ovarian
carcinoma from pre-existent endometriosis: "Not only is there
needed the actual demonstration of both cancer and endometrial
tissue in the same ovary, the two bearing the same histologic
relation to each other that cancer of the body of the uterus bears
to the non-malignant portions of the endometrium of that uterus,
in order to indicate the possible origin of ovarian carcinoma in
this tissue but, to make it conclusive, it must be shown that the
cancer arose in this tissue and that it is not invading it from
some other source." Only one of Sampson's 7 cases can be said to
have satisfied these criteria. However, this was enough to prove
his thesis.
In spite of the writings of Sampson, some pathologists remained
unconvinced with the possibility of malignant transformation in
ovarian endometriosis. Among them, was the great pathologist
Robert Meyer who also reviewed the slides of Sampson's cases
(Thompson 1957). It was not till after about 20 years that other
authentic cases began to appear and nowadays there is no doubt among
all pathologists that ovarian endometriosis may turn malignant. To
the criteria of Sampson, already mentioned, Scott (1953) suggested
that "ideally, an additional qualification might be added: a
microscopic section must show the benign endometriosis running into
and continuous with the malignant epithelium," though he admitted that
"for obvious reasons, this final limitation would be drawing much too
fine a line." All these strict criteria have been fulfilled in
several of the reported cases.
Malignant transformation has also been reported in other sites
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of endometriosis, apart from the ovary: in the recto-vaginal
septum (Perreira and Clayton 1958, Lash and Rubenstone 1959,
Dockerty et al. 195U), in the uterus (Greene 1961, Dockerty 1962),
in the intestine (Weinrod et al. 1956), in the umbilicus (Novak and
Woodruff 1962), in an obturator lymph node (Koss 1963). Several
other examples can be sited.
To go back to our results, we have noticed in reviewing cases
of ovarian endometriosis that anaplastic changes may be encountered,
rarely, in benign cysts. We have also seen that endometriosis in
postmenopausal women retains its capacity for active growth, given
the proper stimulus, as happened in two of our cases in association
with granulosa-theca cell tumours. Complying with the strict
criteria for diagnosing the definite origin of a malignant tumour in
ovarian endometriosis, we could diagnose four of our primary
ovarian carcinomas to be arising in endometriosis.
The real incidence, however, may be higher than what can be
gathered from these proven cases only. It is possible that besides
these cases vdiich retain a definite evidence of their origin,
several others arising in the same way may have all traces of their
origin obliterated by spread of the malignant growth. Malignant
ovarian tumours histologically similar to endometrial growths are
not infrequent. Search for such cases among our material showed
that they accounted for about 12 per cent of all primary malignant
tumours of the ovary. This group was found to include 12 cases of
adenoacanthoma, 38 cases of adenocarcinoma of endometrioid pattern
and two interesting cases histologically identical with the mesodermal
mixed tumours of the uterus. Although an origin from endometriosis
for these cases may be suggested, it is possible that they can arise
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directly from the ovarian serosa without the intermediary of
endometriosis.
Although Thompson (1957) concluded that almost all cases of
primary ovarian adenoacanthoma arise in ovarian endometriosis,
De Santo et al. (1959) interpreted their cases as a form of serous
carcinoma. In our series, the finding of an adenoacanthoma in
association with a mucinous cystadenoma in one case and with a
serous cystadenocarcinoma in another case (Figures 14.5-1+8) may point
to a possible common stem of origin for the three tumour types.
An example of an adenoacanthoma in which evidence of endometriosis
was lacking is shown in Figure 72.
The series of endometrioid carcinoma reported by Long and
Taylor (1961+) was the first series of this newly recognized group
to be reported. The authors estimated the incidence of this group
as about 17 per cent of all primary malignant tumours of the ovary
and suggested an origin from the ovarian surface epithelium either
directly or indirectly from benign endometriosis, implying that the
ovarian serosa may retain the embryologic potential of the coelomic
epithelium to differentiate into various tissues including uterine
epithelium.
We would like to point out here some of the difficulties that
may be encountered in classifying some ovarian carcinomas as of
endometrioid pattern. Some of these difficulties have been pointed
out by Long and Taylor (1961+) and by Scully et al. (1966).
1. Occasional cases of ovarian carcinoma present difficulty in
classification. These are usually those which are either
undifferentiated or show a mixed pattern of differentiation. In
undifferentiated tumours, a more thorough examination of other
U-8
parts may give a clue (Figures 16, 17). In tumours showing a
mixed pattern (Figures 11+, 15)» the predominant pattern is
usually accepted.
Endometrial carcinoma in the uterus, though commonly typical, is
not always so. A mucinous type of endometrial carcinoma may
rarely he noted (Haines and Taylor 1962). It is interesting to
note that in malignant transformation in ovarian endometriosis,
areas of mucinous carcinoma were noted by Moss and Runals (19U8).
Another unusual pattern in endometrial carcinoma of the uterus
is the clear cell type suggestive of a mesonephric origin
(Rutledge et al. 1965)• It is interesting to note that in some
cases of malignant transformation in ovarian endometriosis, this
pattern has been noted (Plate, 1966, Gray and Barnes 1966, Scully
et al. 1966). Scully et al. (1966) believe that the occurrence
of clear cell carcinomas of the type often regarded as mesonephric
in the endometrium and in ovarian endometriosis raises doubt
concerning the mesonephric origin of tumours of similar appearance
that are encountered in the ovary, broad ligament, cervix and
vagina in the absence of a demonstrable relationship to
endometriosis. In spite of these occasional aberrant
differentiations in endometrial carcinoma of the uterus, in
classifying cases of ovarian carcinoma as being of endometrioid
pattern one has to consider only the typical and usual pattern.
The presence of endometrial carcinoma in the uterus in association
with endometrioid carcinoma in the ovary raises doubt whether the
ovarian tumour is primary or secondary. Several authors would
accept that the ovarian tumour is primary if the endometrial
carcinoma is disproportionately small, low-grade and no more than
k9
minimally invasive of the myometrium (Long and Taylor 196L,
Scully et al. 1966, Schueller and Klrol 1966)* In 5 out of the 17
cases of primary ovarian endometrioid carcinoma, so classified "by
Scully et al. (1966), there was an associated endometrial
adenocarcinoma in the uterus.
Apart from the possible relationship to endometriosis,
recognizing the cases of endometrioid carcinoma of the ovary in a
separate group may have a clinical value. Thus, a better prognosis
has been described for these cases (Long and Taylor 1961}., Schueller
and Kirol 1966). Long and Taylor (1961}.) found a 5 year survival
rate of 70 per cent in their series. A conservative management in
cases of ovarian adenoacanthoma was compatible with long periods of
survival (Thompson 1957). Again, there may be a place for the use
of progestational drugs in the treatment of advanced cases of
endometrioid carcinoma of the ovary, in the way they are used for
advanced endometrial carcinoma of the uterus (Anderson 1965).
Ovarian tumours resembling the mesodermal mixed tumours of
the uterus have been very rarely encountered. The recent trend in
the histogenesis of these peculiar tumours is to regard them as of
endometrial stromal derivation (Willis i960). In the ovary, Willis
(i960) expressed his view that they undoubtedly arise from foci of
endometriosis. Cases of carcinosarcoma have in fact been
occasionally reported in relation to ovarian endometriosis (Tuthill,
1938; MacFarlane and Pritchard, 195k; Marcella and Cromer, 1959).
In one of our two cases, the origin from endometriosis was highly
likely, although not definitely proved. Sternberg (1963), however,
although admitting the theoretical possibility of the origin of these
tumours from endometriosis, states that proof is lacking and classifies
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them as of coelomic epithelial origin differentiating as a mixture
of malignant Mtfllerian tissues.
In discussing the various types of malignant tumours to which
the endometrium may give rise, the endometrial stromal sarcoma may
also he mentioned. Sarcomatous transformation in endometriosis
has "been occasionally observed in the colon (Perraro et al. 1956),
in the rectum (Mallory, 1936) and in pelvic endometriosis (Pava
et al. 1963)# Cases have also been reported as stromal
endometriosis, in uterine adenomyosis (Hunter and Lattig, 1958)
and in ovarian endometriosis (Koller and Rygh, I960; Benjamin and
Campbell, I960).
The origin of benign ovarian tumours in endometriosis has
been suggested. Corner et al. (1950) and Scully et al. (1966)
described mucinous cystadenomas arising in ovarian endometriosis.
In conclusion, it may be fair to say that in the present
state of our knowledge the incidence of malignant transformation
in ovarian endometriosis can only be put down in a vague and
approximate way as lying somewhere between a minimum including only
the definite cases and a maximum including all the cases showing a
histological picture compatible with an endometrial origin.
Review of reported cases of malignant transformation in ovarian
endometriosis
It is interesting to analyse the cases of definite malignant
transformation in ovarian endometriosis in an attempt to define their
clinical and pathological features. For this purpose, we added to
our four definite cases, -UB other cases from the literature (Sampson
1925, case 5; Tuthill 1938; McCullough et al. 19*+6; Teilum 19*1.6;
Novak 19*1-7; Kuzma 19*1-7» case 1; Miller et al. 19*v7; Rauramo 19*1-7;
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Moss and Runals 1948; Comer et al. 1950, cases 4 and 5; Bacher
and Hertzog 1951; Scott 1953, case 3; Fredrikson 1953# case 1;
Hunter and Klein 1954, cases 1 and 2; Dockerty 1954, 2 cases;
Postoloff and Rodenberg 1955; Kumar et al. 1955; Weinrod et al.
1956; Thompson 1957, cases 3, 5, 7, 10, 14 and 17; Greene and
Enterline 1957, cases 1 and 2; Ferriera and Clayton, 1958; Wade
I960; Burt and Emson 1961, 3 cases; Concannon et al. 1962;
Dockerty 1962, cases 5, 6, 7, 8 and 9; Freedman et al. 1964;
Gray and Barnes 1965, cases 1, 2, 4 and 5; Ridley 1966; Plate
1966; Cbstet. Gynec. Survey, 1966). This is not meant, however,
to be a comprehensive review of all reported cases, though it
probably includes all acceptable cases in the English literature.
A summary of the features of these cases is given in Table X.
Age
The age of the patients ranged widely from 19 to 61 years.
19 years 1 case
20 - 29 " 3 cases
30 - 39 " 12 "
40 - 49 " 18 "
50 - 59 " 14 "
60 - 61 " 2 "
Age not stated 2 "
Endometriosis apparently may turn malignant long after the
menopause and the cessation of ovarian activity. However, 16 out of
the 52 cases were encountered in patients below the age of 40 years.
This relatively high ratio of patients in the younger age groups is
probably more apparent than real. This is because the slowly
growing adenoacanthoma is more commonly encountered in the younger
age groups and it is this type of tumour which is more liable to
keep intact its histogenetic origin than the more rapidly growing
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adenocarcinoma which is more common in the older age groups. The
19 year old patient had a carcino-sarcoma.
Parity
Twenty two patients out of hh in whom the parity was knov/n
were nulliparous and none of the patients had more than three
pregnancies.
Clinical features
The frequency of the leading symptoms was as follows:
Pain 23 cases
Lump or abdominal enlargement 19 cases
Uterine bleeding 12 cases
Urinary symptoms 6 cases
Asymptomatic 6 cases
Not stated 2 cases
Pain was the most frequent presenting symptom. Judging from
the gross appearance of the endometrial cysts in these cases, where
the malignant growth was almost invariably a more or less small mass,
the pain apparently had a similar mechanism to the pain in cases of
benign endometriosis, being caused by bleeding from the endometrium
inside the cyst. Variations in the pattern of the pain can also be
explained by variations in the pattern of bleeding from the malignant
endometrium. Different from the periodic menstrual-related pain
typical of benign endometriosis, the pain in these cases was
frequently more or less continuous and when intermittent attacks
were experienced, they were not related to menstruation. In some
cases, the patient began to get attacks of pain after the menopause.
Progressive increase in the severity of the pain was possibly also
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related to an increase in the degree of "bleeding. A practical
suggestion out of these observations is that the possibility of
malignant transformation should be considered in the patient known
to have endometriosis, if the typical periodic pattern of pain
changes, if the pain increases abruptly in severity or if attacks of
pain start after the menopause.
In some cases, the cyst enlarged to form an abdominal lump or
to cause a feeling of abdominal enlargement without causing any
marked pain. Commonly, however, the patient complained of both
pain and the feeling of a lump. The abdominal lump may be noticed
to develop rapidly (Welnrod et al. 1956). The enlargement of the
endometrial cyst was not caused by the bulk of the malignant growth
which was almost invariably small in these cases but by distension
due to bleeding from the malignant endometrium. The detection of
an enlarging mass in a patient known to have endometriosis may
direct attention to the possibility of malignant transformation
(Dockerty 1962, case 7),
In one of our cases, and in two other cases (Teilum, 19U6;
Dockerty 1962, case 5)» the patient presented with acute abdominal
pain which proved on emergency laparotomy to be caused by rupture
of an endometrial cyst that had undergone malignant transformation.
Acute spontaneous rupture of ovarian endometrial cysts is a rare
condition (Koskela, 196/4-) • Pregnancy is the only significant factor
predisposing to rupture which has been hitherto described (Scott,
19/414.). We would like to stress malignant transformation as another
possible predisposing cause for acute rupture of endometrial cysts
that should be carefully excluded in all such cases.
The three features of pain, an enlarging lump and spontaneous
5k
rupture have the common underlying factor of intra-cystic bleeding
from the malignant endometrium# A marked tendency for the
malignant endometrium to bleed inside the endometrial cyst seems to
play an important role in detecting these cases at an early stage#
It is possible that some cases would lack such a feature, and in
these as well as in malignant transformation developing in non-cystic
endometriosis, the tumour may only be detected at a later stage.
An interesting symptom was uterine bleeding, often associated
with the presence of endometrial polypi. Out of 30 cases in which
the endometrial picture was reported, the endometrium was described
as hyperplastic in 15 cases. This observation may possibly be
looked upon as reflecting the response of the endometrium, in
different locations, to a common stimulus, and we may recall here
that in one of our cases of primary adenoacanthoma of the ovary, areas
of squamous metaplasia were encountered in the benign uterine
endometrium (Figures 73» 7k) • whatever the explanation of this
observation may be, uterine bleeding was apparently responsible for
bringing a number of these cases to early notice.
In 6 cases the condition was asymptomatic. The case of
Novak (19U7) was operated upon because of the presence of a pelvic
mass. The patient of Miller et al. (I9b7) bad an asymptomatic mass.
The case of Postoloff and Rodenberg (1955) was detected daring
examination for stress incontinence, and case 10 of Thompson (1957)
during investigation of infertility. The appearance of a tender
adnexal mass, in a patient known to have endometriosis, decided
laparotomy in case 7 of Dockerty (1962), In one of our cases,
operation was done for an asymptomatic pelvi-abdominal mass.
Again, it should he mentioned that tnese patterns of clinical
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presentation were only those of the cases encountered at a
sufficiently early stage to demonstrate their definite origin from
endometriosis. It is possible that other cases without these
symptoms may not be detected till a later stage when all evidence
of their origin would have been eradicated.
Operative findings
At the time of operation, suspicion of the endometriotic origin
of an ovarian malignant growth may be aroused by two factors which
were almost constant in the reported cases: marked adhesions (not
due to the extension of the growth) and the brownish colour of the
fluid content of the cyst (observed when the cyst is opened after
removal, aspirated or, as happened unfortunately frequently,
inadvertently ruptured during removal). The presence of other
stigmata of pelvic endometriosis will provide an additional feature
but was not common in the reported cases.
Side of the tumour
In 23 cases the tumour was in the right ovary and in 17 cases
in the left. In 7 cases, the tumour was bilateral. In only one
of these (Corner et al. 1950, case 5) the bilateral!ty was
interpreted as due to spread from one ovary to the other. The
remaining cases were interpreted as separate primaries arising in
bilateral endometriosis.
Gross pathological picture
The malignant endometrial cysts commonly showed one or more










The presence of any of these features in an endometrial cyst
should raise suspicion about malignant transformation. These
features can also be correlated with the clinical picture. The
tendency of the growth to project inside the cyst favours the
development of intra-cystic bleeding with its previously discussed
sequelae. The size of the cyst deserves further comment. A large
size is very unusual for benign endometrial cysts; the largest
encountered by Sampson was 15 cm. in diameter (Sampson 1925)•
Malignant endometrial cysts, on the other hand, may reach very large
sizes, apparently due to recurrent bleeding from the endometrium.
The cyst reported by McCullough et al. (191+6) contained about i+,000 ml.
of dark brown fluid, and in case 11+ of Thompson (1957)» the large
cyst had to be emptied with a trocar before removal and 2,700 ml. of
dark brown fluid were evacuated.
In 7 cases, however, the gross picture of the malignant
endometrial cyst was not characteristic. This necessitates careful
microscopical examination in all cases of ovarian endometriosis.
It is also likely that in the advanced cases, endometriosis will
not be apparent to the naked eye.
Microscopical picture










The frequency of the adenoacanthoma in these cases is probably-
more apparent than real. The adenoacanthoma is known to be
commonly a slowly growing tumour (Thompson 1957). Hence, it is
more likely to keep intact its relation to an endometriotic origin
whereas a more rapidly growing adenocarcinoma is liable to overgrow
the tissue of its origin and its relation to endometriosis may be
missed. Again, the characteristic picture of the adenoacanthoma
and its well-known relation to endometriosis are sufficient to
stimulate the pathologist to make a careful examination of the case,
where cases of adenocarcinoma are more liable to pass as cases of
ovarian carcinoma, unless the relation to endometriosis is evident.
In our material of primary malignant ovarian tumours, the ratio of
the adenoacanthoma to the endometrioid adenocarcinoma was 1:3. If
only the cases of definite origin in endometriosis are encountered,
the ratio is 1:1. It is interesting to note also here that the
adenoacanthoma was tie more common type in the younger age groups.
Thus, below the age of 1+0 years, 10 cases of adenoacanthoma were
encountered, compared with five cases of adenocarcinoma.
Generally, the squamous component of the adenoacanthoma was
histologically benign. However, McCullough et al. (191+6) reported
a squamous cell carcinoma arising in endometriosis and in the case
of Moss and Runals (191+8) areas of squamous cell carcinoma were
encountered. In one of our cases, the squamous component was also
malignant (Figure 67).
In the case of Rauramo (191+7)» a picture suggestive of Brenner
tumour was described in some areas of the adenocarcinoma. In the
case of Moss and Runals (191+8), areas of mucous carcinoma were
encountered. The adenocarcinoma in the case of Plate (1966) and
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in case 2 of Gray and Barnes (1965) showed a clear cell pattern.
Prognosis
Data about the follow up of cases included in this review
were rather fragmentary. Eleven patients were reported to be
living and well for periods of five years or more. In three cases,
the patient died after 6-18 months. In four other cases, a
recurrence of the tumour was noted. In two cases, this involved
the region of the broad ligament and occurred in the second year
(Bacher and Ilertzog 1951, and one of our cases). In two other
cases, the recurrence involved the intestine and occurred after
five years (Welnrod et al. 1956; Dockerty, 1962, case 8).
In speculating on the possible prognosis in these cases,
several points may be considered:
1. The tumour may well be detected at an early stage becoming
symptomatic for reasons we have already set out.
2. A low grade of malignancy is common in the cases that are
recognized although, as previously pointed out, there is the
likelihood that the higher grades of malignancy are missed due
to the overgrowth of any traces of their origin.
3. Adhesions due to endometriosis may be extensive and may make the
operation formidable and possibly Incomplete. Inadvertent
rupture of the cyst during removal was not infrequent in the
reported cases.
1*.. There is suggestive evidence in these cases that malignancy may
develop in other sites of endometrial tissue, either simultaneously
or at a later date. In 5 of the reported cases, bilateral tumours
were considered to have developed independently in endometriosis
involving both ovaries. The development of a separate
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adenoacanthoma in the uterus was reported "by Freedman et al.
(196h). Dockerty (I95h) suggested that independent foci of
neoplasm in the uterus and ovary may account for some of the cases
where adenoacanthoma is found in both the uterus and ovaries. In
the cases of Weinrod et al. (1956) a separate adenoacanthoma
developed in intestinal endometriosis five years after the removal
of an ovarian adenoacanthoma# In our case 1, the tumour removed
one and a half years after the original operation was interpreted
as a malignant transformation in an endometriotic lesion left from
the previous operation. Thompson (1957) suggested that the
presence of an adenoacanthoma in multiple sites may depend more on
the ability of the normally placed endometrium and the ectopic
endometrial implants to respond to factors which incite adenoacan-
thomatous change, than on the ability of the adenoacanthoma to
metastasize.
These points raise the question of the extent of operation in
these cases. The detection of these growths at an early stage,
their usually low grade of malignancy as well as the young age of
many of the patients may tempt towards a more conservative approach
(Thompson 1957)* The risk of leaving endometrial tissue, normal
or ectopic, in which an endometrial carcinoma may subsequently
develop or may be already present at a very early stage is possibly
small but should probably be also taken into consideration.
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SUMMARY
In an approach to the problem of malignant transformation in
ovarian endometriosis, we have reviewed a series of 592 cases of
ovarian endometriosis and a series of U18 primary malignant
ovarian tumours, encountered during a period of 10 years.
Anaplastic changes we re encountered in four "benign endometrial
cysts. Malignant tumours histologically similar to endometrial
growths were encountered in 52 cases. Of these, only four could "be
shown to have a definite endometriotic origin. Analysis of these
and of U8 cases from the literature suggests that some clinical and
pathological characteristics were common in these cases. The
relation of these characteristics to the detection of the growths
at an early stage is discussed.
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TIIS OCCURRENCE OF GRANULOSA AND THECA CELL TUMOURS IN
CLINICALLY NORMAL OVARIES
The frequency with which granulosa and theca cell tumours
may "be present for long periods without causing clinical enlargement
of the ovary is not generally realized. During the review of the
ovarian tumours in our series we encountered several cases of this
type. For their special interest, from both the clinical and
pathological point of view, we went through the files beyond the
period of 10 years included in the review. A series of 25 such
tumours will be the subject of the present discussion. The
clinical records of the patients were traced, their clinical features
analysed, the histological sections were reviewed and other sections
were cut for further study in several of the cases.
Incidence
Of 91 cases of granulosa and theca cell tumours examined in the
pathology laboratory of the Department of Obstetrics and Gynaecology
of the University of Edinburgh since 1950, 25 tumours were
encountered in ovaries that were normal-sized or only slightly
enlarged, and were judged clinically to be normal.
Summary of the clinical features
The age of the patients in the 25 cases of small tumours
ranged from hi to 80 years with only one patient below the age of
50 years. In the total series of 91 granulosa and theca cell
tumours of all sizes, age ranged between 17 and 86 years with 23
patients below the age of 50 years.
Eleven patients were nulliparous and all were postmenopausal
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for periods varying from 2 to 31 years.
With the exception of 3 cases, the presenting symptom was
postmenopausal "bleeding. Of these 3 patients, one was operated
upon for the presence of large uterine fibroids, another had a
large twisted fibroma of the opposite ovary and the third had an
adenocarcinoma of the opposite ovary. The duration of the history
of postmenopausal bleeding varied from two weeks up to 6 years.
Delays were largely due to reluctance on the part of the
gynaecologist to operate in the absence of a palpable tumour.
Thus, only eleven of the patients had a laparotomy within one year
of the start of the bleeding, 6 patients were operated upon in the
second year, 3 in the third year, one after 1+ years and one after
6 years.
The management of the patients presenting with postmenopausal
bleeding followed several lines. In 2 patients, laparotomy was the
first line of treatment. In 12 patients, laparotomy was performed
after an initial curettage showing endometrial hyperplasia (7 cases)
or carcinoma (5 cases). In two patients, curettage was performed
and hysterectomy was done when the bleeding recurred. In k patients,
the decision for laparotomy was only taken after 2 or 3 curettings
had been performed. In 2 patients, after an initial curettage,
deep X-ray therapy to stop ovarian function was given. In both cases,
the treatment failed. One of these two patients had the X-ray
treatment repeated 3 times and was only operated upon after 3 years
when an early adenocarcinoma of the endometrium was also discovered.
The second of these two patients had a laparotomy after intermittent
bleeding for 6 years.
It is interesting to note that a history of radiation menopause
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was present in 3 other cases in this series. One patient had a
radium-induced menopause for the treatment of dysfunctional
premenopausal "bleeding 18 years before. /mother patient had the
same treatment 31 years before the occurrence of postmenopausal
bleeding and the detection of an endometrial adenocarcinoma. The
third patient received radiotherapy for the treatment of fibrosarcoma
of the groin at the age of 28 years. Her periods stopped since then
and she presented 2k years later with uterine bleeding and
endometrial hyperplasia.
Oestrogen assays were available in 2 of the patients with post¬
menopausal endometrial hyperplasia. In one patient, aged 75 years
and menopausal for 27 years, the 2k hours urine volume contained a
total of 17*8 microgram oestrogens. In the second patient, 66 years
old and 10 years postmenopausal, the total oestrogen values were
38*7 microgram per 2k hours urine volume. The total mean urinary
oestrogen excretion in the normal postmenopausal patient is of the
order of 5*8 microgram per 21+ hours with a range of 3*1 to 8*1
microgram (Kellar et al. 1959).
Summary of pathological features (Figures 75-92)
All the tumours were unilateral, with the exception of one case
of bilateral thecoma. Seventeen of the tumours were thecomas and
8 were granulosa-theca cell tumours. In our total series of 91
cases, only 28 were thecomas. The appearance described as
luteinization was more frequently observed and also more marked than
in the large tumours (Figures 80, 87, 89). In 3 of the cases, the
tumour was almost completely luteinized. In spite of their small
size, the tumours often showed evidence of old fibrosis, and
hyalinization was usually marked and in some cases replaced a large
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part of the tumour. The ovary, apart from the tumour, was
commonly the seat of a variable degree of cortical stromal hyper¬
plasia. In one case, foci of lutein cells were included in the
hyperplastic ovarian stroma (Figure 92). Hyperplasia of the hilus
cells was prominent in one case. A small fibroma was also present
in the same ovary in one case. Corpora-albicantia-like structures
were prominent in some of the cases of granulosa cell tumours
(Figure 78).
In 3 patients, the endometrium was inactive. These were the
three patients, already mentioned, who presented with other large
tumours in the uterus or opposite ovary. In 15 cases, the endometrium
showed marked proliferative activity or cystic hyperplasia (Figures
77» 81, 90, 91)• In the remaining 7 cases, endometrial carcinoma
was present. In 5 out of these 7 cases, the ovarian tumour was a
thecoma. It is also worthy noting that in the total series of
91 cases of granulosa and theca cell tumours, eleven cases of
concomitant endometrial carcinoma were encountered. In other words,
in 7 out of eleven cases in which a granulosa or theca cell tumour
was associated with endometrial carcinoma, the ovary showed no
clinical enlargement. Two of the cases of endometrial carcinoma in
this series are of special interest. Endometrial curettage, two
years before in one patient and 3 years before in the other patient,
showed postmenopausal active hyperplasia. The second patient
received in the interval deep X-ray therapy to stop ovarian function.
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DISCUSSION
Although granulosa and theea cell tumours of very small size
have "been occasionally noted in previously published series (Biggart
and Macafee 1955)* they apparently received no special attention.
Our study of a group of 25 such cases revealed some interesting
features worthy of discussion.
In our material, 25 out of 91 granulosa and theca cell tumours
were detected in ovaries showing no clinical enlargement. The real
incidence of these small tumours may even "be higher since they are
more liable to be missed than the larger tumours, especially if they
are hormonally inactive. The relative frequency of these tumours
should direct attention to their possible presence in the postmeno¬
pausal patient presenting with evidence of abnormal oestrogen!c
activity, even when the ovaries are palpably normal.
Several observations suggest that these cases do not simply
represent early tumours but rather a variant of granulosa and theca
cell tumours characterized by a very slow ana possibly limited
capacity for growth. Thus, the tumours were encountered not at an
earlier age but rather at a later age than the larger tumours.
Furthermore, the history of these patients often revealed evidence
of long standing abnormal oestrogenic activity before operation.
Pathological examination also often showed a pronounced degree of
fibrosis and hyalinization in the tumours. In the present state of
knowledge, factors governing the rate and capacity of growth in
tumours are not well understood. However, two pathological features
in our series are worthy of note in this connection. The first is
the predominance of the thecal type of tumour and this is in accord
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with the observation that thecomas are generally more slowly
growing and relatively more benign than the granulosal type of tumour#
The second feature is the more frequent and more marked appearance of
luteinization in these small tumours. Since this distinctive
histological appearance is probably indicative of steroid storage
in the cells, it may be suggested that there is a correlation
between a low potential for growth and a capacity of the cells for
steroid storage. It is interesting in this aspect to note that
the so-called lipoid cell tumours of the ovary are usually of a small
size (Haines and Taylor, 1962).
The association of endometrial carcinoma with feminizing
mesenchymal tumours has been reported, the figures varying from 3 to
27 per cent (Hertig and Gore, 1963), In our material, the incidence
of endometrial carcinoma was disproportionately more high with the
small tumours than with the larger tumours. Thus, 7 cases of
endometrial carcinoma were encountered among the 25 cases of small
tumours, whereas in the other 66 cases of granulosa and theca cell
tumours In our material, only U cases of endometrial carcinoma were
encountered. Several factors may be considered to explain this
relatively high frequency. One of these may be the predominance of
thecomas in these small tumours, since thecomas are more notable than
the granulosa cell tumours for this association (Greene, 1957)• The
older age of the patients may be another factor. It is also possible
that more of these small tumours are detected when the endometrium
is malignant than when it is benign because operation is less
readily undertaken when the endometrial curettings are benign.
However, despite all these possible factors, the frequency of the
association is probably not fully explained. It may also be
73
mentioned that Greene (1957) noted that 7 out of 13 mesenchymomas
in association with endometrial carcinoma were not detected before
operation. Here, a possible explanation may be ventured; these
small tumours escaping clinical recognition for a long time are
expected to exert a prolonged oestrogenic effect on the endometrium,
more than is possible with the larger rapidly growing types. In
two cases in this series, the progression from postmenopausal
hyperplasia of the endometrium to adenocarcinoma was noted after
2 years in one patient and 3 years in the other# For all probability,
the small tumour was present over these periods. The possibility
of the presence of a small undetected functioning tumour of the ovary
in a case of endometrial carcinoma is worthy of remembering. Such
a condition may be responsible for failure of treatment by radium
as it probably was in a case mentioned by Sparling (1950).
The possibility that radiation may play a role in the
development of feminizing ovarian tumours in the human as well as in
the experimental animal has been suggested (McKay et al. 1953). It
was therefore of interest to note that 5 patients in this series
received radiotherapy, usually to stop ovarian function, before the
discovery of the tumour. It is possible, however, that some of the
patients may have had the tumour at the time of the radiotherapy.
Indeed, this appears to be the most plausible explanation in 2 of
our cases as well as in some other similar reported cases (Maxwell,
1956; Sparling, 1950; Pratt, 1950). In other words, the
presence of the undetected functioning tumour was the cause of the
radiotherapy and not the reverse. It is important to remember that
a patient bleeding around the time of the menopause and showing
evidence of oestrogenic activity may have an undetected functioning
7h
ovarian tumour, especially if a standard dose of radiotherapy
fails to stop ovarian activity. In 2 other cases in this series,
the long interval of amenorrhoea "between the induction of menopause
for abnormal uterine bleeding and the presentation of the tumour
makes it more probable that the tumour has developed after the
menopause. In these 2 cases, however, it may be argued that the
ecological relation, if any, is with the ovarian dysfunction at the
time of the menopause and not with the irradiation.
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SUMMARY
The frequency with which granulosa and more particularly
theca cell tumours may "be present for long periods without
causing clinical enlargement of the ovary is not generally
realized. In our material, 25 out of 91 tumours were of this
type. These small tumours appear to have a very slow and
possibly limited capacity for growth but are endocrinologically
active. Endometrial carcinoma was present in 7 out of our 25
cases. A history of ovarian irradiation was present in 5 cases.
The significance of these observations is discussed.
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CHAPTER 3
OBSERVATIONS OH VERY RARE TUMOURS OF THE OVARY
In the first chapter of this thesis, we tabulated ovarian
tumours according to frequency into common, uncommon, rare and
very rare tumours. As a rough index, it was pointed out that
generally more than one thousand consecutive cases of ovarian
tumours are needed to get one of the tumour's in the very rare group.
In this chapter, a detailed account of the very rare ovarian
tumours which we diagnosed during our review will be given. The
rarity of the tumours, the lack of clarity about their status and
the diagnostic difficulties to which they may give rise justify
their grouping together here for discussion.
The tumour types that will be dealt with are the following:
1. Primary mesodermal mixed tumours of the ovary.





PRIMARY MESODERMAL MIXED TUMOURS CP TII5 OVARY
It is very rare to encounter in the ovary tumours resembling
the mesodermal mixed tumours of the uterus. A search of the
literature is hampered by the multitude of names under which these
tumours may have been reported. The case of Katsunuma et al.
(1959) was stated to be the first case reported under the title of
mixed mesodermal tumour of the ovary. Other authors have mentioned
cases of this type but without giving further details (Willis, I960;
Sternberg, 1963)* It is also possible that the cases of ovarian
carcinc-sarcoma reported by Tuthill (1938), MacFarlane and Pritchard
(195*4.) and Marcella and Cromer (1959) belong to the same group.
Cases reported as rhabdomyosarcoma of the ovary (Sandison, 1955,
Payan, 1965) possibly also belong to the same group.
The diagnosis of mesodermal mixed tumours in the ovary is
based primarily on the same criteria for the similar uterine tumours
(Taylor, 1958). However, two more criteria should be added in the
case of the ovary: firstly, the possibility of a spread from a
uterine primary should be excluded and secondly, care ^iould be taken
not to mistake cases of teratoma with these tumours. Mesodermal
mixed tumours are menodermal while teratomas are tridermal. Other
teratomatous elements should be looked for. This difficulty does
not arise in the uterus where teratomas are practically unknown.
As regards the pathogenesis of these rare tumours in the ovary,
Willis (i960) expressed his view that they undoubtedly arise from
foci of endometriosis. In one of our own two cases, an origin
from endometriosis was highly likely though not definitely proved.
Sternberg (1963), on the other hand, although admitting the
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theoretical possibility of the origin of these tumours from
endometriosis, states that proof is lacking and classifies them
as of coelomic epithelial origin differentiating as a mixture of
malignant Miillerian tissues.
The following two cases of mesodermal mixed tumours of the
ovary were encountered in our series of 173^ ovarian tumours. The
two cases were originally diagnosed as ovarian carcinoma but a more
thorough examination during our review allowed us to reclassify them
as primary mesodermal mixed tumours of the ovary.
Case 1: This patient, aged 59 years, para 0 and 19 years
postmenopausal presented with an abdominal mass. At operation, the
presence of ascites, together with a twisted tumour of the left
ovary, more than 20 cm. in diameter, was noted. A total hysterectomy
with bilateral salpingo-oophorectomy was carried out. An extensive
right pleural effusion, present before the operation, cleared
gradually after removal of the tumour. On pathological examination,
the uterus was found to be normal and the endometrium showed a mild
degree of proliferative activity. The right ovary and the tubes
were unremarkable. The sections available from the tumour showed
three different pictures. One part had the appearance of a benign
adenomyoma (Figure 93). Another part showed the transformation
of the stroma of the tumour to a loose myxomatous type, with
clxzsters and individually dispersed malignant cells and also with
areas of degenerate chondrous tissue (Figure 9U)* In a third part,
the epithelial elements showed the pattern of endometrioid
carcinoma (Figure 95). Extensive areas of haemorrhage and necrosis
were seen in the tumour, possibly due to the torsion.
Although in this case the origin of the mesodermal mixed tumour
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from the associated endometriosis was highly probable, we could not,
in the absence of the original specimen, demonstrate to our
satisfaction a transitional zone between the two lesions.
Case 2: This patient, aged 6k years, para 0 and 20 years
postmenopausal, was diagnosed to have a mobile ovarian tumour.
Total hysterectomy with bilateral salpingo-oophorectomy was performed.
The tumour was confined to the left ovary with no evidence of spread.
However, the patient died k months after the operation with ascites
and liver enlargement. On pathological examination, the
endometrium was atrophic with several cystic inactive glands. The
cervix showed superficial infection. Both tubes and the right
ovary were histologically normal. The left ovarian tumour showed
several cystic areas containing blood stained fluid but was largely
solid. Microscopical examination showed the presence of malignant
epithelial elements in a richly cellular stroma. The epithelial
elements showed largely a well differentiated glandular pattern
(Figure 96). The stroma showed the picture of broad irregular
bands, interlacing in various directions. In the interstices
collections of large cells, rounded, oval or racket shaped and
with abundant eosinophilic cytoplasm were encountered here and
there (Figure. 97)• These cells were interpreted as rhabdomyoblasts.
Further sections stained with Heidenhain's iron haematoxylin




Brenner tumours were considered as entirely benign until 20
years ago, vixen Von Numers (19U5) reported the first two possible
cases of malignant forms of the Brenner tumour. Several cases
were subsequently reported. Idelson (1963) reviewed the literature,
analysed the 25 cases reported and reported one case of his own.
At least two other cases were reported after Idelson's review
(Arffmanp, 1962; Shay and Janovski, 1963)• It is doubtful,
however, if all the reported cases were really authentic. Epithelial
clumps in an ovarian carcinoma may simulate the appearance of the
Brenner tumour. Figure 99 shows such an example. Strict criteria
should therefore be fulfilled before this diagnosis is made
(Idenson, 1963)* most important among which is that definitely
benign parts of the tumour should be demonstrated.
Variable microscopical pictures have been described in the
previously reported cases. With the exception of two cases
(Behrens, 1953, Bamforth et al. 1951) the malignancy arose from
the epithelial elements. In the case of Behrens (1953) benign
glands were present but atypical mitoses and pleomorphism were
displayed by the stromal element. In case 1 of Bamforth et al.
(1951) malignancy was shown by both epithelial and stromal elements.
Different patterns were described for the epithelial malignancy in
the reported cases. Some cases showed a squamoid pattern with the
malignant epithelial cells aggregated in small and large sheets.
In other cases, adenomatous propensities were marked in the
malignant epithelial areas. In still another common pattern, large
cystic structures were noticeable. Thfc.se were lined by atypical
Brenner epithelium and sometimes showed papillary projections.
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Often the tumours displayed pictures far from uniform and displayed
a mixture of different patterns.
The endometrium was noted to be hyperplastic in some of the
cases and abnormal uterine bleeding was also encountered. In the
case of Shay et al. (1963) a malignant Brenner tumour was reported
in association with endometrial carcinoma.
The following case is the only case I encountered in our
material. The original diagnosis was an adenocarcinoma. This
case showed the presence of the benign and malignant Brenner tumour
in one section with evident transitions.
Case report: Mrs. A,F.t aged 80 years was admitted to
hospital with the complaint of lower abdominal pain of 2-3 months
duration. Her periods had ceased at the age of UO years but
during the past 12 years she had more or less regular episodes of
bleeding which she interpreted as a return of the periods. She
was a para 3. She had no alimentary symptoms. She had some
difficulty in passing urine but no dysuria. Micturition was
slightly more frequent. Her appetite was good and her weight was
steady. Bxamination showed the presence of a pelvi-abdominal
tumour. Laparotomy was performed and a tumour of the left ovary
was removed together with a supravaginal hysterectomy and right
salpingo-oophorectomy.
The tumour was about 9 inches in diameter, with its surface
lobulated, smooth and glistening. Mild adhesions were present.
The tumour was cystic but with solid areas near the base (Figure
100). The fluid content was yellow and rather gelatinous. The
uterus and opposite ovary and the tubes were normal.
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Microscopical examination of the solid areas showed the
typical appearance of "benign Brenner tumour. The cell islands
looked mostly inactive with peripheral hyaline degeneration and/or
central liquifaction (Figure 101). The cystic part of the tumour,
on the other hand, showed the picture of a papillary
cystadenocarcinoma, with the multl-layered malignant epithelium
showing a marked structural similarity to the Brenner pattern
(Figure 102). Evidence of stromal invasion was present.
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MALIGNANT TERATOMA
In the first chapter of this thesis, the classification of
cases of ovarian teratoma was outlined. A distinction between
malignant transformation in a benign cystic teratoma and the
malignant teratoma (the solid malignant teratoma) was made. Here
we are going to describe an unusual case of solid malignant teratoma
In which the component tissue elements were of mature adult type.
The malignant potential of the tumour was proved by recurrence of
the growth.
Tumours of similar nature have been reported by other authors.
Peterson (1956) summarized 10 reported cases. Although in 3 of
these, implants of neuroglial tissue were present in the peritoneal
cavity, Peterson regarded these cases as benign and labelled them
as solid histologically benign teratomas of the ovary. Benirschke
et al. (i960) reported 3 cases of similar nature but in whom the
tumours spread widely and caused the death of two patients. It is
therefore possible that the long survival of the patients reviewed
by Peterson was largely due to the complete removal of the tumour
and not to its benign potential. On the evidence of the cases of
Benirschke et al. (i960) and of our own case, we prefer to label
these cases as solid well-differentiated malignant teratomas, rather
than benign teratomas.
Case report; The patient was a 11+ years old girl vdio has
never menstruated and who has always been small for her age. She
was quite well until several weeks before admission to hospital,
when she first noticed a dull pain in the right side of her abdomen.
Her abdomen was also noticeably gradually enlarging. Her appetite
was not so good lately. Nausea and some vomiting were present for
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the last few days. Her "bowels were regular. She had occasional
nocturnal urinary frequency. She had a tonsillectomy at the age
of 10 years. Her 5 brothers and 2 sisters were all well.
The patient, on examination, had no axillary or pubic hair
and her breasts were not well-developed. Heart and chest were free.
The abdomen was considerably distended to a girth of 2k inches by a
large tensely cystic tumour arising from the pelvis and extending to
within a finger breadth of the xiphi-sternum. Both lung fields
were clear on X-ray examination. Intravenous pyelography showed
that both ureters were compressed by a large tumour with patchy
calcification.
Lapatoromy was carried out. Free fluid was present in the
peritoneal cavity. A right ovarian semi-solid tumour, 8x6x6
inches with a large pedicle was present. The left ovary was
normal. The tumour and the right tube were removed.
Pathological examination of the tumour showed the appearance
of a well-differentiated teratoma containing a wide range of tissue
forms: brain, ependyma, choroid plexus (Figure 103), squamous
ciliated and mucinous epithelium, hair follicles, fat, nerve fibres
and smooth muscle. All these tissues were of adult mature type.
Six months later, the patient presented with a firm mass on
the left side of the abdomen, reaching almost to the level of the
umbilicus. The patient was still amenorrhoeic and the abdominal
mass was apparently asymptomatic. The patient was admitted
again to hospital and laparotomy was performed. The uterus was
found to be pushed up out of the pelvis by a large multilocular
cyst with solid areas and about k inches in diameter, lying in the
pouch of Douglas. The left ovary, tube and uterus appeared to be
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normal. Fine granular deposits were present on the peritoneum
V
between the uterus and bladder and on the greater omentum. The
liver was normal. The tumour in the pouch of Douglas was
removed and biopsies were taken from the greater omentum and the
pelvic wall peritoneum.
Pathological examination of the tumour again showed only
well-differentiated recognizable adult tissues, including bone,
cartilage, squamous and mucinous epithelium. The peritoneal
biopsies were composed only of neuroglial tissue (Figure 10h).
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MALIGNANT ADENOPIBRQMA
The potential of malignancy in the adenofibroma and
cystadenofibroma of the ovary has "been already discussed in the
first part of this thesis. A distinction was drawn "between
malignant transformation in the cystic and in the solid part of
the tumour. Carcinomatous transformation in the glandular
elements in the solid part of the tumour is a very rare occurrence.
The following report discusses such a case.
Case report: The patient was 72 years old, para 0 and
menopausal for 22 years. She was first seen with an attack of
deep-seated thrombophlebitis and pulmonary embolism. On
abdominal examination, a big mobile cystic mass, reaching up to
two fingers above the umbilicus was discovered. She had no
vaginal bleeding. At operation, a left ovarian tumour together
with the uterus and right appendages were removed. There was no
ascites and no evidence of peritoneal or liver metastases.
On pathological examination, the uterus was found to be
atrophic with few seedling fibroids. The endometrium showed a
moderate degree of proliferative activity. The cervix was benign.
The tubes and right ovary were normal. The left ovarian tumour
shov/ed the appearance of unilocular cyst, 11+ x 9 x 9 cm. with a
solid rounded firm mass, 7*5 x 5 cm. arising from part of the
cyst wall and projecting in the cavity. Microscopically, the
cystic part showed a lining of benign cubical epithelium with
occasional stunted papillae and psammoma bodies (Figure 105).
The solid part of the tumour shoved 1+ different pictures:
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1. "benign small glands widely dispersed in fibrous tissue,
typical of benign adenofibroma (Figure 106).
2. small glands crowded together in large compact clusters
(Figures 107, 108).
3. loss of gland pattern and arrangement of the cells in clumps
and columns, surrounded by a fibromatous stroma. The cells
show malignant characteristics and the appearance may suggest
superficially a malignant Brenner tumour (Figure 109).
i*. Anaplastic looking cells dispersed singly or in small clusters
in the fibromatous stroma (Figure 110).
The four histological pictures could be seen in the same
section and there was no doubt about the transition from one part
to another. The stroma of the tumour was largely fibromatous
but occasional areas of peri-epithelial thecal reaction were
marked (Figure 110)•
Figures 111 and 112 show a similar picture in another tumour
which we encountered but in which detailed examination was not
po ssible.
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MESOBLASTOMA OF T ;ILUM
Since Schiller's description in 1939 of the tumour which
he designated as mesonephroma, the status of this tumour has always
been the source of confusion. The opinion today is still divided.
Some authors would not recognize the tumour as an entity (Willis,
I960; Haines and Taylor, 1962). Others maintain the mesonephric
origin as suggested by Schiller (1939) or a meso-metanephric
origin (Novak and Woodruff, 1963)# Others claim a germ cell
origin (Teilum, 1965). It seems that this divergence of opinion
is partly due to different authors speaking about different tumour
types and partly due to much stress being laid on certain structures
in the tumour which are not always present and which suggested
different appearances to different authors. These are the
glomeruloid structures of Schiller and the endodermal sinuses of
Teilum. An epithelial tumour of the ovary may show the picture
described as mesonephroma (Figures 113,llh). The picture can be
striking in some cases but it is doubtful whether or not a
mesonephric origin underlies its development. The tumour discussed
in the writings of Teilum is of a different nature. Its main
characteristic is the primitive mesenchymal type of stroma and the
paucity of epithelial elements. At least a superficial resemblance
to embryonic mesenchyme can be seen. Teilum's interpretation of
the tumour as an extra-embryonic mesoblastoma may well be correct,
though the interpretation of the epithelial spaces in the tumour
as homologous with the endodermal sinuses or as yolk sac endoderm
(Teilum, 1965) is debatable.
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We encountered two tumours In our series which answer to the
description of Teilun^s tumour. In hoth cases, the patient was
"below the age of 20 years, a common characteristic for this type of
tumour, in contrast to the malignant epithelial tumours of the
ovary.
Case 1: This girl, aged 17 years, was first seen complaining
of abdominal enlargement and a sense of tightness of 16 months
duration. Her periods, starting at the age of 13 years, were some¬
what irregular. She was found, on examination, to have large
bilateral pleural effusions, ascites and an abdominal mass the size
of 20 weeks pregnancy. Laparotomy was performed and a large right
sided ovarian tumour was removed. The tumour was already ruptured
before the abdomen was opened. The patient was allowed home after
10 days.
The tumour was firm and solid and measured 19 x 12 x 11 cm.
Its surface was slightly lobulated. On section, it was partly
solid and partly cystic, multiple small cysts being present. The
solid areas had a rather gelatinous appearance and were yellowish
apart from extensive blood staining. On microscopical examination,
the tumour showed numerous spaces which varied greatly in their size
and outline, lying in a stroma of loose mesenchymal connective tissue
composed of stellate and spindle shaped cells with scanty cytoplasm
widely separated by abundant clear intercellular material (Figure 115) •
The spaces were mostly lined by flattened cells, occasionally cubical
and some of them showed short stumpy papillae projecting into the
lumen. Only a very occasional mitotic figure could be seen. Large
areas of interstitial haemorrhage and necrosis were present in parts
of the tumour.
One week after discharge from hospital, the patient noticed
stiffness in the right side of her neck. This was found to be due
to enlarged lymph nodes at the base of the neck. One of these was
biopsied and found to be invaded by a similar tumour to the original
primary. The patient kept well for a year and then she developed
abdominal pain and nausea. She was re-admitted to hospital and
laparotomy was again performed. The left ovary was healthy except
for a warty implant on its surface. The pouch of Douglas was filled
with malignant looking material and there were innumerable small
studs of similar material on the peritoneum, including many on the
greater omentum, but all below the level of the umbilicus. The
liver, kidneys and lymphatic nodes all appeared to be in the clear
and the malignancy, though inoperable, was localized to the pelvis,
broad ligaments, general peritoneum, omentum and the intestine.
The bulk of the mass was removed mainly for biopsy reasons and most
of the omentum was amputated. The patient made a good recovery,
was discharged home and was able to go about but she always had
some nausea and abdominal pain. Three months later, she died.
Case_2: This patient, aged 18 years, had been the subject of
sharp intermittent attacks of pain in the right side of the abdomen,
for the past two weeks. Over the last 2h hours, the pain has been
more severe and almost continuous. Her periods have been irregular
over the past three months. She was unmarried. Laparotomy was
performed and a cystic tumour of the right ovary was removed. This
was the size of a 20 weeks gestation, was twisted and showed no
gross evidence of spread.
On pathological examination,the tumour showed an identical
picture to that described for the tumour in case 1.
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The patient presented 8 months later with evidence of
abdominal and pelvic recurrence. Laparotomy showed the presence
of gross ascites as well as nodular growths everywhere from the
pelvic organs to the liver and it was decided that it was no
longer possible or safe to remove the uterus and left appendages.
The abdomen was closed. An attempt was made to treat the
patient with endoxan. Recurrent ascites necessitated paracentesis.
She died 1+ months later.
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SUMMARY
Very rare types of ovarian tumours, of which only one
or two cases were encountered in our series of 173*4- tumours, are
presented in detail. They include the following tumour types:
primary mesodermal mixed tumour, malignant Brenner tumour,
malignant teratoma, malignant adenofibroma and mesoblastoma.
The diagnostic difficulties in these rare cases are discussed.
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CHAPTER h
OVARIAN ENLARGEMENT SIMULATING TUMOUR FORMATION IN A VIRILIZED
PATIENT DURING PREGNANCY
A certain degree of ovarian enlargement is usual in normal
pregnancy (Nelson and Greene 1958). Polycystic change or hyper-
thecosis in association with virilization may also lead to a
certain degree of ovarian enlargement (Scully, 1963)• The
enlargement, however, is usually moderate in both cases. In this
unusual case, a virilized patient had two successive pregnancies
and was delivered by Caesarean section each time. On both
occasions, her ovaries were found to be grossly enlarged, simulating
tumour formation.
Case report: Miss B.H. was first seen at the age of 16 years.
She had her first period at the age of 12 years. For the first year,
her periods recurred every 28 days and lasted for k-5 days. In the
second year, the interval lengthened to 3-k months. In the third
year, she had only 2 periods and in the fourth year she had only one
period, 8 months before presenting for treatment. In the past 2-3
years, she noticed that her arms and legs have become covered with
hair. Hair appeared on the chin during the last year. She had
had appendicectomy at the age of 8 years, and had been obese ever
since. A pilonidal sinus was excised 7 months before. Intermittent
pain in the left flank recurred on 5 occasions during the last b-5
months. On examination, the patient was seen to be grossly obese
and hirsute. Her voice was feminine and the brests were well
developed. Striae were present on the abdominal wall. The blood
pressure was 135/75. The external genitalia were normal. The
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patient was admitted for investigation. X-ray of the skull was
free. Intravenous pyelography was normal. Urine examination
showed occasional glycosuria. Glucose tolerance test showed a
fasting level of 115 and a one hour peak of 205 mgn/100 ml.
Urinary neutral 17-ketosteroids were estimated on two occasions.
The first specimen (970 ml.) showed 17 mgn/100 ml. The second
specimen (1030 ml.) showed 5*9 mgm/100 ml. At this stage, the
diagnosis of adreno-genital syndrome with a possible tumour on
the right side was considered. Peri-renal insufflation was there¬
fore performed. On the left side, the kidney was not so well out¬
lined "but there was no downward displacement. On the evidence of
these radiological findings, the chances of the patient*s harbouring
a tumour of the adrenal were considered to be remote. The patient
was put on a reducing diet and oral cortisone therapy was tried.
However, no improvement was observed.
Two years later, the patient was engaged to be married. When
she was next seen, her periods had returned and she looked quite a
different person. One year later, she was in labour at full-term.
The vagina was found to be tough and unyielding, so much so that it
was found impossible to apply forceps, and it was decided to carry
out Caesarean section. The foetus, a male, 6 pounds and 10 ounces
in weight, was unfortunately stillborn. Anoxia, inhalation of
meconium and some pneumonic reaction were the pathological findings
revealed by post-mortem examination. Inspection of the ovaries
at the time of Caesarean section showed gross enlargement. The
external appearance was described by the operator as a mass of sago
grains in blackcurrant juice. The right ovary was resected.
Two years later, the patient attended the gynaecological out-
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patient department for treatment of secondary amenorrhoea. On
the basis of the previous ovarian findings, she was now diagnosed
as a case of the Stein-Leventhal syndrome. Conservative management
resulted in the return of normal menstruation and she was followed
up for about one year. When she was next seen, about one year
later, she was pregnant for 12 weeks. The pregnancy was uneventful
apart from an episode of urinary infection, an attack of chicken-pox
and treatment for trichomonas vaginitis. In view of her long
history of infertility, it was decided to deliver her by elective
lower segment Caesarean section. She was delivered of a live-born
male infant, 5 pounds and 13 ounces in weight. At the time of
operation, her remaining left ovary was found to be grossly enlarged
to several times the normal size and again showed the sago-like
appearance seen in the previous operation. A wedge was resected
from this ovary.
Pathological description
The pathological picture of the ovary, on the two occasions,
was essentially similar. The right ovary, removed at the time of
the first Caesarean section was kidney shaped and measured 8»5 x
5*5 x U cms. The outer surface was studded with multiple small
cysts, giving the appearance of sago grains (Figure 116). The cut
surface showed multiple peripheral small cysts in the ovarian cortex
(Figure 117)« In the wedge resection from the left ovary, solid
nodules of variable sizes were present in the cystic ovary
(Figure 118).
Microscopically, marked proliferation of theca interna cells
dominated the picture. Multiple layers of theca cells surrounded
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growing, atretic and cystic follicles (Figure 119)• The
granulosa cell layer was of normal thickness or atrophic. The
solid nodules seen in the gross specimen were also made up of
theca lutein cells (Figure 120) and some of them were traceable to
the thecal proliferation around follicular structures. Small foci
of theca lutein cells were also scattered in the hyperplastic
ovarian stroma (Figure 121) in both cortex and medulla. The corpus
luteum was not encountered in either specimen. The superficial
part of the ovarian cortex showed no marked fibrosis. The hilum
of the ovary showed prominent rete tubules but no preponderance
of hilus cells.
DISCUSSION
The unusual ovarian changes in this case should be discussed
in relation to the virilization of the patient as well as in
relation to pregnancy. That the virilization of this patient was
related to the ovarian pathology is suggested by the normal findings
of the investigation of the adrenal and pituitary glands as well
as by the lack of response to cortisone therapy. Moreover, the
ovarian pathological picture of hyperthecosis is compatible with
the clinical picture of virilization. Here, it may be pointed out
that there is some confusion of the literature in defining the
Stein-Leventhal syndrome and the hyperthecosis syndrome. In the
syndrome which carries their name, Stein and Leventhal (1935)
emphasised the polycystic appearance and the thickened tunica as the
outstanding pathological features. Fraenkel (I9h3) coined the
term hyperthecosis to the condition characterised by the presence of
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nests of lipid-laden lutein cells in the ovarian stroma, usually
in association with virilization. It is generally recognised that
"both conditions do overlap. In the polycystic ovary, luteinization
of the theca cells around the follicles may "be prominent and foci of
theca lutein cells may "be seen in the stroma. An ovary, the seat
of hyperthecosis, may show also peripheral cysts. In the opinion
of Shippel, both conditions are facets of the same basic disturbance
and should be regarded as stages of one syndrome (Shippel, 1955).
Scully, on the other hand, though admitting that the two syndromes
overlap in both their clinical and pathological pictures, prefers
to classify them separately, since in their classical forms they can
be distinguished (Scully, 1963)• Thus, clinically, the presence
of Cushingoid features and overt virilization characterises
hyperthecosis. In the Stein-Leventhal syndrome, virilization is
usually limited to hirsutism and Cushingoid features are not common.
Therapeutically, the good results of wedge resection are less
frequently obtained in the hyperthecosis syndrome. Our case
combines features of both conditions and affords an example of
their overlap. The gross obesity, abdominal striae as well as the
diabetic tendency suggest Cushingoid features of the hyperthecosis
syndrome. Pathologically, though admittedly a pregnancy effect is
added, multiple peripheral cysts were present together with foci of
luteinized cells in the stroma. In this discussion, the term
hyperthecosis will be used rather loosely to embrace both conditions.
Spontaneous pregnancy in the hyperthecosis syndrome is not
unusual (Lynch et al. 1959). The influence of psyche is well
demonstrated in our case. The psychological effect of the patient's
engagement could override the abnormal pathology and induce the
return of ovulatory menstruation.
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In discussing the relation of the ovarian changes in this
unusual case to pregnancy, it may he noted that normal pregnancy
is usually associated with some degree of hyperplasia and lutein-
ization of the theca cells (Nelson and Gresne, 1958). The exact
extent of this change is ill-defined hut does not seem to he
marked (Lynch et al. 1959). However, pregnancy may rarely he
the cause of marked ovarian enlargement due to hyperplasia of theca¬
lutein cells. This enlargement may he cystic or solid in nature.
Cystic enlargement is exemplified by the multiple theca-lutein cysts
often associated with trophoblastic growths. It may however
he encountered in their absence. Girouard et al. (1961+) reviewed
15 such cases from the literature and added two cases of their own.
Of the 17 cases, 6 were concomitant with foetal hydrops from rhesus
sensitization, 5 were associated with multiple pregnancy and 6 were
encountered with apparently normal pregnancies. The most plausible
explanation for this cystic change is a sustained high level of
chorionic gonadotrophin. Solid ovarian enlargement in relation to
pregnancy has been recently described under the title of pregnancy
luteoma (Sternberg, 1963)* The pathological lesion has been
interpreted as probably representing an abnormal hyperplasia of
theca-lutein cells (Sternberg and Barclay, 1966). The only
significant common factor in these cases was multiparity. This type
of pregnancy luteoma has been, so far, never described in relation
to trophoblastic neoplasms and there seems to be no evidence fbr
incriminating the same etiologic factor, a high level of chorionic
gonadotrophin, in its causation.
The exaggerated hyperplasia of theca-lutein cells in our case
was of a solid nature and similar to that described in the cases of
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pregnancy luteoma. The findings in our case suggest that this
type of exaggerated hyperplasia of theca-lutein cells probably has
as an important underlying factor, a pre-existent hyperplasia of
theca-lutein cells. Shippel (1955) discussed the role of pregnancy
in the production of the hyperthecosis syndrome and suggested that
hyperthecosis may persist after pregnancy. It is possible that the
repeated pregnancies may have a cumulative effect and this may
explain the relation of pregnancy luteoma to multiparity. Shippel
(1955) also pointed out that several factors may lead to hyperplasia
of the theca cells. These include anovulatory cycles, conditions
which tend to stimulate the reticulo-endothelial system and local
pelvic irritative conditions. Undoubtedly, however, an element
of ovarian responsiveness Eiodifies the effect produced by these
factors in the production of hyperthecosis and possibly also will
play a role in defining the response to pregnancy.
Data from the literature about the picture of the ovary during
pregnancy in patients diagnosed clinically as suffering from hyper¬
thecosis are very scanty, although spontaneous pregnancy in these
cases is not unusual. Lynch et al, (1959) described 2 such cases,
which showed marked hyperplasia of theca-lutein cells.
iixaggerated hyperplasia of theca-lutein cells may be
encountered in the absence of pregnancy. Cases are on record in
which the ovary was grossly enlarged as to simulate a tumour. These
include cases described by Geist and Gaines (19U2), Fraenkel (19U3)»
Rottino and McGrath (19U3), Gemzell et al. (1956), Scully (1962),
Koss et al. (196U) and Travis et al. (1965). The case reported by
Stein et al. (1963) possibly also belongs to this group. The
exaggerated hyperplasia in these cases may have had as a possible
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underlying factor a long standing condition. In 3 of the
aforementioned cases, the patients were over l+O years old and in
another 6 the age was above 30 years. In the case of Stein et al.
(1963) the patient was 26 years old but she had U pregnancies and
during each of them an exaggeration of hirsutism was noted, possibly
corresponding to an exaggerated hyperplasia of the theea cells.
As in other fields of ovarian endocrine pathology, it is
futile here to attempt to correlate the hormonal potential with
the morphological picture. The multiple theca-lutein cysts,
well known in trophoblastic growths, are usually associated with no
clinical evidence of abnormal hormonal activity. However, in
the unusual case reported by Alexander and Beresford (1953) multiple
theca-lutein cysts of a similar pathological appearance were
apparently responsible for virilization of the patient. Reported
cases of pregnancy luteoma were usually of no clinical endocrine
significance. However, in the case of Malinak and Miller (1965)»
pseudo-hermaphrodistism of the female foetus was observed.
Culiner and Shippel (19U-9) described a patient who developed signs
of masculinization during pregnancy and at the time of Caesarean
section her ovaries were noted to be grossly enlarged. Follow up
after delivery showed a return of the ovaries to normal size.
Unfortunately, in this case pathological examination was not
performed hut apparently it belongs to the same group of cases we
are discussing. These and other examples illustrate the fallacy
of attributing one particular type of steroid production to a
particular cell in all its physiological and pathological states.
From morphological appearances, cells may be characterised as
showing a picture compatible with steroid production. However, in
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the present state of our knowledge, it must be admitted that
there is no telling what type of steroid or steroids that would
be, nor how much of it is produced.
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SUKMAKY
An unusual case of ovarian enlargement, simulating tumour
formation, is described in a virilized patient at full term during
two successive pregnancies. The enlargement was due to hyperplasia
of the theca-lutein cells. The relevant literature on ovarian
changes in virilized women (in the absence of tumours) and on
ovarian changes during pregnancy is discussed. This condition
should be borne in mind because if encountered an ovarian biopsy








The demonstration of a sex difference in mammalian interphase
nuclei "by Barr and Bertram in 19U9 opened a new era in the field of
cytogenetics. Studying the effect of fatigue on the neurones of
the cat, the two workers noted the movement of what appeared to "be a
nucleolar satellite during depletion and restoration of Nissl
material. This satellite was present only in female cats. This is
how this far reaching discovery of nuclear sexual dimorphism was
first made. Subsequent studies extended this observation to other
mammals and to man (Moore and Barr 195U) • Apart from unsuitable
necrotic nuclei, the imprint of sex was shown to be present through¬
out the various tissues and organs of man. The sex chromatin was
also shown to be still recognizable in pathological, inflammatory
or neoplastic tissues (Moore and Barr 1955"b» 1957). In an attempt
to simplify the sex chromatin test for clinical use and to avoid
the minor operation of obtaining a skin bioosy specimen, the buccal
smear method was introduced by Marberger et al. (1955) and Moore and
Barr (1955a).
Morpholop;ical characteristics of the sex chromatin
Position: The favoured position of the sex chromatin is
against the nuclear membrane. There is also a tendency for the
sex chromatin to be located at one tip of elongated nuclei such as
those of smooth muscle fibres (Moore and Barr 195U). It is not
known why the sex chromatin tends to assume a definite position in
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the nucleus. This position, however, seems to vary in various
species, various tissues, conditions of growth and altered cell
metabolism. The change in the position of the sex chromatin
during chromatolysis of motor neurones in the cat was the
observation that led to its discovery. Other possible positions
for the sex chromatin apart from lying adjacent to the nuclear
membrane, are a juxta-nucleolar position and a free position in
the nucleoplasm*
Shape; The sex chromatin is usually planoconvex, one side
being flattened against the nuclear membrane, but it may be
spherical, triangular, irregular or disc shaped (Moore and Barr 1953).
The shape of the sex chromatin is influenced by its position in the
nucleus. \*Vhen it lies free of other components of the nucleus,
it tends to be spherical.
Size: The sex chromatin of female nuclei is of the same
order of size in different representatives of the mammalian class,
with mean dimensions of 0»8 x 1*1 micron but there appear to be
minor differences in its size from one type of cell to another. An
abnormally small or large size of the Barr body may indicate an
abnormal X chromosome.
Staining affinities: The reaction of sex chromatin to stains
is that of chromatin and chromocentres in general. It has an
affinity for basic dyes such as haematoxylin. Deoxyribonucleic
acid (DNA) is apparently an important constituent of the sex
chromatin, since it is Feulgen positive. The Peulgen stain can
differentiate the sex chromatin from nucleoli.
Frequency of nuclei with sex chromatin; The percentage of
nuclei with sex chromatin in the female varies according to the type
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of tissue examined, the type of preparation, the technical quality
and the use of different criteria hy different authors. The nervous
tissue shows a high percentage of sex chromatin while the buccal
mucosa shows a much smaller percentage. The influence of the type
of preparation is shown hy the difference between smears or whole
mounts of thin membrane where entire nuclei are examined and
histological sections where only sections of the nuclei are available.
Some workers include in their counts only chromocentres adjacent to
the nuclear membrane while others include chromocentres of identical
morphology in other positions as well. Generally, in suitably
stained material, a percentage of 50 to 80 per cent of chromatin
positive nuclei (with an average of 66 per cent) is to be expected
in female tissues. In similar preparations from males, a
chromocentre that is larger than other chromatin particles but
usually smaller than the typical sex chromatin of the female occurs
in 0-15 per cent of nuclei with an average of about 5 per cent.
To explain the absence of a Barr body (sex chromatin) in
certain cells and its presence in others v/ith the same XX chromosome
complement, De Mars (1962) has claimed that the sex chromatin is
present only during the few hours preceding cell division, i.e. only
after chromosome duplication has taken place. Miller (1961+)» on
the other hand, suggested that the Barr body is present only when
the X-chromosome forming it is condensed and is absent when the
involved X is despiralized and presumably replicating its own DRA.
This would account for the lower incidence of chromatin positive
cells in rapidly dividing cultures from human females, since a
greater proportion of these cells would be duplicating the X-chromo¬
some that forms the sex chromatin.
106
A diminished incidence of Barr bodies may he due to sex
chromosome mosaicism when one of the cell lines has a single X
chromosome (Vaharu et al. 1961) or it may he encountered in cases
with a deletion of part of one X chromosome (Jacobs et al. I960).
Thus, a low positive count may direct attention to a sex chromosome
abnormality.
A possible effect of antibiotics and hormones on the sex
chromatin has also been suggested. Sohval and Casselman (1961)
suggested that certain antibiotics, possibly by inhibiting SNA
synthesis, might reduce the size of Barr bodies and could lead to
misinterpretations of sex chromatin tests. Smith et al. (1962)
have shown a low incidence of sex chromatin in newborn females.
A diminished incidence of Barr bodies in patients treated with
hydrocortisone or A.C.T.H. has also been claimed (Taylor, 1963b).
Variations in the incidence of chromatin positive cells have also
been described in the different phases of the menstrual cycle
(Del Campo and Ramirez, 1965).
Number of sex chromatin masses per nucleus: Usually one mass
of sex chromatin is encountered in nuclei that are normally diploid.
In those rare sites where the presence of polyploid nuclei is normal
e.g. liver cells, amnion and bronchial epithelium, more than one
mass of sex chromatin may be present. In patients with chromosomal
abnormalities and in abnormal embryonic as well as malignant tissue,
also more than one mass of sex chromatin may be present. In
diploid cells, the maximum number of sex chromatin masses per cell
can be worked out from the formula, n - 1 where n is the number of
X chromosomes. Observations on polyploid cells suggest that one
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diploid set of autosomes seems to prevent the formation of sex
chromatin from one X-chromosome (Editorial, Lancet i960). Thus,
in a tetraploid cell with an XXYY pattern, sex chromatin would "be
absent in spite of the presence of two X chromosomes, and in a
tetraploid XXXX cell two sex chromatin masses are seen instead of
three (Klinger and Schwarzacher i960). Different from the n - 1
rule operating in diploid cells, an n - 2 rule seems to hold in
tetraploid cells, Triploid cells, on the other hand, seem to "behave
as diploid cells in this aspect (Kittwoch et al. 1963).
Derivation of the sex chromatin
Sex chromatin was originally thought to arise "by fusion of
heterochromatic portions of two X chromosomes (Barr and Bertram
192+9)• It is now evident that sex chromatin is formed from a
single heterochromatic X chromosome (Miller 1962+). This is
supported by observations along several lines.
The direct demonstration of abnormal sex chromosome complements
in individuals with abnormal sex chromatin patterns has now made it
possible to show that the maximum number of sex chromatin masses in
cells from any individual is one less than the number of X
chromosomes (Barr and Garr 1962). The sex chromatin masses in
these polysomic X individuals are all of the same size as the Barr
bodies in normal females with two X chromosomes. The possible
explanation is that each sex chromatin mass is formed by a single
heteropyknotic X chromosome and that one X chromosome in each
diploid XX cell is isopyknotic and cannot form a Barr body.
More convincing evidence of the single X nature of the sex
chromatin has come from studies of the pattern of chromosome
108
duplication by the use of radioactive MA precursor (H^ «* thymidine).
One of the two X chromosomes of normal females completes
replication of its MA later than most of the other chromosomes of
the complement (Gilbert et al. 1962). No late replicating X
chromosome is present in XY males or X0 females* In XXX and XXXY
individuals there are two late replicating X chromosomes and in an
XXXX female there are three (Grurabaeh et al* 1963)* The number of
X chromosomes with a late replication is thus identical with the
maximum number of Barr bodies and one less than the number of X
chromosomes. Furthermore, the late replicating X chromosomes tend
to lie at the periphery of metaphase figures from colchicin-treated
cultures tjiukherjee et al* 196h), a position comparable to that of
sex chromatin in interphase nuclei.
Another bit of evidence of the single X origin of sex chromatin
is the occurrence of very large (or very small) Barr bodies in
individuals with one very large (or very small) X chromosome in
addition to a structurally normal X chromosome. In all such
cases tested, the structurally abnormal X chromosome has been the
late replicating X chromosome which supports the hypothesis that
Barr bodies are formed only by late replicating X chromosomes
(Miller 196h).
Genetic evidence also points to the existence of only one
single X chromosome in active state in each cell. Geneticists
have known for a long time that heterochromatin i*e. chromosomal
segments that stain intensely during interphase and prophase when
other segments stain very lightly, is genetically inactive (Cooper
1959). The genetic inertness of heterochromatin has recently
been shown to be due to its inability to synthesize messenger RNA
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(Hsu, 1962). Since females possess two X chromosomes while males
possess only one, a double dose for each of the genes on the X
chromosome is to be expected in females. For autosomal genes,
such a double dose of allelo-morphic genes is bound to produce
double the gene effect. This does not happen with the X chromosomes
denoting that one must be inactive. This phenomenon, called dosage
compensation, can be studied in man, by measuring the activity of
the enzyme glucose-6-phosphate dehydrogenase (G-6-PD) in red blood
cells. The formation of this enzyme is controlled by a gene on the
X chromosome. The main activity of G-6-ED in red blood cells of
normal males is approximately the same as that in normal females,
in X0 individuals and in individuals with 3 or h X chromosomes
(Grumbach et al. 1962).
An attractive explanation for the presence of a single active
X chromosome is provided by the Lyon hypothesis (Lyon, 1962).
According to this hypothesis, at a certain atage of embryonic
development one of the two X chromosomes in somatic cells of the
normal mammalian (including human) female is inactivated so that
it takes little or no part in directing cellular activities. The
inactive X chromosome becomes heterochromatlc and capable of forming
sex chromatin. The other X chromosome remains active. This
process of inactlvation of the X chromosome affects at random the
maternal or paternal X chromosome. Once inactivation has taken
place, the same X chromosome remains inactivated in the progeny
of each cell of the embryo. The hypothesis thus implies that all
the somatic cells in the body of the mammalian female can be
divided into two classes: those with maternal derived (matroclinous)
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active X chromosome and those with paternal derived (patroclinous)
active X chromosome. It is interesting to note that this could
he verified in the mule, whose two X chromosomes coming from a
horse and a donkey are morphologically different. Mukherjee
and Sinha (196U) have shown that the matroclinous and the patro¬
clinous X chromosomes were equally frequently the late replicating
chromosomes in leucocytes cultured from a mule.
HUMAN CHROMOSOMES
Reliable studies on human chromosomes have been possible
only recently after the introduction of satisfactory methods for
chromosome analysis. Classical cytological procedures, without
the aid of ancillary treatment, do not allovs for easy or reliable
observation (Ford and Hamerton, 1956). Some means is needed to
spread and disperse the densely crowded chromosomes in the
equatorial plate during metaphase. This could be achieved by
hypotonic treatment to cause swelling of the cytoplasm and then
flattening of the mitotic cells to spread the chromosomes as far
as possible into a single plane inside the cell either by direct
mechanical squashing or by air drying after alcoholic fixation.
It is essential also to get as much dividing cells for examination
as possible. In tissues where mitotic activity is naturally
marked, e.g. bone marrow and testis there is usually enough cells
for examination. In other tissues, culture in vitro is needed
to obtain sufficient dividing cells for the purpose of analysis.
One of the steps of modern technique is also the pretreatment with
drugs that inhibit the formation of the mitotic spindle such as
colchicine or its less toxic derivative desacetyl methylcolchicine
(Colcemid, Ciba). The exposure to a spindle inhibiting drug has
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a characteristic effect on the morphological appearance of the
chromosomes. The chromosomes appear shorter than they would have
been at metaphase in a natural mitosis and the chromatids (the two
half-chromosomes which will become daughter chromosomes at
anaphase) are somewhat thicker than normal and diverge to a greater
or lesser degree from the centromere (the point where they remain
attached to one another). The consequence is that instead of
being linear structures in which the precise position of the centro¬
mere may be difficult to define, they have a bilateral symmetry,
looking something like an X when the centromere is median and like
a V when it is nearly terminal.
Chromosome count: Early in 1956, Tjio and Levan working in
Sweden reported counts of U6 chromosomes in human tissues. Their
preparations were of high quality and they revealed the chromosomes
of the diploid somatic complement with a great degree of detail.
Their preparations were made from tissue cultures set up from lung
explants obtained from aborted foetuses. Before the work of T^io
and Levan (1956), the diploid somatic complement in man was taken
as 1+8 •
Identification of individual chromosomes: The important
features for the identification of a chromosome are its relative
length and its centromere position. The particular way in which
the chromatids chance to lie is irrelevant. Experience has also
shown that the presence of satellites on the short arms of the
chromosomes does not provide a means for discrimination between them.
For the identification of individual chromosomes, the classification
generally adopted is that agreed upon at a meeting in Denver by the
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human chromosome study group in I960. In the Denver system, human
chromosomes are classified into seven groups, each group
designated "by the arabic numerals of the extreme chromosomes of the
group, joined by a hyphen: group 1-3, l+-5» 6-12, 13-15» 16*18,
19-20 and 21-22. The Denver system may, however, be cumbersome to
use in certain instances, for example in the expression of a
reciprocal translocation between undefined members of two separate
groups. In this case, the lettering system used by Patau et al.
(i960) is more convenient. In this system, the 7 groups can be
indicated by the letters A to G. Thus, it is easier to refer to
a D-G translocation instead of saying that there is a translocation
between a chromosome from group 21-22 and another from group 13-15.
The Denver numbering can be combined with Patau letters whenever
individual chromosomes could be unequivocably distinguish -ble,
for example A^, and A^ (Hauschka, 1961).
The characteristics of the various chromosome groups are as
follows:
Group A (l-3)i These are large chromosomes with approximately
median centromeres, The three chromosomes are
readily distinguished from each other by size and
centromere position.
Group B (I4.-5): These are large chromosomes with submedian
centromeres. The two chromosomes are difficult
to distinguish but chromosome h is slightly larger.
Group C (6-12): This is a group of medium-sized chromosomes with
submedian or subterminal centromeres. The X
chromosome is difficult to distinguish from pair 6.
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This large group presents major difficulties in
the identification of individual chromosomes.
At the London conference on the normal human
karyotype (1963)» it was suggested that the
four most metacentric pairs of chromosomes in
the group should he numbered 6, 7# 8 and 11.
The three submetacentric chromosomes should then
be numbered 9* 10 and 12.
Group D (13-15)J These are medium-sized chromosomes with nearly
terminal centromeres (acrocentric chromosomes).
Contrary to the belief at the time of the
preparation of the Denver report, the presence
of satellites on the short arms of some members
of this group in occasional preparations cannot
be relied upon in distinguishing individual
members of the group.
Group B (16-18): These are rather short chromosomes with
approximately median or submedian centromeres.
Pair 16 is fairly readily separable from the
group on account of its nearly median centromere.
Group P (19-20): These are two very similar short metacentric
chromosomes.
Group G (21-22): These are very short acrocentric chromosomes.
Again, contrary to the belief at the time of the
Denver report the presence of satellites proved
to be unreliable in the differentiation of the
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two members of this group. The Y chromosome
is sometimes difficult to separate from this
group, though commonly it appears to be a
little longer and to have a more nearly terminal
centromere. There is some indication that it




The techniques used in our study and requiring special
description are:
1. The buccal smear method for the study of sex chromatin.
2. The Feulgen reaction for demonstration of sex chromatin.
3. The method of obtaining chromosome preparations from cultures
of peripheral blood.
i+. The method of obtaining chromosome preparations from cultures
of the ovarian teratoma.
The buccal smear method for the study of sex chromatin:
The smear is obtained in the following way: The mouth is
opened and the angle drawn laterally with the little finger of the
hand holding a clean slide. This reveals the buccal pouch.
Gently but firmly a tongue blade is drawn forward a number of times
along the buccal reflex or floor of this pouch. A white milky
material is obtained which is rich in cells. While the slide is
held over a bottle of fixative, this milky material is quickly
spread upon the glass slide and immediately dropped into fixative
(95 per cent ethyl alcohol). The Feulgen method was used in
staining in our cases.
The Feulgen method of staining (Pearse I960):
1. Bring sections to water and remove mercury if necessary.
2. Rinse briefly in cold N-HC1.
3. Place in N-HC1 at 60°C for the optimum time for hydrolysis
(5 minutes for material fixed in Zenker).
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U. Rinse briefly in cold N-HC1. and then in distilled water.
5. Transfer to Schiff's solution for the optimum time to 1 hour
with de Tomasi).
6. Drain and rinse in three changes of freshly prepared bisulphite
solution ( 5 ml« 10 per cent K^SgO^, 5 ml, N-HC1., water to
100 ml•)•
7. Rinse in water.
8. Counterstain if desired (1 per cent aqueous light green for
1 minute or 0*5 per cent alcoholic fast green for £ to 1 minute).
9. Dehydrate in alcohol.
10. Clear in xylene and mount in Canada balsam.
Result: DNA appears in shades of reddish purple.
Method of obtaining chromosome preparations from cultures of
peripheral blood:
The method used is based on that described by Moorhead et al.
(I960). The steps involved are:
1. setting up the culture.
2. cytological processing.
3. preparation of the slides.
1. Setting up the culture:
(All containers, instruments and solutions are sterile)
1. Inject 15 - 20 ml. freshly drawn blood into a universal
container containing commercial heparin.
2. Add 0*1+ ml. phytohaemagglutinin, leave in iced water for
30 minutes and then centrifuge gently (350 r.p.m.) for 5-10
minutes. By this time the red cells have sedimented and
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the majority of the nucleated cells are In suspension in
the plasma.
With a syringe and long needle transfer the plasma containing
the cells into a clean universal container.
Mix by aspiration and do a nucleated cell count.
The cell count is adjusted to between 1,000 and 2,000 cells
per cubic millimeter by the addition of tissue culture medium
199. Usually, the final suspension has 1 part plasma:
h parts 199•
Six to 10 ml. aliquots of the final suspension are set up in
universal containers.
The cultures are incubated at 37°C for approximately 2 to 3 days.
Cytological processing:
Three hours before harvesting the culture, 0*1 ml. of 0*02 per
cent solution of eolcemid is added for each ml. of culture.
After the eolcemid has been in the culture for about 3 hours,
the culture is well shaken and transferred to a 15 ml.
centrifuge tube. It is then spun down and the supernatant
fluid removed leaving only one drop in which the cells are
resuspended.
The cells are resuspended in 5 - 10 ml. of 0»95 per cent
solution of sodium citrate previously warmed to 37°C and left
in this solution for 15 to 30 minutes.
The cells are spun dovm and the sodium citrate removed except
for one drop in which the cells are resuspended. Two ml. of
fixative, consisting of 3 parts ethyl alcohol:1 part glacial
acetic acid, is added to the cells very slowly and carefully,
with constant agitation of the cells.
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5. The cells can "be stored in this fixative in the refrigerator.
3. Preparation of slides;
1. The cells are spun down from fixative immediately prior to
making the slides. The fixative is removed and the cells are
resuspended in fresh fixative consisting of 3 parts methyl
alcohol:1 part glacial acetic acid.
2. The cells are again spun down, the fixative removed and they
are resuspended in fresh fixative consisting of 3 parts methyl
alcohol:1 part glacial acetic acid.
3. A clean slide is immersed in iced water till it is cold, the
excess water is shaken off and a couple of drops of the cell
suspension are dropped on the slide. The majority of cells
immediately stick to the slide 'sdiich is then quickly tilted on
filter paper and the excess liquid drawn off. The slide is
immediately waved vigorously over a spirit lamp until
completely dry. This usually takes about 20 seconds. (A
hair dryer can also be used for the same purpose).
i+. The slide is stained in 1 per cent solution of aceto-orcein
for 20-60 minutes, rinsed quickly in k5 per cent acetic acid,
dehydrated, cleared and mounted.
Solutions
1. Heparin - Evans Pulvarin Heparin.
2. Phytohaemagglutinin - Burroughs Wellcome Phytohaemagglutinin,
diluted as suggested by the manufacturers.
3. Tissue culture medium 199 Glaxo Laboratories.
Eagle's medium is equally satisfactory.
U. Colcemid - Ciba Laboratories.
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5. Acetic Orcein - 1 gm. synthetic orcein added to 60 ml. hot
glacial acetic acid, cooled, then 1+0 ml. distilled water added
and then filtered.
Method of obtaining chromosome preparations from cultures of the
ovarian teratoma
The technique used was hased on that described by Harnden (i960)
for obtaining chromosome preparations from skin biopsy. The steps
involved are: 1. Setting up the culture.
2. Maintaining the culture.
3. Cytological processing.
1+. Preparation of slides.
1. Setting up the culture:
The biopsy material is cut into pieces of approximately 1 mm.
square and placed in the bottom of the culture bottle (baby feeding
bottle). The pieces of tissue are embedded in a plasma clot by
adding equal amounts of chick embryo extract and cock plasma.
Culture fluid is added. The bottle is gased with 5 per cent COg
in 02, sealed and kept at 37°C.
2. Maintaining the culture:
1. The primary culture is left untouched for up to 5 days by which
time cells should have started to emerge from the explants.
2. The medium is now changed three days a week throughout the life
of the culture.
3. Aftfetr 10 days or a fortnight cells should have spread extensively
from the explants. The medium is removed and replaced by pre-
warmed 0*25 per cent trypsin in Ca and Mg free flanks' solution.
The culture is then incubated for about 10 minutes at 37° C
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which time the cells should have detached from the bottle. The
fluid containing the cells is collected and centrifuged very
gently for 5 minutes and the pellet resuspended in culture fluid.
i+. This suspension is transferred to a culture bottle with an
appropriate amount of culture fluid (10 ml. to an 8 oz. baby
feeding bottle). The bottle is gased with 5 per cent C02 in
air and sealed with a silicone rubber bung and incubated.
5. After a few days the bottom of the bottle is covered with a
monolayer of cells. This culture is trypsinized and routine
subcultures made from it.
3. C.ytological processing;
1. Select a culture showing numerous mitotic figures; a moderately
heavy culture about 2k hours after subculture is usually suitable.
2. Colchicine to a final concentration of 0*00025 w/v is added without
interrupting incubation and allowed to act for about k hours.
3. The cells are then digested and collected as for a subculture
but they are resuspended in Hanks basic salt solution. They
are immediately spun again and resuspended in 0*95 per cent
sodium citrate and the hypotonic treatment continued for about
20 minutes.
1+. The cells are then spun down at 500 r.p.m. for 5 minutes and the
supernatant decanted.
5. The cells are flicked up in the remaining drop of liquid and
fixative (3 parts absolute alcohol:1 part glacial acetic acid)
added very slowly. The cells are left to fix for at least
30 minutes.
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1+. Preparation of slides:
The fixative is replaced by 75 per cent acetic acid and one
or two drops of the suspension are placed on a clean slide which
has been standing in iced water (the surplus water has been shaken
off) and the slide is immediately dried. The slide is stained in
2 per cent acetic orcein for at least 3 hours at 37°C, rinsed
quickly in U5 per cent acetic acid, dehydrated, cleared and mounted.
The culture fluid
This consists of:
70 per cent Eagle medium (Burroughs Wellcome)
20 per cent human serum
10 per cent chick embryo extract.
The pH of the medium is adjusted to 7*2 by means of bicarbonate
which equilibrates with the C02 in the gas phase. Kanamycin is
routinely used as an antibiotic. Penicillin and cephalosporin
are kept in reserve.
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CHAPTER 3
»1<iii ■una ■■ iiiii ■ in
SgX CHROMATIN AND CHROMOSOME ANALYSIS IN OVARIAN TERATOMA3
The development of ideas about the nature and origin of
teratomas provides an interesting reflection of the rate of progress
in methods of scientific investigation. Theories of teratogenesis
may he seen to have followed four phases.
The striking foetus-like characteristics of the teratoma
have been known for centuries and these encouraged the belief that
they were the product of conception in the form of an included twin
or an ovarian pregnancy or as the outcome of parthenogenesis
(Blackwell et al. 19U6). These speculations were based on simple
observations of the gross morphology of teratomas.
Later, the application of rigorous histological techniques to
these specimens quickly exposed the Inaccuracies and exaggerations
of earlier descriptions and discredited the idea of the foetal
nature of these tumours (Nicholson 1930). The alternative
suggestion was developed that teratomas are neoplasms originating
from foci of cells which, at a very early stage of embryogenesis,
escape from the control of primary organizers (Willis I960). These
cells retain their primitive totipotency and may produce tumours
which contain tissues representative of all three germ layers, but
they totally lack any vertebral organization.
The recent demonstration of sex chromatin (Barr and Bertram,
19k9) provided one method of testing these conflicting hypotheses.
The concept of the teratoma as a neoplasm implied that it should
have the same genetic sex as the host, whereas older ideas of the
feotal nature of the teratoma suggested that there might be some
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discrepancy "between the sex of the host and the tumour. The first
report of sex chromatin studies on teratomas revealed such a
discrepancy in that some testicular teratomas proved to be chromatin
positive (Hunter and Lennox 195*4-) • Since then, a large number of
similar studies on both female and male teratomas have been reported
(Tavares, 1955J Moore and Barrj 1955t4 Levij, 1955; Sohval and
Gaines, 1955, Mancini, 1956; BrCin*ing, 1956; Riviere, 1956;
Tavares, 1958; Maltzeff and Sacco, 1958; Myers, 1959; Hiens, I960;
Theiss et al. I960; Taylor, 1963a; Girelll and Higoli, 1963;
Talwalker, 1963; Taylor, 1965)• Undoubtedly, sex chromatin gives
invaluable information about the X chromosome complement of the
cell. However, it is less reliable in malignant tissues (Lennox,
1963); it is subject to technical misinterpretations (Lennox, 1963);
it gives no idea of the Y chromosome complement of the cell; and it
gives no information about autosomes.
Consequently, it is now necessary to supplement sex chromatin
studies with full chromosome analysis. So far, only three reports
describing a total of 8 teratomas have been described (Galton and
Benirschke, 1959; Corfman and Richart, 196*4.; Harnden, 1965). We
have studied the sex chromatin pattern in 187 ovarian teratomas.
In 6 other cases, chromosome analysis was also performed.
Material and Methods
The material for the sex chromatin study was selected from the
material collected in the department over the past 10 years. One
hundred and eighty seven specimens were considered adequate for study.
All of these were benign ovarian cystic teratomas with the single
exception of one solid histologically benign teratoma. The
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specimens had been fixed in formalin or Zenker fluid and the
slides were stained with haematoxylin and eosin. In a few cases,
additional sections were cut and stained with the Peulgen method.
Various tissues were studied in each specimen hut squamous
epithelial cells were selected for routine counting, 100 suitable
nuclei being studied in each case.
Six fresh benign cystic teratomas were subjected to
chromosome analysis, according to the method previously outlined.
Prom each specimen, several representative pieces of tissue were
taken. Each was divided into two parts, one for histologic study
and the other for tissue culture, in order to allow accurate
correlation between the nature of the tissue and its chromosome
constitution. The small fragments of tissue were grown as explants
In plasma clots and chromosomes were prepared from subcultures.
Results
Sex chromatin: In the 187 specimens we studied, the
percentage of cells with demonstrable sex chromatin varied between
23 and 8? per cent with a mean of 56 per cent. The sex chromatin
was well demonstrable in almost all tissues of the teratoma
(Pigs. 122, 123, 12kt 125)* In several tumours, an occasional
cell appeared to show double sex chromatin, but in no case was this
the predominant cell type. These findings indicate that our specimens
were chromatin positive as in normal female tissues.
Chromosome analysis: The distribution of chromosome counts
is shown in Table XXV.
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mm 5k 1 2 -
2k6 2k 3
!
1 1 18 - - 1
231 k - - - k - mm -
239 17 1 1 1 11 1 1 1
280 k2 5 2 k 30 - - 1
TOTAL 15k 9 7 7 123 2 3 3
As is shorn in the Table, a total of 13k cells were counted,
of which 123 had k& chromosomes, 23 had counts in the hypoploid
range and 8 cells were hyperploid. Sndoreduplication was noticed
in one cell from case no.259. Visual analysis revealed a normal
karyotype in all 6 cases (Pig* 126). Case no. 280 showed a minor
structural variation, two members of the D group having marked
enlargement of the short arms. This is unlikely to be of
significance and is regarded as a normal variant (Court Brown et al.




The results of* previous studies of sex chromatin in ovarian
teratomas, together with our own data, are summarized in Table XV.
The vast majority are chromatin positive, hut a few have been
reported as chromatin negative. Undoubtedly, some of these
anomalous results were derived from material which was unsuitable
for the demonstration of sex chromatin. Furthermore, in any
highly malignant tissue there may be anomalous sex chromatin and
this may explain some of the chromatin-negative malignant ovarian
teratomas (Lennox, 1963)• There is also one well-documented benign
ovarian teratoma which contained double sex chromatin (Taylor, 1962).
Similar results from studies on extra-gonadal teratomas in females
have been reviewed by Taylor (1963a), and comparable findings of
chromatin negative and doubly chromatin positive cells have been
reported. It seems likely that whereas the majority of female
teratomas have a "female" sex chromatin pattern, a few may show
anomalous nuclear sex.
The results of sex chromatin studies in male teratomas, both
testicular and extragonadal, have been reviewed by Ashley (1962)
and Taylor (1963a). Here, the findings are even more striking in
so far as 2+0 per cent are chromatin positive, while a few cases of
sex chromatin mosaicism and double sex chromatin have also been
recorded. Many testicular teratomas are highly malignant and this
may invalidate the interpretation of some of these results. Never¬
theless, anomalous sex chromatin has been clearly demonstrated in
benign male teratomas and it is impossible to dismiss all of these
results as artifacts.
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These findings suggest that there may "be some discrepancy
between the nuclear sex of the host and that of the teratoma, and
so cast doubt on the concept of the simple neoplastic origin of
these tumours and raise again the possibility of their origin from
germ cells. One simple explanation would be that these anomalous
tumours may arise in hosts with similarly abnormal sex chromatin.
Teratomas have been rarely described in males with Klinefelter's
syndrome (Taylor, 1963a), but it has been firmly established that
the majority of teratomas occur in hosts with normal sex chromatin
(Myers, 1959; Ashley and Theiss, 1958; Ashley and Mostofi, 1959;
Court-Brown et al« I960),
The most plausible theories of teratogenesis from germ cells
are based on hypothetical mechanisms of parthenogenesis.
1. Normal haploid gametes may fuse to form diploid cell (Hunter and
Lennox, 1954). In the female, the fusion of haploid, 23X,
cells would invariably produce chromatin positive diploid cells,
46jxx, In the male, the presence of both X-bearlng, 23X, and
Y-bearing, 23Y, cells could combine to form diploid cells with
XX, XY, or YY sex chromosome complement in the ratio of 1:2:1.
f
If YY cells are non-viable, this ratio becomes XX:XY - 1:2.
2. .Reduplication of haploid gametes could also produce diploid
cells (Tavares, 1955). In the female, this would invariably
produce chromatin-positive cells, 46XX. In the male, it would
produce equal numbers of chromatin-positlve cells, 46^X, and
chromatin-negative cells, 46/YY. This theory implies that cells
with a YY sex chromosome complement are viable. Data derived
from the ratio of chromatin-positive to chromatin-negative male
teratomas are still inconclusive in favouring either of these
128
hypotheses (Taylor, 1965).
3# Meiotlc nondisjunction may "be followed "by the fusion of aneuploid
gametes (Taylor, 1962). By such a mechanism, chromatin-negative
teratomas may have a U5^0 chromosome constitution, chromatin-
positive male teratomas may have LtffexYf and doubly chromatin-
positive teratomas may have Ij-T^CXX.
Other mechanisms such as failure of reduction division or
polyploidy are also possibilities. There are undoubted
difficulties to all of these parthenogenetic theories. The most
serious problem is that meiosis is thought to occur in males only
after puberty (Hamilton, et al. 1962), while the first meiotic
division in oogenesis occurs during intra-uterine development but
is arrested at the dictyotene stage (Ohno et al. 1962).
It is clear that these hypothetical suggestions can be
elucidated only by full chromosome analysis. So far, Galton and
Benirschke (1959) have studied one malignant ovarian teratoma,
Harnden (1965) has analysed one benign solid teratoma, and Gorfman
and Rlehart (196U) have studied six benign ovarian cystic teratomas.
Our own report adds a further 6 benign tumours. All of th se have
proved to have a normal diploid female karyotype,
This evidence excludes the possibility that teratomas may
themselves be haploid. Furthermore, they have a normal karyotype
and do not have any autosomal anomaly. This latter possibility
may be suggested by the finding of an extra autosome in an amorphous
acardiac foetus (Rashad and Kerr, 1965). The features of disordered
organogenesis in this foetus were very similar to those of some
teratomas.
These studies do not provide an answer to the origin of
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anomalous sex chromatin in some teratomas since all our specimens
were normally chromatin positive. Further information is more
likely to come from chromosome analysis of testicular teratomas.
The study of chromatin-positive male tumours should give definite
evidence as to the histogenesis of teratomas.
SUMMARY
Nuclear sex was studied in 187 cases of benign ovarian
teratoma and chromosome analysis was performed in 6 cases after
culture. All cases studied were chromatin positive and the
chromosome analysis in the 6 cases showed a h£/XX pattern. The
bearing of these results on the problem of the histogenesis
of the teratomas is discussed.
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TABLE XV
Sex chromatin studies in female gonadal teratomas










Levij (1955) 20 20
Sohval and Gaines




Mancini (1956) 12 12
'
BrGning (1956) 50 21 9 20
Riviere (1956) 64 64
Maltzeff and Sacco
(1958) 4 4
Myers (1959) 47 47




Taylor (1963a) 12 10 1 1
Girelli and Rigoli
(1963) 12 10 2
Talwalkar (1963) 12 12
Present
investigation 187 187
TOTAL 520 475 1 21 23
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CHAPTER h
THE RrlLATION8IIIP B Tr.. OVARIAN TUMOURS AND INTERSEX STATE:
WITH SPECIAL REFERENCE TO THE DIoGiaMINCMA AND ARHUEH03LRSTCMA
The association "between intersex states and ovarian tumours,
particularly the disgerminoma and arrhenohlastoma, has at least
two points of interest. It has immediate relevance to our under¬
standing of the nature and histogenesis of these tumours, and it
is of practical importance to the clinician in his management of
intersex states.
In the first three decades of this century many clinical and
pathological studies of this problem were reported and this epoch
may "be said to have ended with a more or less general acceptance
of Robert Meyer's views. In a series of publications (1931a»
1931b), he drew a sharp distinction between two types of ovarian
tumour «foich are associated with intersex states. In one variety,
which he called disgerminoma, he postulated that the intersex state
favoured the occurrence of the tumour, but the tumour was in no way
responsible for the abnormal sex development. The other type he
called arrhenoblastoma and suggested that this tumour was itself
directly responsible for virilization so that the intersex state
was reversible when the tumour was removed.
Meyer wrote disgeriainoma with the prefix "dis". Most later
authors have used the spelling with the prefix "dys", implying that
the germinal cells from which the tumour arises have undergone an
error of development or differentiation. For historical reasons we
have preferred to use Meyer's original spelling.
The introduction of methods of analysis of chromosomes and
sex chromatin has led to a better understanding of intersex states
132
and this new information has raised several problems ^foich appear
to complicate Meyer's concepts. Morris (1953) suggested that some
tumours which had been previously reported as arrhenoblastoma? may
in fact have been testicular tumours occurring in association with
the syndrome of testicular feminization in genetic males.
Carpentier et al. (1956 ) went further and postulated that some
other ovarian tumours, particularly the disgerminoma and chrdri-
carclnoma, may also be derived from testicular tissue. Overzier
(1963) considered that an intersex state should be suspected in
every patient with a disgerminoma. Scott (1965) has gone so far
as to suggest that an intersex state may underlie the development
of all disgerminomas in the female, and he advocates a return to the
term used by early French pathologists, seminoma ovarii. He implies
that the testicular seminoma and the ovarian disgerminoma are
identical and postulates that the presence of either of these
tumours is dependent on the presence of an XY cell line in the
gonad.
It seems timely to attempt a synthesis of both the cytogenetic
and pathological evidence on this problem. In this chapter, we
describe the results of a combined cytogenetic and histological study
of 5 cases of disgerminoma and 5 cases of arrhenoblastoma, and present
a critical analysis of the relevant literature.
HfrtSrla,! fflcl Methods
The material for this study consists of all the cases of
these rare tumour types that were encountered in our files during
the period of 10 years covered by our general review. Three other
cases of disgerminoma were included in this study: one more recent
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case, and two cases from the files of the pathology department
of the Royal Hospital for Sick Children, Edinburgh (by the hind
permission of Dr. A.D. Bain). The histopathology of the original
slides was re-assessed. Sex chromatin was studied in slides
stained both with haematoxylin and with Peulgen. The clinical
records of each patient were reviewed, and whenever possible the
patient was recalled for assessment of sex chromatin from a buccal
smear, and for chromosome analysis of peripheral blood leucocytes.
Case reports and results
Case 1: The patient was 59 years old. She married at the
age of 1+6 and had no children. Her periods were regular until the
menopause at 52 years. Seven years later, she presented with
postmenopausal bleeding. A pelvic tumour was detected, and total
hysterectomy and bilateral salpingo-oophorectomy were performed.
Fifteen months later, she died with a recurrent abdominal mass.
The left ovary was replaced by a disgerminoma and dermoid
cyst, and the uterus contained multiple fibroids. Normal ovarian
tissue could not be found in the sections made from the tumour, but
the other ovary was normal. The squamous epithelium of the dermoid
cyst, the healthy ovary and the uterine fibromuscular tissue proved
to be chromatin positive. Some of the cells of the disgerrainoma
appeared to be chromatin positive but in general these nuclei were
unsuitable for analysis. However, the fibroblasts of the stroma
of the tumour were definitely chromatin positive.
Case 2: The patient was 16 years old and unmarried. Her
periods began at the age of 15 and were subsequently irregular.
Examination revealed a large pelvic tumour, and the urine showed a
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high titre of chorionic gonadotrophin. At first, she was thought
to he pregnant hut a laparotomy was subsequently performed. A
large right ovarian tumour was found, and a total hysterectomy and
bilateral salplngo-oophorectomy performed. The clinical and endo¬
crinological aspects of this unusual case have already beer-
reported (Hobson and Baird, 1966)•
The ovarian tumour was a disgerminoma, and a corpus luteum
was found in the right ovary immediately adjacent to the tumour
cells (Pig. 127)# The other ovary was normal and the endometrium
was in the secretory phase. The healthy ovary, myometrium and
tumour stroma were chromatin positive. (Pig. 128). The tumour
cells were unsuitable for the demonstration of sex chromatin. A
buccal smear was chromatin positive, and chromosome analysis of
peripheral blood leucocytes revealed a normal female karyotype,
U6/XX (Pig. 129) .
Case 3: The patient, viho was 18 years old and single,
presented with abdominal distension, hypertension, proteinuria and
pretibi'al oedema. At first she was thought to be pregnant with
pre-eclamptic toxaemia, but pelvic examination revelaed a swelling
discrete from the uterus. Subsequent laparotomy showed a tumour
of the left ovary and left oophorectomy was carried out.
The ovarian tumour was a disgerminoma (Pig. 130). Nuclei of
the tubal epithelium and of stromal fibroblasts of the tumour were
chromatin positive (Pig. 131)» but the tumour cells were unsuitable
for analysis. A buccal smear was chromatin positive, and
chromosome analysis of peripheral blood leucocytes revealed a normal
female karyotype, ij-6/XX (Pig. 132).
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Case U: The patient was 19 years old and unmarried. She
had a laparotomy at the age of 7 when she presented with an
abdominal tumour. The right ovary contained a large tumour, and
right oophorectomy was followed by a course of radiotherapy. At
the age of 19 years she was treated for an incomplete abortion.
The ovarian tumour was a disgerminoma (Pig. 133). Although
the tumour cells were unsuitable for analysis, the stromal elements
were chromatin positive. She had a chromatin positive buccal
smear, and chromosome analysis showed a normal female karyotype,
b6/XX (Pig. 13U).
Case 5: The patient was h years old and presented with
a symptomless abdominal swelling. At laparotomy a left ovarian
tumour was discovered and the left ovary was removed.
This tumour was a disgerminoma with marked lymphocytic
reaction. The tumour cells were unsuitable for analysis, but
stromal elements were clearly chromatin positive. This patient
could not be traced for further cytogenetic investigation.
Case 6; The patient was 16 years old and presented with
primary amenorrhoea. There was normal breast development, but
infantile external genitalia, and neither axillary nor pubic hair.
At laparotomy, there was no uterus and the gonads were slightly
enlarged and lay on the brim of the pelvis. Both gonads were
removed.
The gonads were at first reported to contain bilateral well-
differentiated arrhenoblastomas, of testicular tubular adenoma type
(Pig. 135)• The capsules of the tumours resembled ovarian stroma
but contained no follicles. The tubular elements of the tumour
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were lined with Sertoli cells "but there were no spermatogenic
elements. There were occasional collections of Leydig cells.
The nuclei of the stroma cells, Sertoli cells and Leydig cells were
chromatin negative.
Prior to our investigation, this patient had already "been
found to have a chromatin negative buccal smear and a normal male
karyotype, L\6/XK (MacGregor, 1966). This is an illustration of
the association of a testicular tubular adenoma with the clinical
syndrome of testicular feminization in a genetic male.
Case 7: The patient was 18 years old and presented with
primary amenorrhoea. At subsequent laparotomy, the uterus was
absent and gonads were found to be enlarged. Both gonads were
removed.
Again, these gonadal tumours were at first thought to be
well-differentiated arrhenoblastoxaas and the histological picture
was identical to that described in case 6. The nuclei of both
the tumour cells and stromal cells were chromatin negative.
Nuclear sexing and chromosome analysis had been performed
prior to our investigation, and the patient proved to be chromatin
negative with a normal male karyotype, 1+6/XY, (KacGregor, 1966).
This case represents another example of the association between
testicular tubular adenoma and testicular feminization.
Case 8: The patient was 2b years old. She had been married
for four years and had one child aged one year. She presented with
secondary amenorrhoea and hirsutism following delivery. At
laparotomy she was found to have a left ovarian tumour and this was
removed. Following this operation her periods returned, the
hirsutism disappeared, and she subsequently had two further pregnancies.
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This tumour was an arrhenohlastoma of intermediate to
sarcomatous type (Fig. 55). The Sertoli cells, Leydig cells and
stromal elements of the tumour were chromatin positive (Fig, 136).
The patient could not he traced for further examination.
Case 9: The patient was 1Z+ years old and presented with
abdominal pain and swelling. There was no evidence of virilization
and she had not reached the menarche. At laparotosay, a large cystic
left ovarian tumour was removed. She died with a pelvic
recurrence 21 months later.
The tumour was an arrhenoblastoma. Nuclei of the stromal
elements of the tumour were chromatin positive but nuclei of the
tumour cells were unsuitable for analysis.
Case 10: The patient who was married and aged 2U> presented
with abdominal swelling of recent onset and secondary oligo-
menorrhoea for four years. At laparotomy, a large right ovarian
tumour was removed.
The tumour was a well-differentiated arrhenoblastoma. The
histological picture shov/ed a predominantly tubular pattern with
a few areas similar to granulosa cell growth. Nuclei of both
tumour cells and stromal fibroblasts proved to be chromatin positive.
Tliis patient could not be traced for further investigation.
In summary, all five patients with a disgerminoma were
phenotypically normal and had a normal female sex chromatin pattern,
while three of them had a normal female karyotype. Of the five
tumours originally diagnosed as arrhenoblastomas, two proved to be
testicular tubular adenomas replacing the undescended testes of
genetic males with the testicular feminization syndrome.
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DISCUSSION
For the purpose of clarity, the discussion will he divided
into 3 parts:
1. Gonadal tumours in intersex patients; a general survey.
2. Disgerminoma and intersex states
3. Arrhenohlastoma and intersex states.
1. GONADAL TUMOURS IN INT>HdhX IWTlElSfTS: A GENERAL SURVEY
The realization that the gonads of intersex patients may he
the seat of tumour formation is comparatively recent. According
to Gilbert (19U2), the first case describing this association was
that of Gruber (1859)• Gilbert (19U2) reviewed the literature
and reported on 61 cases, including one of his own. Melicow and
Uson (1959) judged the number of cases in the literature to be
about lhO but they apparently did not take into consideration the
overlap between the various series mentioned in their review.
Many of the reported cases, however*, do not lend themselves to
proper analysis. The replacement or destruction of the gonadal
tissue by the tumour, especially if it is malignant, may render
the diagnosis of the gonadal sex difficult or impossible. This
is especially so if the tumour Is bilateral and replacing both
gonads or if it is unilateral but the opposite gonad is absent or
rudimentary. The introduction of the methods of nuclear sexing
and chromosome analysis in man has proved a great aid in these
cases. A brief review of the occurrence of gonadal tumours in
the various types of intersex will now be given.
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True hermaphrodites:
Tumours of both testicular and ovarian types have been
encountered in the bisexual gonads of true hermaphrodites.
Tumours have been described in the ovotestis (Essenberg and
Feinberg, 1937| Botella-Llusia, I960), in the testis (Stirling,
1959) and in the ovary (Gresham and Pairgrieve, I960; Bani, 1956;
Weed et al. 19^7) • It is possible that tumours in true
hermaphrodites are more frequent than ihat may be gathered from
the case reports. The histological direct evidence of the bisexual
nature of the gonads may be lost when a tumour replaces most of the
gonad. Indirect evidence for true hermaphroditism aay be suggested
by the presence of an ovarian tumour of a type not encountered in
the testis, in association vwith testicular tissue in the same or
opposite side, even if no definite ovarian tissue could be
demonstrated (Vaughn and Gonzales-Angulo» 1961)• Cverzier (1963)
also pointed out another possible indirect evidence in these cases,
if only one type of gonadal tissue is present. This is to
demonstrate the opposite nuclear sex in the presence of mature
testicular or ovarian tissue, cases of Klinefelter1s syndrome
being excluded.
Male ps^^ohe^phro^^sr
A main feature of male pseudohermaphroditism is cryptorchidism.
The liability of the undescended testes to neoplastic change has
been documented by various studies (Gilbert and Hamilton, 19b-0j
Campbell, 1959)* decent figures from the testicular tumour panel
show that 6*6 per cent of patients with tumours of the testis either
exhibited or gave a history of delayed testicular descent
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(Fergusson, 1962). It is also recognized that the abdominal
testis carries more risk of malignancy than the inguinal testis
(Campbell, 1959). The exact underlying factor for this peculiar
predisposition to neoplasia in the undescended testes is not known.
It may be accounted for by the abnormal ectopic location of the
testis where it is exposed to small unnoticed traumatic disturbances,
either by muscle movement or direct violence or by the loss of the
important heat-regulating mechanism of the scrotum (Murray and Ewert,
19U7). It has also been suggested that a common factor may underlie
both the testicular maldescent and the predisposition to neoplasia.
Willis (i960) has suggested that the occurrence of the neoplasm in
the retained testis has perhaps an endocrine background and that
ectopia is only one expression of the gonadal anomaly or of a more
general endocrine anomaly predisposing to tumour formation in the
gonadal tissues. Sohval (1956) suggested a defect of gonadal
development, testicular dysgenesis, to account for the liability to
neoplasia in these cases. The tumour commonly found in the ectopic
testes of male pseudohermaphrodites is the benign testicular tubular
adenoma first noticed by Pick in 1905. This tumour is often
encountered as an accidental finding, sometimes microscopic, in the
ectopic testis, but it may replace the whole testis and may reach a
large size (Neubecker and Theiss, 1962). The adenoma is formed of
tubules lined by Sertoli cells. In the opinion of several authors,
these Sertoli cell adenomas are not neoplasms in the ordinary sense
but rather simple hyperplasias or hamartomas (Stalker and Hendry,
19521; Langley, 195U; Craig et al. 1961} Neubecker and Theiss,
1962). Their uniformity, marked differentiation and occasional
multiplicity in the same testis support this interpretation.
11ll,
Sertoli cell adenomas are very rarely encountered in the other¬
wise normal testis. Of the 17 cases reviewed by Stalker and
Hendry in 195k» 11 were in pseudohermaphrodites and 6 in the
ectopic testes in otherwise normal persons. Adlington and Salia
(I960) reported bilateral tubular adenomata in the scrotal testes
of a mentally retarded and enuretic baby.
The second type of benign tumour that may be encountered in
the testes of these patients is an interstitial cell adenoma or
Leydig cell tumour (Daino et al. 1963)* Hyperplasia of Leydig
cells is usually apparent in undescended testes and sometimes is
so marked, or localized as to suggest an adenoma.
Malignant testis tumours of all types have been found in these
cases. The commonest is the seminoma but tupours described as
embryonal carcinoma (Gilbert, 1942)> terato-carcinoma (Taub, 1954)»
malignant teratoma (Carmichael and Oldfield, 1934) and chorion-
epithelioma (Buffalo, 1933) have all been encountered. A mixture
of tumour types may also be encountered (Taub, 1954).
Testicular feminization syndrome
The peculiar type of male pseudohermaphroditism associated
with complete external feminization deserves special discussion.
Hie term testicular feminization was given to this condition by
Morris in 1933* Morris also noted the liability of these patients
to develop testicular tumours. In a review of 82 cases, he found
7 with malignant tumours and 23 with benign testicular adenomas.
Because of the risk of malignant change, Morris urged the view of
prophylactic removal of the gonads in these patients. Hauser
(1963), however, pointed out that the risk of malignant change,
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estimated from the collected reviews of reported cases, is some¬
what exaggerated "because in the past this was a common type of
clinical presentation. The diagnosis of the syndrome v/as seldom
made in patients presenting with primary amenorrhoea and was only
made if operative exploration was required for some complication.
Nowadays, fewer cases are encountered presenting primarily with a
tumour. Morris and Mahesh (1963) noted that of fifty reported
cases, 30 years of age or older, eleven had malignant tumours.
This, however, may not really represent a high incidence of
malignancy above the age of 30, as the authors interpreted, but
rather that 11 out of 50 cases who present with testicular
feminization after the age of 30, do so because of the presence of
a malignant tumour. This is possibly partly due to the fact that
fewer and fewer patients present with conditions such as primary
amenorrhoea and sterility after the age of 30 years. A comforting
observation, in this connexion, is that no malignant tumour has been
reported in these cases below the age of lh years. These patients,
therefore, should undoubtedly be left to complete their puberty
before castration is considered*
A curious feature of the testes in this syndrome which is very
rarely encountered in other types of cryptorchidism is their
liability to cyst formation. These cysts may be large enough to
be an indication for operation (Morris and Mahesh, 1963).
Female pseudohermaphroditism
The ovaries of female pseudohermaphrodites are rarely the
seat of tumour formation. The alleged relation of the ovarian
disgerminoma to intersex states will be dealt with more fully in
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another part of this discussion. Claret and Mcintosh (1951+)
reported a dermoid cyst in the ovary of a female pseudohermaphrodite.
An interesting case of endometriosis in a female pseudohermaphrodite
reared as a male and presenting unusually as renal colic was
reported by Zielinski and Szkodny (1961+). Case 1 of Melicow and
Uson (1959)# In vfoich the patient was interpreted as a female
pseudohermaphrodite, is doubtful. Corpora albicantia and
granulosa cysts were described but no follicles, the histological
type of the tumour (a teratocarcinoma) is unusual in the ovary,
the mascullnization of the patient suggests the presence of
functioning testicular tissue, the opposite gonad was absent and
the result of chromatin sexing in the patient was stated to be
doubtful.
Adrenogenital syndrome.
To my knowledge, there have been no reports of tumour formation
in the ovaries of patients with the adrenogenital syndrome. Hilar
cell proliferation was, however, noted in some cases (Landing, 195*+;
Hooft, et al. 1956). It may be difficult to distinguish these from
nodules of aberrant adrenal tissue. It is interesting to note that
adrenogenital!sm in males may also be associated with hyperplastic
testicular adrenal rests which may be difficult to distinguish from
a testicular interstitial cell tumour (Glenn and Boyce, 1963; Miller
and Murray, 1962).
Klinefelter syndrome
In spite of the testicular dysgenesis, tumours seem to be very
uncommon in the testes of patients with this syndrome. An
embryonal cell carcinoma was reported by Beattie (1957). An
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interstitial cell tumour was reported by Arduino and Glucksman
(1963) • The nuclear sex of patients with testicular tumours
was investigated by Ashley and Theiss (1958) and found to be male.
In an interesting case presented by Klotz et al. (1959)# the father,
grandfather and grand uncle of a patient with Klinefelter*s syndrome
had had cancer of the testis. The authors considered, in view of
the rarity of malignant tumours in the testes of patients \yith
Klinefelter's syndrome that this strong family history did not
justify a prophylactic orchidectomy.
Gonadal dysgenesis
Gonadal dysgenesis, where both gonads are represented by
remnants of tissue that do not contain any germ cells, should in a
discussion of gonadal tumours, be clearly differentiated from
mixed or atypical gonadal dysgenesis, and from the condition of
rudimentary testes. In mixed gonadal dysgenesis a testis is
present on one side and a primitive undifferentiated gonad or no
gonad is on the other side (Sohval, 1961+). The replacement of the
testis by a tumour, in a patient with mixed gonadal dysgenesis may
make its differentiation from gonadal dysgenesis almost impossible.
In the syndrome of rudimentary testes, the gonads are rudimentary
but contain recognizable testicular tissue (Boczkowski and Teter,
1966).
Tumours have been described in the streak gonads of patients
with gonadal dysgenesis but these were all benign and possibly more
hyperplastic than neoplastic. In h cases described by Stange
(1957) the tumours were two cases of hilus cell hyperplasia, an
early Brenner tumour and a rete adenoma. Another hilus cell
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adenoma in a streak gonad was reported "by Warren et al. (1961+).
Cases of mixed gonadal dysgenesis with a tumour in the testis
have been reported. In these, histological evidence of testicular
tissue was still available in spite of the presence of the tumour
(Teter and Tarlowski, I960; Ober, 1962; Reddy and Vittal, 1963;
Lewis et al. 1963a» Miller et al. I960; Naidu et al. 1965;
Pinkerton, 1965). In the case of Ober (1962), the ovarian-like
stroma in the rudimentary gonad was taken as an evidence for its
being an ovary (in the absence of ovarian follicular structures or
germ cells), and the intersex state was therefore interpreted as
true hermaphroditism. In view of the absence of ovarian paren¬
chymatous tissue, the case is here regarded as one of mixed
gonadal dysgenesis.
Tumours in a testis, with the opposite gonad represented also
by a rudimentary testis, have been reported (Robinson et al. 1962+;
Teter et al. 196i+b; Philip and Teter, 1961+).
The risk of the development of malignancy in the streak gonads
of patients with the classical Turner syndrome does not seem to be
significant. Dominguez and Greenblatt (1961+) reported a case. The
case of Toth and Feher (1962), however, was atypical in that an
enlarged clitoris was present.
Extra-gonadal tumours in intersexes
Apart from gonadal tumours, it is interesting to note that
extra-gonadal tumours have been occasionally noted in intersexes.
In some cases this was apparently a fortuitous association as in the
case of carcinoma of the caecum reported in a patient with testicular
feminization by Tranquade et al.(l962). and that of the bladder
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carcinoma in a male pseudohermaphrodite reported hy Hammar and
Forbes (1965) and that of the extra-gonadal teratomas in
Klinefelter"s syndrome mentioned by Taylor (1965). Carcinoma in
the female genital tract in male pseudohermaphrodites has also
been reported (Burkart et al. 1963» Smith, 1964). The incidence
of carcinoma of the breast in patients with the klinefelter syndrome
was stated to be similar to that in females (Jackson et al. 1965).
Mammary carcinoma in a true hermaphrodite was reported by
Moriarty (1944). Bilateral fibrocystic disease of the breast
with intra-ductal papilloma and epithelial hyperplasia has been
reported in a patient with testicular feminization, whose sister,
who also never menstruated, died of breast cancer (Caffrey and
Fritzlen, 1965). rfhe developmental proximity of the genital
ridge and the nephrogenic anlage imparts some interest to the case
of Wilms tumour reported in a male pseudohermaphrodite by Stump
and Garrett (1954) and to the case of nephroblastoma in association
with agonadism reported by Angstrom (1965). The possible role of
hypogonadism in the development of pituitary gland tumours has also
been discussed (Kelly, 1963). Willemse (1962) reported a patient
as suffering from Turner's syndrome and acromegaly. An interesting
point in this latter case was the apparent non-responsiveness of
the patient to the excessive amounts of circulating growth hormone.
Finally, it may be mentioned that leukemia was noticed to occur
much more frequently among individuals with abnormal sex chromosome
complements (Lewis et al. 1963b) and their relatives (Miller et al.
1961; Baikie et al. 1961).
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2. DISGEPUINOKAS AND INTERSEX STATES
Disgerminomas are most commonly found in the ovaries of
phenotypically normal women. Pregnancies have both preceded and
followed the removal of a disgerminoma (oantesson, 19U7), and at
least 23 cases of disgerminoma occurring during pregnancy have "been
reported (Pece, 1961+). Figure 127 shows a corpus luteum
immediately adjacent to tumour cells. The stromal cells in our
five cases were consistently chromatin positive. In our cases
the tumour cells were unsuitable for demonstrating sex chromatin,
but other authors have found a high incidence of sex chromatin in
some disgerminomas (Sohval and Gaines, 1955; Theiss et al. I960;
Hienz, 1961), Finally, we report here the results of chromosome
analysis in three patients with a disgerminoma in each of whom
there was a normal female karyotype, U6/XX. The evidence appears
to be incontrovertible that disgerminomas usually occur in the
ovaries of genetic females.
However, it is commonly believed that there is a significant
association between ovarian disgerminomas and intersex states and
statements to this effect appear in most of the standard textbooks.
The series of the 27 disgerminomas in intersex cases collected by
Meyer (1925, 1931b) forms the basis for this belief. However, it
has not been sufficiently recognized that Meyer used the term
disgerminoma to refer to tumours of both the testis and ovary and
that his series included no definite cases in female pseudohermaphrodites.
In fact, his series includes no example where the gonad which was
the site of the tumour could be definitely identified as an ovary,
and in only one of his cases was the other gonad shown to be an
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ovary. Furthermore, this latter case which was originally
reported "by Moots (1921) was subsequently considered to be an
arrhenoblastoma rather than a disgerminoma (Javert and Finn, 1951).
In another four of his cases, Meyer considered that the
contralateral gonad was probably an ovary, but this opinion was
not based on histological evidence.
This illustrates a peculiar difficulty in analysing the
cases reported in the literature. The nature of the gonad bearing
the tumour is often obscured by the tumour, and the structure of
the contralateral gonad is rarely described. For example, Meyer
could identify gonadal sex in only 7 out of his 27 cases.
The application of nuclear sexing and chromosome analysis to
this problem might be expected to supplement gonadal sexing based
on histological evidence. We have, therefore, collected from the
literature 36 cases of tumours of the seminoma-disgerminoma type in
intersex patients in which one or more of the following pieces of
information was available - a histological report on one or both
gonads, sex chromatin analysis, or chromosome analysis of the
patient. Fourteen of these tumours were described as seminomas
and the other 22 as disgerminomas. Cases reported as embryonal
carcinoma, teratocarcinoma and gonadoblastoma have been excluded.
A summary of these cases is presented in Table XVI. This provides
information on four specific points,
1. Nature of the gonad which contained the tumour?










The one case where the site of the tumour was identified as
an ovary was described "by Long et al. (19U1). This diagnosis was
apparently "based on the finding of ovarian stroma. However, this
cortical type of tissue is not specific to the ovary as it can also
be found in ectopic testes (Morris and Mahesh, 1963). Two other
features of this case suggest a testicular origin for this tumour.
The findings of a deep voice, hirsutism and penile erections suggest
that the patient was a male, unless it is assumed that the tumour
was actively androgenic. Secondly, calcified concretions were
present in the tumour. These are practically unknown in ovarian
disgerminoaas but are common in the tumours of dysgenetic testes
(Teter et al.. 196ii-b).
The three cases in which the tumour was found in an ovotestis
need further comment. In the case described by Essenberg and
Feinberg (1937) the tumour was situated in the testicular part of
an ovotestis. In the case originally described by Polano (1921)
and reviewed by Meyer (1925» 1931b), one gonad was replaced by the
tumour, while in the contralateral gonad, an ovotestis, Meyer found
a focus of disgerminoma cells in the ovarian component. Meyer
considered that this was a separate primary disgerminoma arising
in ovarian tissue, but it is difficult to exclude the possibility
that it may have been a metastatic deposit from the other gonad.
In the case of Botella-Llusia (i960) an early focus of what were
apparently disgerminoma cells was found between the testicular and
ovarian components of one ovotestis. In this case, the origin of
the tumour cannot be definitely ascribed to either testis or ovary.
One can conclude from these data that no case of intersex
with a disgerminoma has been reported where the tumour has been
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proven to have arisen in ovarian tissue. Undoubtedly, the vast
majority have arisen in testicular tissue.
2. Nature of the other gonad!
The nature of the gonad on the side opposite to the tumour
was reported as follows:
The two cases in which the other gonad was described as an
ovary were those of Essenberg and Feiriberg (1937) and Stirling
(1959)• In both cases the patient was a true hermaphrodite and
the tumour developed in a testis.
Two of the cases in which the nature of the gonad was not
identified deserve comment. In the case of Gorriden (191+9) both
gonads were replaced by tumour tissue. The gonad contained a
disgerminoma, and the author describes an epididymis attached to
this tumour. The other gonad was replaced by a typically ovarian
type of tumour, a mucinous cystadenoma, and this suggests that this
gonad was an ovary. This is most probably an example of true
hermaphroditism (Melieow and Uson, 1959)» Moehlig's case (191+2)
was unusual. One gonad, a testis, contained a disgerminoma, and
there were two other separate gonads in the pelvis. One of these
was removed and found to be a hypoplastic testis. The other gonad
was thought to be an ovary, but it was neither removed nor was a
biopsy taken.
One can conclude that in many intersex cases with a










which the contralateral gonad proved to be either a normal ovary
or an ovotestis, it is likely that the gonad which was the site
of the tumour was either wholly or partly testicular - i.e. all
of these patients were probably true hermaphrodites.
3. oex chromatin studies:
There is information about sex chromatin in 19 patients of
whom 16 were chromatin negative and three were chromatin positive.
The three chromatin positive cases require further comment.
In one case (Philipp and Stange, I960), only 23 per cent of nuclei
from a buccal smear were chromatin positive. This low count is
suggestive of some form of chromosomal mosaicism rather than a
simple XX sex chromosome complement. Furthermore, the contra¬
lateral gonad in this case was rudimentary. In the second case
(Teter and Tarlowski, i960) the tumour replaced one gonad while
the contralateral gonad was again rudimentary. The presence of
calcification in this tumour suggests that it was testicular in
origin. In neither of these two cases was chromosome analysis
performed. The third case (Botella-Llusia, I960) was a true
hermaphrodite with bilateral ovotestis. This patient was found
to have a normal female karyotype, MS/XX.
One can conclude that the majority of intersex patients with
a disgerminoma have been chromatin negative. The three chromatin
positive patients which have been reported were probably either true
hermaphrodites with testicular tissue or chromosome mosaics in
association with dysgenetic gonads. One feature common to all of




Chromosome analysis was carried out in 9 eases and the











The one case with an apparently normal female karyotype has
already "been discussed (Botella-Llusla, I960), and shown to "be an
example of true hermaphrodite with a U6/XX karyotype. The
presence of testicular tissue despite the apparent absence of a Y
chromosome has already been well documented (Kamden and Armstrong,
1959). With this exception, no intersex state with a disgerminoma
and a normal female karyotype has yet been described. Furthermore,
every case has had an XY cell line, with the further exception of
one patient with a hfi/XO karyotype.
These four observations lead to the conclusion that in patients
with an intersex state there has been no clearly documented example
in vdiich a disgerminoma has originated in ovarian tissue.
Undoubtedly, in the majority of cases it was shown to derive from
testicular tissue. As a corollary to this statement, there is no
well established case of a female pseudohermaphrodite with a
disgerminoma, the patients reported being either male pseudoherma¬
phrodites or true hermaphrodites. The liability of a female
pseudohermaphrodite or a true hermaphrodite to develop an ovarian
disgerminoma is probably the same as in women with normal sex
development.
However, tumours other than disgerminoma have occasionally
153
"been found in the ovaries of intersex patients. Examples of
mucinous cystadenomas (Corriden, 191+9; Bani, 1956; Greshara and
Fairgrieve, I960), Brenner tumour (v/eed et al.. 191j7; Gtange,
1957)» thecoma (Vaughn and Gonzales-Angulo, 1961), granulosa-theca
cell tumour (Hauser et al.. I960), and dermoid cyst (Claret and
Mcintosh, 195k)9 have been reported. The small number of such
case reports, however, suggests that the risks of any type of neo¬
plastic transformation in the ovary may not be increased by the
existence of an intersex state.
On the other hand, the incidence of testicular tumours is
undoubtedly increased in patients with an intersex state.
Cryptorchidism is common in these cases, and the liability of
ectopic testes to neoplasia is well documented (Dixon and Moore,
1953)* It is significant that in these cases the tumour,
although commonly a seminoma, is not infrequently a teratoma,
embryonal carcinoma, teratocarcinoma or chorionepithelioma, as we
have mentioned in part I of this discussion. In one series of
61 testicular tumours in male pseudohermaphrodites, there were 38
seminomas, 11+ teratomas, and 9 miscellaneous tumours (Gilbert,
191+2).
The remarkably close association between the gonadoblastoma
and intersex states is now well documented. Of the cases described,
so far, all were associated with abnormal sex development, all
proved to be chromatin negative, and in all the cases in which
chromosome analysis is available an XY cell line was reported
(Philip and Teter, 196U)• It seems likely that the gonadoblastoma
is a variant of the testicular seminoma rather than the ovarian
disgerminoma, being a tumour of dysgenetic testes.
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The age distribution of seminomas and disgerminomas is
relevant to this argument. Testicular seminomas are relatively
rare in younger age groups, only 12 per cent being found in males
under the age of 30 (Pergusson, 1962). By contrast, 80 per cent
ovarian disgerminomas, in patients with normal sex development,
occur before the age of 30 years (Santesson, 19i|-7)« However,
many of the disgerminomas which have been reported in intersex
cases were found in older age groups, and the age distribution in
these is more comparable to that of testicular seminomas rather
than ovarian disgerminoraas (Willis, I960). This may support the
belief that these tiuiours in intersex cases are closely related to
the seminoma type of tumour.
Apart from the association with intersex states, few cases
have been reported as ovarian disgerminoma in association with
masculinization (Gough, 1938; Seegar, 1938; Ber, 19U9; Plate,
1953; Usiziraa, 1956). Careful analysis of these cases, however,
shows that they were probably intersexes with the virilization due
not to the tumour itself but to a testicular gonad in v^hich the
tumour developed. The removal of the gonad and its tumour
naturally resulted in amelioration of symptoms. Menstruation was
not stated to be established in any single case, although the
youngest patient was 15*5 years old. The presence of ovarian
tissue was also not established by histological examination in
any of the cases. The opposite gonad was described as rudimentary
in two of the cases (Gough, 1938; Plate, 1953)* In the case of
Plate (1953), subsequent chromosomal analysis showed that the
patient had a U6/XY pattern (Scott, 1965).
A simple concept of the relation of the disgerminoma—seminoma
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type of tumour to Intersex states emerges from this review.
These tumours undoubtedly occur most commonly in the testes or
ovaries of patients with normal sex development. However, the
risk of developing a seminoma is increased in ectopic testes
whether or not there is an associated intersex state. The
incidence of other forms of neoplasms is also increased in ectopic
testes, "but probably to a lesser extent (Pergusson, 1962). This
implies that the significant aetiological factor is possibly the
site of the testis rather than the abnormal sex development.
Furthermore, there is no evidence that the incidence of neoplasia
is increased in the ovaries of intersex patients.
This argument has a clinical application. In intersex
states there is an increased risk of gonadal neoplasia only if
testicular tissue is present. This may be indicated by the
presence of an XY cell line which is strong presumptive evidence
of testicular tissue. However, it is important to realize that
the finding of a normal female karyotype does not exclude the
presence of testicular tissue, for, as we have shown, a true
hermaphrodite possessing both ovarian and testicular tissue may
have an XX sex chromosome complement. As a corollary to this,
the finding of a tumour of the seminoma-disgerminoma type in an
intersex patient is strong evidence for the presence of testicular
tissue.
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3. nRPIIMGHL<LdTCMA AND INTHdSZK STATED
Pick (1905) reported the first description of an extremely
well-differentiated arrhenoblastoma in a female patient. He
remarked on its close resemblance to the typical tubular adenoma
of the undescended testis, and suggested that his case may in
fact have been a testicular tumour arising from an ovotestis.
However, Meyer (1931) included Pick's tumour and similar cases as
examples of well-differentiated arrhenoblastomas, and the status
of the tubular adenoma of Pick as an ovarian tumour has been
generally accepted. However, with the recognition of the
testicular feminization syndrome (Morris, 1953)* it is now
appreciated that the presence of bilateral cryptorchidism is
compatible with a female phenotype. Moreover, in this syndrome,
the undescended testes are commonly the site of tubular adenomas
which may replace the whole testis. In these cases, if the
opposite gonad is not examined, or if it is also replaced by the
tumour, an erroneous diagnosis of ovarian arrhenoblastoma may be
made. This risk is increased by the common finding of an ovarian-
like stroma in the capsule of these testes (Morris and Mahesh, 1963).
It is impossible to know how frequently this error has been
made. In two of our eases in which an arrhenoblastoraa was
initially reported, the correct diagnosis proved to be testicular
tubular adenomas in genetic males. In an incomplete review of the
literature, we have encountered nine cases reported as ovarian
tumours in females where the true diagnosis may be testicular
feminization (Behrend and Levine, 1936; Anderson, 1937; Dudman,
1939; Novak, 19U3 - 2 cases; Jolles and Gleave, 19M-5; Goldberg
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and Maxwell, 19U7; Javert and Finn, 1951; Langley, 195U).
The features common to these cases are primary amenorrhoea,
absence of masculinization, and an absent or rudimentary uterus.
Sex chromatin analysis will clarify the diagnosis in most
of these cases. As we have shown, ovarian arrhenoblastomas are
chromatin positive, while testicular tubular adenomas are
chromatin negative. It should be emphasized that the histological
appearance of a testicular tubular adenoma and a well-differentiated
ovarian arrhenoblastoma may be indistinguishable. Not all of
this type of tumour occur in male testes, and a number of cases
have been described in parous women (Javert and Finn, 1951)♦ This
emphasises the value of routine sex chromatin analysis as an




1. A study of five cases of ovarian disgerminoma and five cases
of arrhenoblastoma is presented.
2. All five patients with a disgerminoma were phenotypically normal
females and had a normal female sex chromatin pattern, while three
of them had a normal female karyotype. Of the five tumours
originally reported as arrhenoblastomas, two proved to he testicular
tubular adenoma replacing the undescended testes of genetic males
with the testicular feminization syndrome.
3. A review is presented of 36 reported cases of intersex with
tumours of the seminoma-disgerminoma type with special reference
to the nature of the ipsilateral and contralateral gonads, and the
sex chromatin and chromosome analysis of the patient. It is
concluded that no disgerminoraa occurring in an intersex patient
has been proven to have arisen in ovarian tissue, while in the
Minority of cases it has been shown to have originated in
testicular tissue.
h. There is probably no increased risk of any type of neoplastic
change in the ovaries of intersex patients. By contrast, there
is an increased risk of testicular tumours, including the seminoma,
in male intersexes. This is thought to be a function of the
ectopic position of the testes rather than the abnormal sex
development per se.
5. The histological similarity of the well-differentiated
arrhenoblastoma and the testicular tubular adenoma may lead to
errors in diagnosis. Sex chromatin analysis is invaluable in
these cases.
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SUMMAHT
1. A consecutive series of 173U ovarian tumours was studied.
2. Data about the incidence, age distribution, bilaterality and
the relative frequency of the various tumour types were
presented. The pathological diagnosis was re-assessed and the
tumours were re-classified. Observations on individual types
of ovarian tumours were presented.
3. The possible origin of malignant tumours in ovarian endo¬
metriosis was investigated in our series of JLp.8 primary ovarian
tumours and in a series of 592 cases of ovarian endometriosis
examined during the same period. The literature was also
reviewed in order td elucidate the clinical and pathological
features of these cases.
U. Attention was directed to the frequency with which granulosa
and more particularly theca cell tumours may be present for
long periods without causing clinical enlargement of the ovary.
A clinlco-pathological study of a series of 25 such cases was
presented.
5. Certain very rare types of ovarian tumours were diagnosed during
the re-evaluation of the diagnosis in our cases. The following
tumour types were presented in detail: primary mesodermal mixed
tumours, malignant Brenner tumour, malignant adenofibroma,
malignant well differentiated teratoma and mesoblastoma.
6. An interesting case of ovarian enlargement simulating tumour
formation in a virilized patient during pregnancy was studied
and discussed.
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7. Cytogenetic techniques were applied to the study of the
problem of the histogenesis of teratomas. Nuclear sex was
studied in 187 cases of benign ovarian teratomas and chromosome
analysis was performed in 6 cases. The bearing of the results
on the problem of the origin of teratomas was discussed.
8. The relationship between ovarian tumours and intersex states,
with special reference to the disgerminoma and arrhenoblastoma,
was investigated, in the light of the modem cytogenetic
advances. The evidence was presented that there was probably
no increased risk of any type of neoplastic change in the
ovaries of intersex patients. By contrast, there is an
increased risk of testicular tumours, including the seminoma,
in male intersexes. This is thought to be a function of the
ectopic position of the testis rather than the abnormal sex
development per se. The histological similarity of the well-
differentiated arrhenoblastoma and the testicular tubular
adenoma may lead to errors in diagnosis. Sex chromatin
analysis proved invaluable in these cases.
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2 t Percentage of malignancy in ovarian tumours in the various age groups.
The following may be noted s
1. At no age period was the chance of an ovarian tumour to be malignant more
tlmn or e^ual to its chance of being benign.
2. The percentage of malignancy was ^uite high below the age of 20 years
ana after the age of 40 years.
PERCENTAGEOFMALIGNANTTUMOURS
3 t Bilateral ovarian tumours, benign and malignant in the various age groups.
Hote s A bilateral ovarian tumour was more commonly malignant in the fourth ana
fifth decades only. Sarlier, the bilateral tumours were more commonly benign.











HISTOLOGIC CLASSIFICATION OF THE PKIMAHI COMMON EPITHELIAL TUMOURS
1. Serous cystomas
Fig. 4 t Serous benign cystadenooa. X 25
A psammous body is also seen.
Fig. 5 t Serous oystadenoma with proliferative activity of the epithelial cells ( and
nuclear abnormalities) but with no infiltrative destructive growtfc. X 40.
Low potential malignancy.





Fig. 7 : Mucinous benign cystadenoma. X 40.
Fig. 8 : Mucinous cystadenoma with proliferative activity of the epithelial cells (and
nuclear abnormalities)but with no infiltrative destructive growth. X 40.
Low potential malignancy.





Fig. 10 Fig. 11
Endometrioid tumour with proliferative Endometrioid adenocarcinoma. X 40.
activity of the epithelial cella but
with no infiltrative destructive growth.
Low potential malignancy. X 40.
4. Unclassified carcinoma
Fig. 12
Undifferentiated carcinoma ( unclassified ). X 250.
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Fig. 10 Fig. 11
Fig. 12
Epithelial tumours of mixed types.
Pig. 13 t Mucinous (rigkt ) and serous ( left ) areas in a benign cyat&donoma. X 40.
Fig. 14 and 15 t
Ovarian carcinoma showing serous ( Fig. 14)» mucinous ( Pig. 15» left )




Completely undifferentinted, ovarian carcinomas are rare. Examination of other
parts of the tumour often show more differentiated areas. Pig. 16 and 17 illustrate such
an extreme example.
Fig. 16 ! Areas in an ovarian carcinoma showing complete undiffereutiation. X 40.
I




The predilection of the benign cystic teratoma to the childbe&ring period of age
i3 well known. The association with pregnancy is also relatively not infrequent. Fig. 18
illustrates such an example.
Fig. 18 t Benign cystic teratoma removed during pregnancy, showing the presence of decidual
reaction beneath the ovarian serosa (lower part of the figure), X 25.
Striking examples of the phenomenon of tissue correlation are often seen in the
benign teratoma. In fact, the well known association of sabacicus glands, hair follicles,
sweat glands and adipose tissue with stratified squamous epithelium is such an exam le.
Some further interesting examples are shown in the following 3 figures.
Fig. 19 s Respiratory epithelium, cartilage, salivary glands and thyroid tissue in a benign
cystic teratoma, X 40.
Fig. 20 } The association of bone marrow with bone in a oenign cystic teratoma. X 40.
Fig. 18
Fig. 19 Fig. 20
Fig. 21 : The association of brain tissue and chorioid plexus in a benign cystic teratoma.
X 40.
These examples of tissue correlation may be looked upon as abortive attempts towards
organ formation.
Malignant transformation in a benign cystic teratoma indicates tnat anaplastic
changes are confines to a specific tissue element or portion of that element , wit the
remaining tissues in the tumour continuing to exhibit benign properties. This type should
be sharply distinguished from the solid malignant teratoma. Three examples of malignant
transformation in a benign cystic teratoma will be illustrated in the following figures t
a squamous cell carcinoma, a mucinous carcinoma and an argentaffins carcinoma.
Fig. 22 t Squamous cell carcinoma arising in a benign cystic teratoma. X 40.
Fig. 21
Fig. 22
Fig, 23 ana 24 show a mucinous carcinoma arising in a benign cystic teratoma.
Pig. 23 t Active mucinous epithelium lining a gut-like structure ( left ) in
a benign cystic teratoma, A 25.
Fig. 24 : Mucinous carcinoma , presumably arising from the gut-like structure




Argentaffins carcinoma arising in a benign cyatic teratoma
Fig. 25 t Gross appearance of the tumour. The solid malignant tumour is shown to the
right, as a kidney-shaped mess. The relatively large cyst is the benign cystic
teratoma. Hairs can be seen. The dark area (upper left) is an artifact caused
by sebacious material.
Fig. 26 t Argentaffins carcinoma ( carcinoid tumour ) is seen below in relation to the
stratified squamous epithelium of the teratoma (above). X 20
Fig. 26
Solid malignant teratoma of the ovary
Solid malignant teratomas of the ovary are tumours composed of a mixture of tissue
forms, both mesenchymal and epithelial, of a variable degree of maturity. Two examples
are illustrated nere s In one, most of the tissues of the tisnour were poorly differentiated.
In the other, the teratomatous elements were more or less mature and well-differentiated.
Pig. 27, 28 and 29 are from a solid malignant teratoma, in a girl aged 10 years.
Pig. 27 : Mature epidermal tissue in the teratoma. X 63.
Fig. 2b j Anaplastic areas in the tratoma, with a superficial resemolance
to trophoblast, X 63.
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Fig. 28 Fig. 29
Figures 30-34 are from a solid teratoma removed from a patient aged 39 years.
Fig. 30 i Gross appearance of the tumour. The tumour is partly solid and partly cystic.
Fig. 31 s Neuroglial tissue lining the cystic part of the teratoma ( not stratified squamous
epithelium as is usual in benign cystic teratomas ), X 40.
Fig. 32 : Mature skin elements in the teratoma. X 40.
Fig. 31 Fig. 32
Fig. 33 i Salivary glands and respiratory epithelium in the teratoma shown in the previous
figures. X 40.
Fig. 34 : Nerve ganglion, seen in the muscle wall of a gut-like structure in the teratoma,
indicative of a high degree of tissue maturation. X 6 3.
In spite of the maturity of the tissue elements of the teratoma, the prognosis should
be guarded.
STRUMA OVARII
Thyroid tissue in the ovary is liable to the same functional ana pathologic
changes as thyroid tissue in the neck.
Fig. 35 I Struma ovarii showing the appearance of thyroid foetal adenoma. X 250.
. * .
Fig. 33 Fig. 34
35
BrCNKER TUMOUR
In 18 out of 34 Brenner tumours, the ovary was normal-sized or only slightly
enlarged.
Fig. 36 : Small Brenner tumour in the ovary, whole section. X 5.
Fig. 37 i Microscopical picture of the small Brenner tumour shown in the previous
figure. X 65*
The sites of the small Brenner tumours may b8 of hiatogenetic significance.
Fig. 38 t A small cortiqal Brenner tumour, X 65.
An origin from rete structures is not applicable in this case.
Fig. 39 s A Brenner tumour in the hilua of the ovary. Neighbouring thick walled
vessels in the hilum may be seen (left). X 100.
An origin from rete structures is possible.
Fi9- 36 Fig. 37
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Fig. 38 Fig. 39
ADENOFIBROMA Aliv CISTABENGF1BROMA
In 15 out of 50 cases, the tumours produced little or no ovarian enlargement.
Fig. 40 ana 41 illustrate such an example.
Fig. 40 x Whole section of the ovary showing the adenofibroma. X 5.
Fig. 41 x The same tumour under higher magnification, X 65.
Malignant transformation x
This condition is rare and may take one of several histologic types.
Fig. 42 x A borderline papillary lesion in a cystadenofibroma. The fibromatous part
of the tumour is shown to the right. X 20.
Fig. 43 X Abnormal active proliferation of the stromal elements in another part of the
same tumour shown in the previous figure (possibly not malignant). X 63.
Fig- 42 Fig. 43
Fig. 44 t An early polypoid adenocarcinoma in one of the locules of an otherwise
benign cystadenoiibroma. X 20.
Fig. 45 and 4b t A localized nodule of adenofibroma with acanthomatous change , in the
wall of a benign mucinous cystadenoma.
Fig. 45 i Whole section photographed. The nodule is seen to the
right and below. A 5*
Fig. 46 t Higher magnification of the adenoxibroma showing the
acanthomatous change. A 25.
Fig. 45 Fig. 46
Pig. 47 and 48 show an adenofibro^atous area in the wall of a serous papillaxy cyst-
adenocarcinoma and showing acanthomatous change.
Pig. 47 : The whole section photographed. X 5.
Pig. 4fi : Higher magnification of the adenofilroraatoua area, illustrating
the acanthomatous change. X 63.
This case and the previous one are probably examples of the multiple Mullerian
potentialities of the surface epithelium of the ovary.
Fig. 48
FIBROMA
Out of 135 cases of ovarian fibroma, 29 were encountered in normal-sized ovaries*
Fig. 49 and 50 illustrate such an example*
Fig. 49 i (tfhol-i section of ovary, snowing fibroma. X 5.






ARHHiSNOBLAiJi'CMA AND GRANULOSA CELL TUMOUR
Although it has been customary to regard the arrheaoblastonia and the granulosa
cell tumour as tumour types which are sharply distinct in their morphology, histogenesis
as well as in their endocrine potential, this distinction does not seem now to be so
exact.
In tumours of apparently granulosa cell type , a picture suggestive of arrheno-
blastoma may oe seen in some are<.s of the tumour, Fig. 51 and 52 illustrate such an
example. Fig. 51 t A picture typical of granulosa cell tumour. Rosettes may be seen.
X 255.
Fig, 52 : Another area in the same tumour suggests the pattern of testicular
tubular adenoma. Compare with figure 135. X 2^5
In s~me tumours, especially if evidence of hormonal activity iras lacking, it
may be impossible to distinguish a granulosa cell tumour from an arrhenoblastoma.
Two examples ^re illustrated here.
Fig. 53 ! Granulosa cell tumour (middle) or arrhenoblastoma (siaes) ?.
No clinical endocrine manifestations were present. X 63.
Fig. 53
Fig. 54 t Granulosa call tumour or urrhenoblaatoma ?, No clinical endocrine m&nifest-
atxona acre present* The picture is that of a sex cord (Granulosa or Sertoli/
mesenchymal (Theca or Leydig) tumour. X 40.
Fig, 55 I Arrhenoblastoma, associated with clinical masculinisation, Masculi izing
arrhenoblastomas rarely show a resemblance to testicular tissue. Note the
abundant Leydig cells in the tumour. X 175#
Fig. 55
LIPOID CELL TUMOURS
Pig* 56, 57 and 58 show an oeatrogenic hilus cell tumour.
Fig, 56 t Section of whole ovary and the tumour, X 5,
Fig, 57 s The tumour at a higher magnification. X 63.
Fig, 58 t The postmenopausal endometrium showing cystic hyperplasia. X 110.
Fig. 56
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Fig. 57 Fig. 58
Fig* 59 i iu adenoma of hilua cells in the hiluo of the ovazy. (The patient was post¬
menopausal and the endometrium showed cystic hyperplasia) * X 40*
Fig. 59
Fig. 60, 61 and 62 illustrate a lipoid cell tumour, associated with no clinical
evidence of hormonal activity.
Fig, 60 : Whole section of ovary and tumour (nodule at top),
X 5.
Fig. 61 : Microscopical appearance oi the tumour. X 40.
Fig. 62 t Atrophic postmenopausal endometrium. X 110.
Fig. 60
. .-j
Fig. 61 Fig. 62
THE ORIGIN OF MALIGNANT GVAitl TUMOURS IN ENDOMETRIOSIS
Fig. 6'j t Atypical epithelium in an euaometrial cyst.
Note the heaping up and the cellular ana nuclear pleomorphic.
No definite evidence of malignancy with stromal invasion. ^
Fig. 63
Pig. 64 s Ovarian carcinoma arising in endometriosis. Case 1.
An earl/ polypoid malignancy in an ovarian endometrial cyst. X 5.
Pig. 65 i Ovarian carcinoma arising in endometriosis. Case 1.
Higher magnification of the previous figure, to show the transition





Pig. 66 : Ovarian carcinoma arising in endometriosis. Case 1.
Cyst excised IB months after removal of the tumour shown in the previous
two figures : A broad zone of paeuao-xantnorna cell§, suggestive of
endometriosis, is seen lining the cyst. The ovarian carcinoma is seen
above. X 105 •
Fig. 67 t Ovarian carcinoma arising in endometriosis. Case 1.
Tumour excised 18 months after removal of the tumour shown in figure 64
and 65 J Adeno&canthoma allowing the malignant character of the squamous
as well as the glandular component. X 170.
Fig. 66
Fig. 67
Pig, 58 : Ovarian carcinoma arising in endometriosis. Case 2.
A localized papillary adanoacanthoma . £ 105.
Fig. 69 l Ovarian carcinoma arising in endometriosis. Case 3.
Endometrial cyst with two small polypoid malignant growths and an area of
endometrial cystic hyperplasia ( top left ). X 5.
Fi g. 68
Fig 69
Fig. 70 t Ovarian carcinoma arising in endometriosis. Case 4.
Papillary carcinoma arising into and continuous with the benign epithelial
lining of an endometrial cyst. X 30.
Fig. 71 J Ovarian carcinoma arising in endometriosis. Case 4.






Fig, 72 ; Ovarian adenocarcinoma showing acanthomatous change.
Origin in endometriosis could not be demonstrated but cannot be ruled out.
X 90.
Fig. 73 and 74 show the association of ovarian adeno&canthoiau and squamous metaplasia
in the uterine endometrium.
Fig. 73 Fig. 74




Fig. 73 Fig. 74
THE OCCURRENCE OF GRANULOSA AND THECA CELL TUMOURS IN CLINICALLI NORMAL OVARIES
Fig. 75, 76, 77 and 78 ;
The hi8tory of thie patient spanned over three and half years, with irregular
bouts of postmenopausal bleeding. The uterus was curetted three times before total
hysterectomy with bilateral oophorectomy was at last decided upon.
Fig. 75 t Whole section of ovary ana tumour. A 5.
Fig. 76 : Microscopical appearance of the tumour showing a granulosa cell picture.
X 180.
Fig. 77 t The postmenopausal endometrium showing cystic hyperplasia. X 65.
Fig. 76 Fig. 77
Fig. 78 i Corpus-albicans-like structure with granulosa cells , at the periphery of
the granulosa cell tumour shown in figure 75 and 76# X 175.
The origin of granulosa cell tumours in atretic follicles has been suggested.
Fig. 78
Pig. 79, 60 and 81 :
The patient , aged 56 years and postmenopausal for 5 years, suffered from
attacks of uterine bleeding during the last three years. Uterine curettage was
performed twice during this period and showed cystic hyperplasia. Laparotomy
was performed after the second curettage.
Pig. 79 t Whole section of ovary and tumour. X 5.
Pig. 80 } Microscopical appearance of the tumour, showing a theca cell
picture. Luteiniaation was prominent, a feature commonly
observed in these small tumours. X 180.
Pig, 81 : The postmenopausal endometrium showing cystic hyperplasia. X 65.
Fig. 79
i*j» f^itjur- ,'lT
Fig. 80 Fig. 81
62 and 83 i
The granulosa cell tumour in this case was an accidental finding, A large
solid adenocarcinoma was present in the opposite ovary. The endometrium was
inactive.
Pig, 8"y- i Whole section of ovary and tumour, X 5.




64 and 65 t
The patient, aged 57 ye«.rs and 7 years postmenopausal, presented with irregular
uterine bleeding of 15 months duration, Endometrial curettiugs showed cystic
hyperplasia and laparotomy was performed.
Fig. 84 i Isfhole section of ovary and tumour. X 5.
Fig. 85 s Microscopical picture snowing a luteinized tiieca cell tumour. X 40.
Fig. 85
86 and 87 »
The patient, a|fed 56 years, presented with bleeding per vaginun of two years
duration and gradually increasing in severity. Endometrial curettings showed
active cystic hyperplasia «ith some areas showing an irregular adenomatous
pattern. Total hysterectomy with blateral salpingo-oophorectomy was
performed. After operation, the patient suffered from hot flushes which
passed off gradually. The patient, 8 years later, was living and well,
though complaining of senile vaginitis,
Fig. 86 : whole section of ovc.ry ana tumour. X 5.
Fig. 87 : Microscopical appearance showing the picture of a thecn cell
tumour with prominent luteinization, a feature commonly observed
in these small tumours. X 40,
Fig. 87
Fig. 88, 89, 90 and 91 »
This patient was first seen at the age of 69 years, 15 years after the onset of
the menopause. one had vaginal bleeding for 4 days and also complained of genital
prolapse. A Fochergill operation was performed. Uterine curettings showed an active
endometrium ns well as a benign polyp. Bleeding recurred after 8 months and a second
curettage showed endometrial hyperplasia and another polyp. Ten months later, deeding
recurred and the third curettage was performed ana showed a hyperplastic cystic
endometrium with adenomatous areas. One year ana three montns later, the patient
presented with another attacK of bleeding. To til hysterectomy with bilateral salpingo-
oophorectomy was performed.
Fig. 88 t Whole section of ovary and tumour. X 5.
Fi&. 89 t Microscopical appearance of the tumour, showing a theca cell picture with
prominent luteinizetion, a feature tnat was commonly noted in these small
tumours. X 100
Fig. 89
Fig. 90 t Postmenopausal endometrial cystic hyperplasia, second curetting. X 20.
Pig. 91 s The endometrium , two years later, also showing cystic hyperplasia, X 20.
Pull notes in previous page.
Pig. 92 : Hyperplasia of the ovarian stroma with foci of luteinization. The ovary
contained a small theca cell tumour. X 180.
92
OBSERVATIONS ON VERY HARE TUMOURS OP THE OVARY
PRIMARY MESODERMAL MIaEU TUMOURS OF THE OVARY
Fig. 93» 94 and 95 J Case 1.
Fig. 93 * Be.iign udenom/omatous part of the tumour. X 90.
Fig. 94 J Another part of the tumour showing the picture of carcino-sarcooa,
with islands of degenerate chondroua tissue. X 90.
Fi0. 95 * Another part of the tumour snowing the picture of endometrioid
adenocarcinoma, X 90.
In this case, the origin of the tumour from the associated endometriosis
was possible but not proved.
Fig. 93 Fig. 94
Fig- 95
Tig* 96, 97 and 98 t Primary mesodermal mixed tumour of the ovary. Case 2*
Tig* 96 t Epithelial elements in the tumour* X 100.
Tig. 97 t Rh&buomyoblasts. X 450*
Tig. 98 t Striated muscle fibres. Heidenhain's iron haematoxylin, X 1000*
Fig. 97 Fig. 98
MALIGNANT BBENNER TUMOUH
The diagnosis of malignant Brenner tumour should be based on strict criteria*
Epithelial clumps in an ovarian carcinoma may simulate the appearance of the Brenner
tumour* as is illustrated in this example.
Fig. 99 t Not a malignant Brenner tumour. Other parts of the tumour showed
the picture of common ovarian carcinoma. There were no benign
Brenner cell elements. X 140.
 
Tig. 100, 101, 102 t Halignant Brenner tumour.
Pig. 100 t Whole section showing the benign solid part ( left )
and the malignant cystic part (right). X 10.
Fig. 101 i Higher magnification of the benign solid part.
The tumour looks inactive with central cystic
degeneration and peripheral hyaline degeneration.
X 140.
Fig. 102 t Higher magnification of the malignant cystic part.
The picture is that of a papillary cystadenocarcinozaa,
with the multilayered malignant epithelium shoving
a marked structural similarity to the Brenner pattern.





Fig. 103 and 104 are from a case of solid well differentiated malignant teratoma.
The histological picture of the primary tumour showed only adult mature tissues.
The tumour ,however, proved its malignant potential toy recurrence after 6 months.
Fig. 103 * Brain tissue and chorioid plexus in the primary tumour.
Other mature tissues were also present. X 40.
Fig. 104 » Omental metastasis of neuroglial tissue. The peritoneal
biopsies were composed only of this tissue, a feature





Fi^. 1«05» 106, 107, 108, 109» 110 t An unusual case of malignant transformation
in an ovarian adenofibroma.
Fig. 105* The tumour was partly solid and partly cystic.
This figure shows the picture of the cystic
part. A lining of benign cubical epithelium
with occasional stunted papillae and psamcma
bodies can be seen. X 20.
Fig. 106* Solid part of the tumour. Small glands widely
dispersed in fibrous tissue, typical of benign
adenofibroma, can be seen. X 40.
Fig. 107* Solid part of the tumour. A gradual transition
into an adenomatous pattern can be seen. X 25.
Fig. 108* Solid part of the tumour. Glands are crowded
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Fig. 107 Fig. 108
Fig. 109 t Solid part of the tumour (see previous 3 figures).
The gland pattern is lost , the cells are arranged
in clumps and columns and the picture is that of
frank malignancy. X 40.
Fig, 110 t Solid part of the tumour. The picture here is
that of an anaplastic growth. A prominent peri-
epithelial thecal reaction is present in the
stroma( The postmenopausal endometrium showed
a moderate degree of proliferative activity).
X 63.
Fig. 106 - 110 are from one histological section and leave
no doubt about the transition from one picture
to the other.
Fig. Ill and 112 s Another example of malignant transformation in an adenofibroma.
Fig. Ill t Benign part of the tumour. X 25*
Fig. 112 i Malignant part of the tumour. X 40.
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Fig. 111 Fig. 112
MHS0BLA3T0MA OF TiiLLUM
▲ considerable amount of confusion exists in the literature about the status
of this tumour and especially its relationship to the tumour described as mesonephroma
by Schiller and the related clear cell carcinoma. It seems that this is partly due
to different authors speaking about different tumour types , and not the same type
of tumour.
Fig. 113 : A typical example of the clear cell carcinoma. X 63.
Fig. 114 l The picture described as mesonephroma. Note the hob-nail epithelium
lining the epithelial spaces (right) ana the clear cell pattern (left).
The tumour is essentially an epithelial tumour. X 63.
Fig. 115 * Mesoblastoma. The main characteristic of the tumour , as descrioed
by Teilum, are the primitive mesenchymal type of stroma and the
paucity of epithelial elements. Teilum interprets the epithelial
spaces as representing yolk s&c endoderm (Mesoolastoma vitellinum).
X 63.
Fig. 113
Fig. 114 Fig. 115
OVAKI AiSi ENLARGEMENT SIMULATING TUMOUR FORM TION
IN A VIRILIZED PATIENT LURING PRSGNANCX
Fig. 116 t Ovary reiacvea at Caeaarean section. External surface.
Fig. 117 t Ovary removed at Caesarean section. Cut surface.
Multiple small peripheral cysts can be seen. The ovarian enlargement,
however, is mainly solid.
Fig. 117
Fig. 118 t Resected wedge from the other ovary at second Caeaarean section.
Solid nodules of variable sizes can be seen in the cystic ovary.
The microscopical picture of the cysts and the solid nodules is
shown below.
Fig. 119 * Microscopical appearance of the cysts shown in the previous figure.
Multiple layers of luteinized theca cells are seen surrounding the
cystic follicles. The granulosa cell layer is atrophic. X 100.
Fig. 120 I Microscopical appearance of the solid nodules, shown in the resected
wedge above. The nodules are made up of luteinized theca cells.
X 250.
Fig. 11S
Fig. 119 Fig. 120
Fig* 121 t A snail focus of theca lutein calls in the hyperplastic ovarian etrcna.
Several such foci were scattered in the ovary* X 250.
 
SEX CH&CKAEUf AND CHROMOSOME ANALfSXS IN OVARIAN TERATOMAS
Fig. 122 l Sex chromatin in tne stratified squamous epithelium of teratoma.
X 1000.






Tig. 124 t Sex chromatin in neuroglial tissue in teratoma.
X 1000.














Pig. 126 : Karyotypes in six benign cystic teratomas.



















THE RELATIONSHIP BETWRBU OVARIAN TUMOURS AND INTERSEX STATES WITH SPECIAL
REFERENCE TO THE BISCERMINOMA AND ARRHEN OBLASTGK A
Fig. 127 I Case 2. Ovarian disgeiminoma.
Corpus luteum in close proximity to tumour cells. X 100.
Fig. 128 I Case 2. Ovarian disgeiminoae.
Sex chromatin in the fibroblasts of the tumour stroma.
The tumour nuclei are not suitable for analysis. X 1000.
Fig. 129 S Case 2. Ovarian diagexminoma.
Chromosome analysis of peripheral blood leucocytes.
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Fig. 1^0 l Case 3. Bisgerminoma.
Microscopical picture of the tumour. X 17b.
Fig. 1^1 t Case 3» Oisgexminoma.
Sex chromatin in the fibroblasts of the tumour stroma. X 1000.
Fig. 132 t Case 3* Dis^erminoiuu.
Chromosome analysis of peripheral blood leucoe>';s.
A normal 4b/XA karyotype.
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Fig. 133 t Case 4* bisgerminoma.
Microscopical picture of the tumour.
A lymphocytic eollootiott is seen. X 175.
Fig. 134 i Case 4* his^ermincaaa.
Chromosome analysis of peripheral blood leucocytes.
A normal 46/XX karyotype.
Fig. 133
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Fig. 134
Fig* 135 t Case f. Testicular tubular adenoaa.
The case proved to be one of testicular feminization.
X 40.
Fig* 136 1 Case 8. Armenoblastema.
Chromatin positive oells. X 1000
Fig. 135
Fig. 136
THE OCCURRENCE OF GRANULOSA AND
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THE OCCURRENCE OF GRANULOSA AND THECA TUMOURS
IN CLINICALLY NORMAL OVARIES
A study of 25 cases
by
M. F. Fathalla, M.B., Ch.B., D.G.O., D.S., M.Ch.(Cairo)
Department of Obstetrics and Gynaecology, University of Edinburgh
The aim of this report is to draw attention to a
special group of granulosa and theca cell
tumours which cause no significant enlargement
of the ovary and betray their presence only by
evidence of abnormal oestrogenic activity.
Of 91 cases of granulosa and theca cell
tumours, examined in the pathology laboratory
of the Department of Obstetrics and Gynaecol¬
ogy of the University of Edinburgh since 1950,
25 tumours were encountered in ovaries that
were normal-sized or only slightly enlarged.
Clinical Features
The age of the patients in the 25 cases ranged
from 47 to 80 years with only one patient below
the age of 50 years. In our total series of 91
granulosa and theca cell tumours of all sizes,
ages ranged between 17 and 86 years with 23
patients below the age of 50 years. Eleven
patients with the small tumours were nulliparous
and all were postmenopausal for periods varying
from 2 to 31 years.
With the exception of three cases, the present¬
ing symptom was uterine bleeding. Of these
three patients, one was operated upon for large
uterine fibroids, another had a large twisted
fibroma of the opposite ovary and the third had
an adenocarcinoma of the opposite ovary. The
duration of the history of postmenopausal
bleeding varied from 2 weeks up to 6 years.
Delays were largely due to reluctance on the part
of the gynaecologist to operate in the absence of
a palpable tumour. Thus, only 11 of the patients
had a laparotomy within one year of the start of
the bleeding, 6 patients were operated upon in
the second year, 3 in the third year, one after 4
years and one after 6 years.
The management of the patients presenting
with postmenopausal bleeding followed several
lines. In two patients laparotomy was the first
line of treatment. In 12 patients laparotomy was
performed after an initial curettage showing
endometrial hyperplasia (7 cases) or carcinoma
(5 cases). In two patients curettage was perform¬
ed and hysterectomy was done when the bleeding
recurred. In four patients the decision for
laparotomy was only taken after curettage had
been performed two or three times. In two
patients, after an initial curettage, deep X-ray
therapy to stop ovarian function was given. In
both cases, the treatment failed. One of these
two patients had the X-ray treatment repeated
three times and was only operated upon after
three years when an early adenocarcinoma of the
endometrium was also discovered. The second of
these two patients had a laparotomy after
intermittent bleeding for six years.
It is interesting to note that a history of
radiation menopause was present in three other
cases in this series. One patient had a radium-
induced menopause for the treatment of dys¬
functional premenopausal bleeding 18 years
before. Another patient had the same treatment
31 years before the occurrence of postmeno¬
pausal bleeding and the detection of an endome¬
trial adenocarcinoma. The third patient received
radiotherapy for the treatment of fibrosarcoma
of the groin at the age of 28 years. Her periods
had stopped since then and she presented 24
years later with uterine bleeding and endometrial
hyperplasia.
Oestrogen assays were available in two of the
patients with postmenopausal endometrial hyper¬
plasia. In one patient, aged 75 years and post¬
menopausal for 27 years, the 24 hours urine
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Fig. 1
Examples of granulosa and theca cell tumours in clinically normal ovaries. Figures on the left side show a
complete section of the ovary (x 3). On the right side, the microscopical appearance of each tumour is
shown (X 40-63). The appearance of luteinization is noticeable in the last two tumours.
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volume contained a total of 17-8 fxg. oestrogens.
In the second patient, 66 years old and 10 years
postmenopausal, the total oestrogens were 38-7
[jlg. per 24 hours urine volume. The total mean
urinary oestrogen excretion in the normal post¬
menopausal patient is of the order of 5 • 8 fxg. per
24 hours urine with a range of 3 ■ 1 fxg. to 8 • 1 [xg.
(Kellar et ai, 1959).
Pathological Features
All the tumours were unilateral, with the
exception of one case of bilateral thecoma.
Seventeen of the tumours were thecomas and 8
were granulosa cell tumours (Fig. 1). (In our
total series of 91 cases, only 28 were thecomas.)
The appearance described as luteinization was
more frequently observed and also more marked
than in the large tumours. In three of the cases,
the tumour was almost completely luteinized. In
spite of their small size the tumours often showed
evidence of old fibrosis; hyalinization was
usually extensive and in some cases it replaced a
large part of the tumour. The ovary, apart from
the tumour, was commonly the seat of a variable
degree of cortical stromal hyperplasia. In one case
foci of lutein cells were included in the hyper¬
plastic ovarian stroma. Hyperplasia of the hilus
cells was prominent in one case. A small fibroma
was also present in the same ovary in one case.
In three patients the endometrium was in¬
active. These were the three patients already
mentioned, who presented with other large
tumours in the uterus or opposite ovary. In 15
cases the endometrium showed marked prolifera¬
tive activity or cystic hyperplasia. In the remain¬
ing 7 cases endometrial carcinoma was present.
In 5 out of these 7 cases, the ovarian tumour was
a thecoma. It is also worth noting that in the
total series of 91 cases of granulosa and theca
cell tumours, 11 cases ofconcomitant endometrial
carcinoma were encountered. In other words, in
7 out of 11 cases in which a granulosa or theca
cell tumour was associated with endometrial
carcinoma, the ovary showed no clinical enlarge¬
ment. Two of the cases of endometrial carcinoma
in this series were of special interest. Endometrial
curettage, two years previously in one patient
and three years previously in the other patient,
showed postmenopausal active hyperplasia. The
second patient received in the interval deep
X-ray therapy to stop ovarian function.
Discussion
Although granulosa and theca cell tumours of
very small size have been noted occasionally in
previously published series (Biggart and Macafee,
1955), their frequency and significance are not
sufficiently realized. In our material 25 out of 91
granulosa and theca cell tumours were found in
ovaries which showed no clinical enlargement.
The real incidence of these small tumours may
even be higher since they are more liable to be
missed than the larger tumours, especially if they
are hormonally inactive. The relative frequency
of these tumours should direct attention to their
possible presence in the postmenopausal patient
presenting with evidence of abnormal oestrogenic
activity, even when the ovaries are palpably
normal.
Several observations suggest that these cases
do not simply represent early tumours but rather
a variant of granulosa and theca cell tumours
characterized by a very slow and possibly limited
capacity for growth. Thus, the tumours were
encountered at a later age than the larger
tumours. Furthermore, the history of these
patients often revealed evidence of long standing
abnormal oestrogenic activity before operation.
Pathological examination also often showed a
pronounced degree of fibrosis and hyalinization
in the tumours. In the present state of knowledge
factors governing the rate and capacity of growth
in tumours are not well understood. However,
two pathological features in our series are worthy
of note in this connexion. The first is the pre¬
dominance of the thecal type of tumour and this
is in accord with the observation that thecomas
are generally more slowly growing and relatively
more benign than the granulosal type of tumour.
The second feature is the more frequent and
more marked appearance of luteinization in these
small tumours. Since this distinctive histological
appearance is probably indicative of steroid
storage in the cells, it may be suggested that there
is a correlation between a low potential for
growth and a capacity of the cells for steroid
storage. It may also be noted that the so-called
lipoid cell tumours of the ovary are usually of a
small size (Haines and Taylor, 1962).
The association of endometrial carcinoma with
feminizing mesenchymal tumours has been
reported, the figures varying from 3 to 27 per cent
(Hertig and Gore, 1963). In our total series of 91
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granulosa and theca cell tumours, this association
was noted in 11 cases. Of these, 7 were encounter¬
ed among the 25 cases of small tumours and only
4 were encountered in the remaining 66 cases of
larger tumours. This relatively high frequency of
associated endometrial carcinoma with the small
tumours demands an explanation, and several
may be suggested. One may be the predominance
of thecomas in this series, since thecomas more
frequently have this association than granulosa
cell tumours (Greene, 1957). The greater age of
the patients may be another factor. It is also
possible that more of these small tumours are
detected when the endometrium is malignant
than when it is benign, because operation is less
readily undertaken when the endometrial curet-
tings are benign. However, despite all these
possible factors, the frequency of the association
is not fully explained. In two cases in this series
the progression from postmenopausal hyper¬
plasia of the endometrium to adenocarcinoma
was noted after two years in one patient and three
years in the other. In all probability the small
tumour was present over these periods. The
possibility of the presence of a small undetected
functioning tumour of the ovary in a case of
endometrial carcinoma should be remembered.
Such a tumour may be responsible for failure
of treatment by radium, as in a case mentioned
by Sparling (1950).
The possibility that radiation may play a role
in the development of feminizing ovarian
tumours in the human as well as in the experi¬
mental animal has been suggested (McKay et a!.,
1953). Five patients in this series received
radiotherapy, usually to stop ovarian function,
before the discovery of the tumour. It is possible,
however, that some of the patients may have had
the tumour at the time of the radiotherapy.
Indeed, this appears to be the most plausible
explanation in two of our cases as well as in some
other reported cases (Maxwell, 1957; Sparling,
1950; Pratt, 1950). It is important to remember
that a patient bleeding around the time of the
menopause and showing evidence of abnormal
oestrogenic activity may have an undetected
functioning ovarian tumour, especially if a
standard dose of radiotherapy fails to stop
ovarian function. In two other cases in this series
the long interval of amenorrhoea between the
induction of menopause for abnormal uterine
bleeding and the presentation of the tumour
makes it more probable that the tumour
developed after the menopause. In these two
cases, however, it may be argued that the
aetiological relation, if any, is with the ovarian
dysfunction rather than with the irradiation.
Summary
The frequency with which granulosa and more
particularly theca cell tumours may be present
for long periods without causing clinical enlarge¬
ment of the ovary is not generally realized.
Twenty-five out of 91 tumours were found to be
of this type. These small tumours have a very
slow and possibly limited capacity for growth
but are endocrinologically active. Endometrial
carcinoma was present in 7 out of 25 cases. A
history of ovarian irradiation was present in 5
cases.
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Sex chromatin and chromosome analysis in
ovarian teratomas
M. NABIL RASHAD, M.B.
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MELVILLE G. KERR, M.B.
Edinburgh, Scotland
The development of ideas about
the nature and origin of teratomas provides
an interesting reflection of the rate of progress
in methods of scientific investigation. The¬
ories of teratogenesis may be seen to have
followed four phases.
The striking fetuslike characteristics of the
teratoma have been known for centuries and
these encouraged the belief that they were
the product of conception in the form of an
included twin or an ovarian pregnancy or as
the outcome of parthenogenesis.1 These spec¬
ulations were based on simple observations
of the gross morphology of teratomas.
Later, the application of rigorous histo¬
pathologic techniques to these specimens
quickly exposed the inaccuracies and exag-
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gerations of earlier descriptions and dis¬
credited the idea of the fetal nature of these
tumors.2 The alternative suggestion was de¬
veloped that teratomas are neoplasms origi¬
nating from foci of cells which, at a very
early stage of embryogenesis, escape from the
control of primary organizers.3 These cells
retain their primitive totipotency and may
produce tumors which contain tissues repre¬
sentative of all three germ layers, but they
totally lack any vertebral organization.
The recent demonstration of sex chro¬
matin4 provided one method of testing these
conflicting hypotheses. The concept of the
teratoma as a neoplasm implied that it
should have the same genetic sex as the
host, whereas older ideas of the fetal nature
of the teratoma suggested that there might
be some discrepancy between the sex of the
host and the tumor. The first report of sex
chromatin studies on teratomas revealed such
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a disparity in that some testicular teratomas
proved to be chromatin positive.5 Since then
a large number of similar studies on both
female6"20 and male21 teratomas have been
reported. Undoubtedly, sex chromatin gives
invaluable information about the X chromo¬
some complement of the cell. However, it
is less reliable in malignant tissues22; it is
subject to technical misinterpretations22; it
gives no idea of the Y chromosome comple¬
ment of the cell; and it gives no informa¬
tion about autosomes.
Consequently, it is now necessary to sup¬
plement sex chromatin studies with full chro¬
mosome analysis. So far, only three reports
describing a total of 8 teratomas have been
described.23"25 This communication describes
a further study of sex chromatin in 187 be¬
nign ovarian teratomas, and the chromosome
analysis of 6 of these specimens.
Material and methods
The material for the sex chromatin study
was selected from the material collected in
this department over the past 10 years. One
hundred and eighty-seven specimens were
considered adequate for study. All of these
were benign ovarian cystic teratomas with
the single exception of one benign solid
teratoma. Each specimen was fixed in
formalin and slides were stained with hema¬
toxylin and eosin. In a few cases, additional
sections were cut and stained with Feulgen.
Each slide was examined independently by
two observers (M. F. F. and M. N. R.).
Various tissues were studied in each speci¬
men but squamous epithelial cells were se¬
lected for routine counting, 100 suitable nu¬
clei being studied in each case.
Six fresh benign cystic teratomas were
subjected to chromosome analysis using Harn-
den's method.26 From each specimen, several
representative pieces of tissue were taken.
Each was divided into two parts, one for
histologic study and the other for tissue cul¬
ture, in order to allow accurate correlation
between the nature of the tissue and its chro¬
mosome constitution. Small fragments of
tissue were grown as explants in plasma clots
and chromosomes were prepared from sub¬
cultures.
Results
Sex chromatin. In the 187 specimens we
studied, the percentage of cells with demon¬
strable sex chromatin varied between 23 and
87 per cent with a mean of 56 per cent.
In several tumors, an occasional cell ap¬
peared to show double sex chromatin, but
in no case was this the predominant cell
type. These findings indicate that our speci¬
mens were chromatin positive as in normal
female tissues.
Chromosome analysis. The distribution of
chromosome counts is shown in Table I. A
total of 155 cells were counted, of which
123 had 46 chromosomes, 23 had counts in
the hypoploid range and 8 cells were hy-
perploid. Endoreduplication was noticed in
one cell from Case No. 259. Visual analysis
revealed a normal karyotype in all 6 cases
(Fig. 1). Case No. 280 is seen to have a
minor structural variation, two members of
the D group having marked enlargement of
the short arms. This is unlikely to be of
significance and is regarded as a normal
variant.27 All of these 6 cases show a normal
female, XX, sex chromosome complement.







































Table II. Sex chromatin studies in female gonadal teratomas







Hunter and Lennox5 10 10
Tavares6' 7 32 32
Moore and Barrs 4 4
Levij9 20 20
Sohval and Gaines10 10 5 5
Mancini11 12 12
B riming1'' 50 21 9 20
Riviere13 64 64
Maltzeff and Sacco14 4 4
Myers15 47 47
Hienz10 24 17 4 3
Theiss, Ashley, and Mostofi1" 20 20
Taylor18 12 10 1 1
Girelli and Rigoli19 12 10 2
Talvalkar20 12 12
Present investigation 187 187
Total 520 475 1 21 23
Comment
The results of previous studies of sex
chromatin in ovarian teratomas, together
with our own data, are summarized in Table
II. The vast majority are chromatin positive,
but a few have been reported as chromatin
negative. Undoubtedly, some of these anoma¬
lous results were derived from material which
was unsuitable for the demonstration of sex
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Fig. 1. Karyotypes in 6 benign cystic ovarian teratomas.
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malignant tissue there may be anomalous
sex chromatin and this may explain some of
the chromatin-negative malignant ovarian
teratomas.22 There is also one well-docu¬
mented benign ovarian teratoma which con¬
tained double sex chromatin.18 Similar results
from studies on extragonadal teratomas in
females have recently been reported. It seems
likely that whereas the majority of female
teratomas have a "female" sex chromatin
pattern, a few may show anomalous nuclear
sex.
The results of sex chromatin studies in
male teratomas, both testicular and extra¬
gonadal, have also been reviewed.21, 28 Here,
the findings are even more striking insofar
as 40 per cent are chromatin positive, while
a few cases of sex chromatin mosaicism
and double sex chromatin have also been
recorded. Many testicular teratomas are
highly malignant and this may invalidate the
interpretation of some of these results. Never¬
theless, anomalous sex chromatin has been
clearly demonstrated in benign male tera¬
tomas and it is impossible to dismiss all of
these results simply as artifacts.
These findings suggest that there may be
some discrepancy between the nuclear sex
of the host and that of the teratoma, and
so cast doubt on the concept of the simple
neoplastic origin of these tumors and raise
again the possibility of their origin from
germ cells. One simple explanation would be
that these anomalous tumors may arise in
hosts with similarly abnormal sex chromatin.
Teratomas have been described in males
with Klinefelter's syndrome,21 but it has
been firmly established that the majority of
teratomas occur in hosts with normal sex
chromatin.15' 29-31
The most plausible theories of teratogen-
esis from germ cells are based on hypotheti¬
cal mechanisms of parthenogenesis.
1. Normal haploid gametes may fuse to
form diploid cells.5 In the female, the fusion
of haploid, 23X, cells would invariably pro¬
duce chromatin-positive diploid cells, 46XX.
In the male, the presence of both X-bearing,
23X, and Y-bearing, 23Y, cells could com¬
bine to form diploid cells with XX, XY, or
YY sex chromosome complement in the ratio
of 1:2:1. If YY cells are nonviable, this ratio
becomes XX:XY = 1:2.
2. Reduplication of haploid gametes could
also produce diploid cells.6 In the female this
would invariably produce chromatin-positive
cells, 46XX. In the male, it would produce
equal numbers of chromatin-positive cells,
46XX, and chromatin-negative cells, 46YY.
This theory implies that cells with a YY sex
chromosome complement are viable. Data
derived from the ratio of chromatin-positive
to chromatin-negative male teratomas are
still inconclusive in favoring either of these
hypotheses.21
3. Meiotic nondisjunction may be followed
by the fusion of aneuploid gametes.32 By such
a mechanism, chromatin-negative teratomas
may have a 45XO chromosome constitution,
chromatin-positive male teratomas have
47XXY, and doubly chromatin-positive tera¬
tomas have 47XXX.
Other mechanisms such as failure of re¬
duction division or polyploidy are also possi¬
bilities. There are undoubted difficulties to
all of these parthenogenetic theories. The
most serious problem is that mciosis is
thought to occur in males only after pu¬
berty,33 while the first meiotic division in
oogenesis occurs during intrauterine develop¬
ment but is arrested at the dictyotene
stage.34
It is clear that these hypothetical sug¬
gestions can be elucidated only by full
chromosome analysis. So far, Galton and
Benirschke23 have studied one malignant
ovarian teratoma, Harnden25 has analyzed
one benign solid ovarian teratoma, and Corf-
man and Richart24 have studied six benign
ovarian cystic teratomas. Our own report
adds a further 6 benign tumors. All of these
have proved to have a normal diploid female
karyotype, 46XX.
This evidence excludes the possibility that
teratomas may themselves be haploid. Fur¬
thermore, they have a normal karyotype and
do not have any autosomal anomaly. This
latter possibility was raised by the finding of
an extra autosome in an amorphous acardiac




genesis in this monozygotic twin were very
similar to those of some teratomas, and it
seemed possible that a similar anomaly may
be partly responsible for the chaotic disor¬
ganization of teratomas.
These studies do not provide an answer to
the origin of anomalous sex chromatin in
some teratomas since all our specimens were
normally chromatin positive. Further infor¬
mation is more likely to come from the
chromosome analysis of testicular teratomas,
and the study of chromatin-positive male
tumors should give definite evidence as to
the histogenesis of teratomas.
We wish to acknowledge the skilled assistance
of Mrs. Sheila Christie and Miss Aileen Ross in
the cytogenetic studies, and Professor R. J. Kellar
for access to the collection of ovarian tumors in
the Department of Obstetrics and Gynaecology.
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PRIMARY MESODERMAL MIXED
TUMOURS IN THE OVARY
A Report of Two Cases
by
M. F. Fathalla, M.B., Ch.B., D.G.O., D.S.,
M.Ch.(Cairo)
Department of Obstetrics and Gynaecology,
University of Edinburgh
umary mesodermal mixed tumours of the ovary
e exceedingly rare, but they are of interest because
their possible origin in foci of endometriosis
/illis, 1960). Two cases were encountered in a series
418 primary malignant ovarian tumours.
Case 1. This patient, a nullipara, aged 59 years,
esented with ascites and a twisted tumour of the
t ovary, more than 20 cm. in diameter. A total
sterectomy with bilateral salpingo-oophorectomy
is carried out. An extensive right pleural effusion,
esent before the operation, cleared gradually after
ieration. On pathological examination, the uterus
is found to be normal and the endometrium show-
a mild degree of proliferative activity. The right
ary and the tubes showed no remarkable features.
ie sections available from the tumour showed in
le the appearance of an old adenomyoma (Fig. 1 A)
d in the others a picture of carcino-sarcoma with
ands of degenerate chondrous tissue (Fig. IB),
remorrhage and necrosis were marked in some
rts, possibly partly due to the torsion of the
mour.
In this case, the origin of the primary mesodermal
xed tumour from the associated endometriosis was
obable, but in the absence of the original specimen
: could not demonstrate a definite transitional zone
tween the two lesions.
Case 2. This patient, a nullipara, aged 64 years,
d a mobile solid ovarian tumour. Total hysterec-
ny with bilateral salpingo-oophorectomy was
rformed. The tumour was apparently confined to
: ovary, but the patient died four months later with
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ascites and liver -enlargement. No autopsy was
performed. Pathological examination of the operative
specimen showed a normal uterus with an atrophic
endometrium. The cervix was the seat of superficial
inflammation. Both tubes and the right ovary showed
no abnormal features. The left ovarian tumour
showed several cystic areas containing blood stained
fluid but was largely solid. Microscopical examina¬
tion showed the presence of malignant epithelial
elements as well as a richly cellular stroma. The
epithelial elements showed mostly a well differentia¬
ted glandular pattern (Fig. 2A). In the stroma, broad
irregular bands of fibres were interlacing in various
directions. In the interstices, collections of large cells,
rounded, oval or tadpole-like, and with abundant
strongly eosinophilic cytoplasm could be seen which
were interpreted as rhabdomyoblasts (Fig. 2B).
Further sections stained with Heidenhain's iron
haematoxylin demonstrated cross striated muscle
fibres in several areas (Fig. 2C).
Comment
Ovarian tumours resembling the mesodermal
mixed tumours of the uterus arc very rare. A search
of the literature is hampered by the multitude of
names under which such tumours may have been
reported. The case of Katsunuma et al. (1959) was
stated to be the first case reported under the title of
mixed mesodermal tumour of the ovary. Another
case was reported by Edghill et al. (1967). Other
authors have mentioned similar cases but without
giving full details (Willis, 1960; Sternberg, 1963).
Cases of ovarian carcino-sarcoma, probably variants
of this group, have also been reported (Tuthill, 1938;
MacFarlane and Pritchard, 1954; Marcella and
Cromer, 1959). Other cases have been reported under
the - title of rhabdomyosarcoma (Sandison, 1955;
Payan, 1965).
In the diagnosis of a mesodermal mixed tumour of
the ovary, care should be taken to exclude the
possibility of a uterine primary growth. Taylor (1958)
commented on three instances of reputed tumours
having the histological features of mesodermal mixed
tumour, in none of which the uterus was removed so
that the possibility of ovarian metastatic growth
could not be excluded. Care should also be taken not
to mistake cases of teratoma for these tumours.
Mesodermal mixed tumours are monodermal while
teratomas are tridermal. The presence of ectodermal
and entodermal teratomatous elements should be
excluded.
Willis (1960) stated that, in the ovary, these
tumours arise from foci of endometriosis. The three
cases of ovarian carcino-sarcoma, already referred
to, were all described in relation to endometriosis,




I am grateful to Professor R. J. Kellar for permis-
ion to publish these two cases and for help and
dvice. I thank Mr. Low for preparing the photo-
raphs.
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RUPTURE OF LOWER UTERINE
SEGMENT SCAR DURING ABORTION
AT TWENTY-TWO WEEKS
by
John Joyce Foley, M.B., F.R.C.O.G.
Senior Consultant Obstetrician and Gynaecologist
and
M. J. Kettle, M.B., M.R.C.O.G.
Senior Registrar in Obstetrics and Gynaecology
Saint Mary's General Hospital, Portsmouth
Lupture of a lower segment Caesarean scar is
ncommon during pregnancy and very rare during
bortion at the 22nd week.
The patient was 23 years old. Her first three
regnancies ended with spontaneous vaginal deliver-
:s in 1960, 1961, and 1962, the birthweights being
etween 4 pounds 8 ounces (2,025 g.) and 5 pounds
0 ounces (2,530 g.). In 1964 labour began at term in
er fourth pregnancy and because of an uncorrect-
ble transverse lie, lower segment Caesarean section
ras carried out. The operation was described as
jutine, the lower uterine segment being closed in
vo layers with continuous No. 1 chromic catgut.
21
The puerperium was uneventful, and the only rise of
temperature afterwards was to 99° F. on one occasion
on the third postoperative day. She failed to attend
the postnatal clinic. Her fifth pregnancy in 1965 was
normal and ended with a spontaneous vertex
delivery of an infant weighing 5 pounds 5 ounces
(2,390 g.) after eleven hours labour. Again the
puerperium was normal.
On the 11th September, 1966, the patient was
admitted as an emergency case. She gave a history of
22 weeks amenorrhoea, vaginal bleeding for 12
weeks, heavier for one week, and abdominal pains
for six hours. During the previous four weeks the
patient had had some abdominal discomfort. She
denied interference but had not sought medical
advice, hoping that she would abort.
Her mucous membranes were pale, the blood
pressure was 130/80 mm. Hg, pulse rate 100 per
minute and the temperature normal. The uterine
fundus was palpable just below the umbilicus; it was
tender and contracting. Vaginal examination showed
the cervix to be dilating and foetal parts could be
felt in the cervical canal. The haemoglobin concen¬
tration was 8-4 g. per 100 ml. The patient was given
pethidine and appeared to go out of labour. Over the
next 12 hours the pulse rate rose to 130, the uterus
became increasingly tender and tenderness developed
over the lower abdomen. The serum electrolytes
were normal and blood cultures were taken. The first
of four bottles of blood was given and tetracycline
was added to the drip. However, the patient's
condition deteriorated further, the pulse rate rose to
140, the respiratory rate to 50, the abdominal
tenderness became widespread with marked rebound
tenderness and the patient complained of shoulder
pain. It was now obvious that there was intraperiton¬
eal haemorrhage. Laparotomy showed that there
were approximately 1,500 ml. of blood in the
peritoneal cavity. The lower segment incision had
ruptured and the placenta and the upper half of the
foetus projected into the peritoneal cavity. The foetus
and placenta were removed. The bladder was very
adherent and was opened during dissection. This
incision was closed in layers and as the bladder
could not be freed readily, subtotal hysterectomy was
performed. This was done after both internal iliac
arteries had been ligated in continuity. A tube drain
was passed into the vagina through the cervix before
the abdomen was closed. The bladder was drained
continuously for seven days. Recovery was unevent¬
ful.
Histological examination showed no significant
abnormality of the myometrium.
The correct diagnosis might have been made
earlier in this case had it not seemed so unlikely with
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MALIGNANT TRANSFORMATION IN OVARIAN ENDOMETRIOSIS
by
M. F. Fathalla, M.B., Ch.B., D.G.O., D.S., M.Ch.(Cairo)
Department of Obstetrics and Gynaecology, University of Edinburgh
It is now forty years since Sampson (1924, 1925)
first pointed out the possibility of malignant
transformation in ovarian endometriosis. How¬
ever, its frequency and clinical and pathological
characteristics remain widely unrecognized. Few
studies have been made and most of the literature
on the subject has been limited to the reporting
of isolated cases.
Recent interest in this problem has been
aroused by the more general realization among
pathologists of the frequency with which endo-
metrial-like adenocarcinoma is encountered
among cases ofprimary ovarian carcinoma (Long
and Taylor, 1964). The General Assembly of the
International Federation of Gynaecology and
Obstetrics at Mar del Plata in September 1964
adopted a recommendation to introduce a new
group, termed "endometroid", into the histolo¬
gical classification of the common primary
epithelial tumours of the ovary, because the
frequency of occurrence of tumours so designa¬
ted was considered to warrant the status of a
separate group.
Material
For this study we reviewed the histological
material in the Department of Obstetrics and
Gynaecology of Edinburgh University, for a
period of ten years, 1954-1963. Among the total
of 62,938 cases reported on during this period
there were 637 cases of ovarian endometriosis
and 1,734 ovarian tumours. In 45 of the cases of
endometriosis, the diagnosis was only presump¬
tive, due to the absence of well-defined endo¬
metrial elements. The slides of the remaining
592 cases were reviewed for evidence of pre-
malignant or early malignant changes. Of the
1,734 ovarian tumours 418 were primarily malig¬
nant tumours, and these were critically examined




Atypical epithelial activity was encountered
in four endometrial cysts, without any evidence
of stromal invasion. Heaping up in layers, cel¬
lular pleomorphism, variations in the size of the
nuclei, nuclear hyperchromatism and mitotic
figures were noted to variable degree in these
cases. The ages of the four patients were 45, 48,
55 and 60 years.
Post-menopausal benign hyperplasia was
also observed in two cases of ovarian endomet¬
riosis associated with a granulosa-theca cell
tumour in the opposite ovary.
The association of endometriosis with an
ovarian tumour in the same or the opposite ovary
was observed in 52 cases. In 21 of these the
tumour was malignant. In seven cases the endo¬
metriosis and the malignant tumour were en¬
countered in the same ovary. The malignant
tumours in these seven cases were two adeno-
acanthomas, four endometroid adenocarcinomas
and one mesodermal mixed tumour. Definite
evidence for an origin in endometriosis could be
established for the two adenoacanthomas and
for two endometroid carcinomas.
Primary Malignant Ovarian Tumours
In the survey of our 418 primary malignant
ovarian tumours, we classified 52 cases as having
a histological appearance similar to that of
malignant tumours of the uterine endometrium.
Of these 12 were adenoacanthomas, 38 were
adenocarcinomas and two were mesodermal
mixed tumours. These malignant "endometroid"
tumours thus accounted for about 12 per cent
of all primary malignant tumours of the ovary
in our series. Unfortunately the uterus was not
available for examination in 17 of these cases—




Case 1. Papillary malignant growth in an ovarian endometrial cyst (x 5).
The possibility of a metastatic spread from a
primary uterine tumour cannot be excluded on
histological review in these cases.
The association of benign endometriosis with
these malignant endometroid tumours was as
follows. Two cases of adenoacanthoma and two
cases of endometroid carcinoma had their origin
in benign endometrial cysts. In two cases of
endometroid carcinoma and in one case of
mesodermal mixed tumour endometriosis was
encountered in the same ovary as the tumour
but no transitional areas could be satisfactorily
demonstrated. The opposite ovary was available
for examination in 22 of the other cases. In six
of these endometriosis was encountered and in
one case it showed pronounced cystic hyper¬
plasia.
Case Reports
A brief report of the four cases of malignant
transformation in ovarian endometrial cysts will
now be given.
Case 1\ The patient was -51 years old, nulli-
parous and two years ■ postmenopausal. A
diagnosis of uterine fibromyomata and ovarian
endometriosis was made. A total hysterectomy
with bilateral salpingo-oophorectomy was per¬
formed and a localized papillary adenocarcinoma
in an endometrial cyst was found (Fig. 1).
Eighteen months later the patient returned with
abdominal pain, a lump and urinary frequency.
Laparotomy was carried out and a bilocular com¬
pletely encapsulated cyst about 10 cm. in dia¬
meter was removed from the site of the right
broad ligament. During removal one loculus
ruptured with escape of chocolate brown fluid.
Gross pathological examination showed intracys-
tic papillae and microscopical examination showed
adenoacanthoma. An interesting feature was the
apparent malignant nature of both the glandular
and squamous elements in this tumour (Fig. 2).
Although no definite benign endometrial tissue
was encountered in the sections available from
this second tumour, the cyst was partly lined by
a broad zone of pseudo-xanthoma cells (Fig. 3)
and old haemorrhages were abundant in the
stroma. We interpret the second tumour in this
case as representing malignant transformation
in an endometrial lesion left from the previous
operation, rather than a recurrence of the first
localized growth.
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Fig. 2
Case 1. Malignant squamous component in the adenoacanthoma (x 110).
Fig. 3
Case I. A layer of pseudoxanthoma cells forming part of the lining of the
malignant endometrial cyst (x 110).
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Fig. 4
Case 2, Papillary adenoacanthoma in an endometrial cyst (x 95).
Fig. 5
Case 3. Papillary malignant areas in an endometrial cyst. An area of cystic
hyperplasia is shown in the upper left corner (x 4).
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Fig. 6
Case 4. Benign endometriosis running into and continuous with the malignant
epithelium (x 25).
Case 2: The patient was 47 years old and was
operated upon for an asymptomatic abdominal
mass. An adherent right ovarian cyst was found
as well as an anterior wall fibroid. The cyst
ruptured during removal with the escape of
brownish stained fluid and pieces of friable tissue.
Subtotal hysterectomy with bilateral salpingo-
oophorectomy was carried out and the patient
received a post-operative course of deep X-ray
therapy. Three years later, when the patient was
last seen, there was no evidence of any recur¬
rence. Pathological examination of the cyst
showed a localized papillary adenoacanthoma
(Fig. 4). The rest of the cyst wall showed some
atrophic endometrial glands but the lining epi¬
thelium was largely replaced by a broad zone of
pseudoxanthoma cells. The other ovary con¬
tained a small blood cyst.
Case 3: An unmarried woman, 46 years old,
presented with acute abdominal pain and a
tender pelvi-abdominal mass. Laparotomy
showed that the peritoneal cavity was filled with
a light brown opaque fluid, which had come from
a ruptured left ovarian cyst. The cyst was thick
walled, adherent and still distended to about the
the size of a large grapefruit by some brown
thick fluid. Pathological examination of the
removed cyst showed that it was an endometrial
cyst with areas of endometrial cystic hyperplasia
and areas of papillary adenocarcinoma (Fig. 5).
Case 4\ An unmarried woman, 27 years old,
presented with recurrent attacks of hypogastric
pain and an enlarging abdominal lump. A left
ovarian cyst, together with the uterus and the
right ovary were removed. The cyst was about
15 cm. in diameter and contained copious
amounts of dark fluid. Multiple small papillo-
mata were seen to fill almost half the cyst cavity.
Microscopical examination showed a papillary
endometroid carcinoma arising from and con¬
tinuous with the benign epithelial lining of an
endometrial cyst (Fig. 6). The opposite ovary was
the seat of endometriosis.
Discussion
As Sampson (1925) pointed out, two methods
of studying malignant transformation in ovarian
endometriosis are possible—either to study cases
of benign endometriosis in an endeavour to find
early malignant changes in them or to study cases
of ovarian carcinoma to ascertain whether the
carcinoma could have arisen in misplaced endo-
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metrial tissue. We have used both methods. To
prove beyond doubt that an ovarian carcinoma
arises from pre-existent endometriosis the cri¬
teria as suggested by Sampson (1925) and
Scott (1953) must be satisfied. Such direct
evidence may only be available in early cases;
cases detected later may have all traces of their
origin obliterated by spread of the malignant
growth. Indirect evidence for an origin of a
malignant tumour in endometriosis may be its
histological similarity to endometrial growths in
the uterus. Malignant ovarian tumours of endo-
metroid type are not infrequent. In our material
they accounted for about 12 per cent of all pri¬
mary malignant tumours of the ovary. We in¬
cluded in this group cases of adenoacanthoma,
endometroid carcinoma and the rare cases of
primary mesodermal mixed tumours. However,
it is also possible that these tumours can arise
directly from the ovarian serosa, which may
retain the embryologic potential of the coelomic
epithelium to differentiate into various tissues,
including uterine epithelium (Long and Taylor,
1964). In the present state of our knowledge the
incidence of malignant transformation in ovarian
endometriosis can therefore only be given as
lying somewhere between a minimum which
only includes the definite cases and a maximum
which includes all the cases showing a histolo¬
gical pattern compatible with an endometrial
origin.
Review of Reported Cases
We have analyzed the cases of definite malig¬
nant transformation in ovarian endometriosis
which have been reported in an attempt to
define the clinical and pathological features which
were possibly responsible for their early detec¬
tion, when their relation to benign endometriosis
was still intact. For this purpose, we added 48
other cases from the literature to our own 4
cases. (Sampson, 1925, case 5; Tuthill, 1938;
McCullough et al., 1946; Teilum, 1946; Novak,
1947; Kuzma, 1947, case 1; Miller et al., 1947;
Rauramo, 1947; Moss and Runals, 1948;
Corner et al., 1950, cases 4 and 5; Bacher and
Hertzog, 1951; Scott, 1953, case 3; Fredrikson,
1953, case 1; Hunter and Klein, 1954, cases 1 and
2; Dockerty, 1954, 2 cases; PostololT and
Rodenberg, 1955; Kumar et al., 1955; Weinrod
et al., 1956; Thompson, 1957, cases 3, 5, 7, 10, 14
and 17; Greene and Enterline, 1957, cases 1 and
2; Ferreira and Clayton, 1958; Wade, 1960;
Burt and Emson, 1961, 3 cases; Concannon et al.,
1962; Dockerty, 1962, cases 5, 6, 7, 8 and 9;
Freedman et al., 1964; Gray and Barnes, 1965,
cases 1, 2, 4 and 5; Ridley, 1966; Plate 1966;
Eastman et al., 1966). This is not claimed to be
a comprehensive review of all reported cases,
though it probably includes all acceptable cases
in the English literature.
Clinical features
The frequency of the leading symptoms was as
follows:
Pain 23 cases
Lump or abdominal enlargement 19 cases
Uterine bleeding 12 cases
Urinary symptoms 6 cases
Asymptomatic 6 cases
Not stated 2 cases
Pain was the most presenting symptom. Judging
from the gross appearance of the endometrial
cysts in these cases, in which the malignant
growth was quite commonly small, the pain was
caused by bleeding from the endometrium
inside the cyst. The pain in these cases was fre¬
quently more or less continuous and was differ¬
ent from the periodic menstrual-related pain
typical of benign endometriosis. When inter¬
mittent attacks were experienced they were not
usually related to menstruation, except in their
early stages. In some cases the pain began after
the menopause. These observations suggest that
the possibility of malignant transformation
should be considered in case of a patient known
to have endometriosis if the typical periodic
pattern of pain changes, if the pain increases
abruptly in severity or if attacks of pain start
after the menopause.
In some cases the cyst enlarged to form an
abdominal lump or to cause a feeling of abdom¬
inal enlargement without causing any marked
pain. Commonly, however, the patient com¬
plained of both pain and the feeling of a lump.
The abdominal lump may be noticed to develop
rapidly (Weinrod et al., 1956). The enlargement
of the endometrial cyst was not caused by the
bulk of the malignant growth which was almost
invariably small in these cases but by distension
due to bleeding from the malignant endomet-
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rium. The detection of an enlarging mass in a
patient known to have endometriosis may direct
attention to the possibility of malignant trans¬
formation (Dockerty, 1962, case 7).
In one of our cases, and in two other cases
(Teilum, 1946, Dockerty, 1962, case 5) the
patient presented with acute abdominal pain due
to rupture of an endometrial cyst that had under¬
gone malignant transformation. Acute spon¬
taneous rupture of an endometrial cyst is a rare
condition (Koskela, 1964). Pregnancy is the only
significant factor predisposing to rupture which
has been hitherto described (Scott, 1944), but
malignant transformation is another possible
cause.
The three features of pain, an enlarging lump
and spontaneous rupture may all be due to
intracystic bleeding from the malignant endo¬
metrium, and may sometimes draw attention to
these cases at an early stage.
In these cases uterine bleeding often occurred.
Out of 30 cases in which the endometrial
histology was reported the endometrium was
described as hyperplastic in 15 cases. We have
also seen recently a case of primary adenoacan-
thoma of the ovary with the benign proliferative
uterine endometrium showing few areas of
squamous metaplasia.
Gross Appearances
The malignant endometrial cysts commonly
showed one or more of the following gross
pathological features:
Papillary areas 22 cases
Solid areas 13 cases
Abnormal large size 11 cases
Spontaneous rupture 3 cases
The presence of any of these features in an endo¬
metrial cyst should raise suspicion about malig¬
nant transformation. The tendency of the growth
to project inside the cyst explains the intracystic
bleeding already discussed. A large size is very
unusual for benign endometrial cysts; the largest
encountered by Sampson was 15 cm. in diameter
(Sampson, 1925). Malignant endometrial cysts,
on the other hand, may reach very large sizes,
apparently due to recurrent bleeding from the
endometrium. The cyst reported by McCullough
et al. (1946) contained about 4,000 ml. of dark
brown fluid, and case 14 of Thompson (1957)
contained 2,700 ml.
Microscopical Picture




Squamous cell carcinoma 1 case
Carcinosarcoma 1 case
The frequency of the adenoacanthoma in these
cases is probably more apparent than real. The
adenoacanthoma is commonly a slowly growing
tumour (Thompson, 1957) so that its relation
to an endometrioma may remain intact whereas
a more rapidly growing adenocarcinoma is liable
to overgrow the tissue of its origin so that its
relation to endometriosis may be missed. In our
cases of primary malignant ovarian tumours,
the ratio of cases of adenoacanthoma to endo-
metroid carcinoma was 1:3; if only the cases
which definitely arose in endometriosis are con¬
sidered, the ratio is 1:1.
Summary
Malignant transformation in ovarian endo¬
metriosis has been studied by reviewing 592
cases of ovarian endometriosis and 418 primary
malignant ovarian tumours. Anaplastic changes
were encountered in four benign endometrial
cysts. Malignant tumours histologically similar to
endometrial growths were encountered in 52
cases. Of these, only four could be shown to have
a definite endometriotic origin. The clinical and
pathological characteristics of these four cases
and of 48 other cases from the literature have
been reviewed.
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The association between intersex states and
ovarian tumours, particularly the disgerminoma
and arrhenoblastoma, has at least two points of
interest. It has immediate relevance to our under¬
standing of the nature and histogenesis of these
tumours, and it is of practical importance to the
clinician in his management of intersex states.
In the first three decades of this century many
clinical and pathological studies of this problem
were reported and this epoch may be said to have
ended with a more or less general acceptance of
Robert Meyer's views. In a series of publications
(1931a, 1931b) he drew a sharp distinction be¬
tween two types of ovarian tumour which are
associated with intersex states. In one variety,
which he called disgerminoma, he postulated
that the intersex state favoured the occurrence
of the tumour, but the tumour was in no way
responsible for the abnormal sex development.
The other type he called arrhenoblastoma and
suggested that this tumour was itself directly res¬
ponsible for virilisation so that the intersex state
was reversible when the tumour was removed.
Meyer wrote disgerminoma with the prefix
"dis" meaning "both", implying that the germ¬
inal cells from which this tumour arises are pre¬
sent in both the testis and ovary. Most later
authors have used the spelling with the prefix
"dys", implying that the germinal cells from
which the tumour arises have undergone an
error of development or differentiation. For
historical reasons we have preferred to use
Meyer's original spelling.
The introduction of methods of analysis of
chromosomes and sex chromatin has led to a
better understanding of intersex states and this
new information has raised several problems
which appear to complicate Meyer's concepts.
Morris (1953) suggested that some tumours
which had been previously reported as arrheno¬
blastoma may in fact have been testicular
tumours occurring in association with the syn¬
drome of testicular feminization in genetic males.
Carpentier et al. (1956) went further and postu¬
lated that some other ovarian tumours, particu¬
larly disgerminoma and chorioncarcinoma, may
also be derived from testicular tissue. Overzier
(1963) considered that an intersex state should be
suspected in every patient with a disgerminoma.
Scott (1965) has gone so far as to suggest that an
intersex state may underlie the development of
all disgerminomas in the female, and he advo¬
cates a return to the term used by early French
pathologists, seminoma ovarii. He implies that
the testicular seminoma and the ovarian disger¬
minoma are identical and postulates that the
presence of either of these tumours is dependent
on the presence of an XY cell line in the
gonad.
It seems timely to attempt a synthesis of both
the cytogenetic and pathological evidence on
this problem. In this communication we de¬
scribe the results of a combined cytogenetic and
histological study of 5 cases of disgerminoma and
5 cases of arrhenoblastoma, and present a critical
analysis of the relevant literature.
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Material and Methods
Nine of these cases were obtained as a result of
the review of more than 2,000 ovarian tumours
collected in the laboratories of this department
over the last ten years. Histological sections of
one disgerminoma (case 5) came from the path¬
ology department of the Royal Hospital for
Sick Children, Edinburgh. The histopathology
of the original slides was re-assessed. Sex chro¬
matin was studied in slides stained both with
haematoxylin and eosin and with Feulgen.
The clinical records of each patient were
reviewed, and whenever possible the patient was
recalled for assessment of sex chromatin from a
buccal smear, and for chromosome analysis of
peripheral blood leucocytes (Moorhead et al.,
1960).
Case 1. The patient was 59 years old. She married at
the age of 46 and had no children. Her periods were regu¬
lar until the menopause at 52 years. Seven years later
she presented with postmenopausal bleeding. A pelvic
tumour was detected, and total hysterectomy and bilateral
salpingo-oophorectomy were performed. Fifteen months
later she died with a recurrent abdominal mass.
The left ovary was replaced by a disgerminoma and
dermoid cyst, and the uterus contained multiple fibroids.
Normal ovarian tissue could not be found in the sections
made from the tumour, but the other ovary was normal.
The squamous epithelium of the dermoid cyst, the healthy
ovary and the uterine fibro-muscular tissue proved to
be chromatin positive. Some of the cells of the disger¬
minoma appeared to be chromatin positive but in general
these nuclei were unsuitable for analysis. However, the
fibroblasts of the stroma of the tumour were definitely
chromatin positive.
Case 2. The patient was 16 years old and unmarried.
Her periods began at the age of 15 and were subsequently
irregular. Examination revealed a large pelvic tumour,
and the urine showed a high titre of chorionic gonado¬
trophs. At first she was thought to be pregnant but a
laparotomy was subsequently performed. A large right
ovarian tumour was found, and a total hysterectomy and
bilateral salpingo-oophorectomy performed. The clinical
and endocrinological aspects of this unusual case have
already been reported (Hobson and Baird, 1966).
The ovarian tumour was a disgerminoma, and a corpus
luteum was found in the right ovary immediately adjacent
to the tumour cells. The other ovary was normal and the
endometrium was in the secretory phase. The healthy
ovary, myometrium and tumour stroma were chromatin
positive. The tumour cells were unsuitable for the demon¬
stration of sex chromatin. A buccal smear was chromatin
positive, and chromosome analysis of peripheral blood
leucocytes revealed a normal female karyotype, 46/XX.
Case 3. The patient, who was 18 years old and single,
presented with abdominal distension, hypertension,
proteinuria and pretibial oedema. At first she was thought
to be pregnant with pre-eclamptic toxaemia, but pelvic
examination revealed a swelling discrete from the uterus.
Subsequent laparotomy showed a tumour of the left ovary
and left oophorectomy was carried out.
The ovarian tumour was a disgerminoma. Nuclei of the
tubal epithelium and of stromal fibroblasts of the tumour
were chromatin positive, but the tumour cells were un¬
suitable for analysis. A buccal smear was chromatin
positive, and chromosome analysis of peripheral blood
leucocytes revealed a normal female karyotype, 46/XX.
Case 4. The patient was 19 years old and unmarried.
She had a laparotomy at the age of 7 when she presented
with an abdominal tumour. The right ovary contained a
large tumour, and right oophorectomy was followed by a
course of radiotherapy. At the age of 19 years she was
treated for an incomplete abortion.
The ovarian tumour was a disgerminoma. Although the
tumour cells were unsuitable for analysis, the stromal
elements were chromatin positive. She had a chromatin
positive buccal smear, and chromosome analysis showed
a normal female karyotype, 46/XX.
Case 5. The patient was 4 years old and presented with
a symptomless abdominal swelling. At laparotomy a left
ovarian tumour was discovered and the left ovary was
removed.
This tumour was a disgerminoma with a marked lym¬
phoid reaction. The tumour cells were unsuitable for
analysis, but stromal elements were clearly chromatin
positive. This patient could not be traced for further
cytogenetic investigation.
Case 6. The patient was 16 years old and presented
with primary amenoirhoea. There was normal breast
development, but infantile external genitalia, and neither
axillary nor pubic hair. At laparotomy there was no
uterus and the gonads were slightly enlarged and lay on
the brim of the pelvis. Both gonads were removed.
The gonads were at first reported to contain bilateral
well-differentiated arrhenoblastomas. The capsules of
the tumours resembled ovarian stroma but contained no
follicles. The tubular elements of the tumours were lined
with Sertoli cells but there were no spermatogenic ele¬
ments. There were occasional collections of Leydig cells.
The nuclei of the stromal cells, Sertoli cells and Leydig
cells were chromatin negative.
Prior to our investigation this patient had already been
found to have a chromatin negative buccal smear and a
normal male karyotype, 46/XY (MacGregor, 1966).
This is an illustration of the association of a testicular
tubular adenoma with the clinical syndrome of testicular
feminization in a genetic male.
Case 7. The patient was 18 years old and presented
with primary amenorrhoea. At subsequent laparotomy,
the uterus was absent and gonads were found to be
enlarged. Both gonads were removed.
Again, these gonadal tumours were at first thought to
be well-differentiated arrhenoblastomas, and the histo¬
logical picture was identical to that described in Case 6.
The nuclei of both the tumour cells and stromal cells
were chromatin negative.
Nuclear sexing and chromosome analysis had been
performed prior to our investigation, and the patient
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proved to be chromatin negative with a normal male
karyotype, 46/XY, (MacGregor, 1966). This case repre¬
sents another example of the association between testi¬
cular tubular adenoma and testicular feminization.
Case 8. The patient was 24 years old. She had been
married for four years and had one child aged one year,
she presented with secondary amenorrhoea and hirsutism
following delivery. At laparotomy she was found to have
a left ovarian tumour and this was removed. Following
this operation her periods returned, the hirsutism dis¬
appeared, and she subsequently had two further preg¬
nancies.
This tumour was an arrhenoblastoma of intermediate
to sarcomatous type. The Sertoli cells, Leydig cells and
stromal elements of the tumour were chromatin positive.
The patient could not be traced for further examination.
Case 9. The patient was 14 years old and presented
with abdominal pain and swelling. There was no evidence
of virilization and she had not reached the menarche. At
laparotomy a large cystic left ovarian tumour was re¬
moved. She died with a pelvic recurrence 21 months later.
The tumour was an arrhenoblastoma. Nuclei of the
stromal elements of the tumour were chromatin positive,
but nuclei of the tumour cells were unsuitable for analysis.
Case 10. The patient, who was married and aged 24,
presented with abdominal swelling of recent onset and
secondary oligomenorrhoea for four years. At laparot¬
omy, a large right ovarian tumour was removed.
The tumour was a well-differentiated arrhenoblastoma.
This histological picture showed a predominantly tubular
pattern with a few areas similar to granulosa cell growth.
Nuclei of both tumour cells and stromal fibroblasts
proved to be chromatin positive. This patient could not
be traced for further investigation.
In summary, all five patients with a disger-
minoma were phenotypically normal and had a
normal female sex chromatin pattern, while
three of them had a normal female karyotype.
Of the five tumours originally diagnosed as
arrhenoblastomas, two proved to be testicular
tubular adenomas replacing the undescended
testes of genetic males with the testicular femin¬
ization syndrome.
Discussion
A. Disgerminomas and Intersex States
Disgerminomas are most commonly found in
the ovaries of phenotypically normal women.
Pregnancies have both preceded and followed
the removal of a disgerminoma (Santesson,
1947), and 23 cases of disgerminoma occurring
during pregnancy have been reported (Pece,
1964). In case 2 of this report we describe a
corpus luteum immediately adjacent to tumour
cells The stromal cells in our five cases were
consistently chromatin positive. In our cases the
tumour cells were unsuitable for demonstrating
sex chromatin, but other authors have found a
high incidence of sex chromatin in some disger¬
minomas (Sohval and Gaines, 1955; Theiss et ah,
I960; von Heinz, 1961). Finally, we report here
the results of chromosome analysis in three
patients with a disgerminoma in each of whom
there was a normal female karyotype, 46/XX.
The evidence appears to be incontrovertible that
disgerminomas usually occur in the ovaries of
genetic females.
However, it is commonly believed that there
is a significant association between ovarian
disgerminomas and intersex states and state¬
ments to this effect appear in most of the stand¬
ard textbooks. The series of 27 disgerminomas
in intersex cases collected by Meyer (1925,
1931b) forms the basis for this belief. However,
it has not been sufficiently recognized that Meyer
used the term disgerminoma to refer to tumours
of both the testis and ovary and that his series
included no definite cases in female pseudoher¬
maphrodites. In fact, his series includes no
example where the gonad which was the site of
the tumour could be definitely identified as an
ovary, and in only one of his cases was the
other gonad shown to be an ovary. Furthermore,
this latter case which was originally reported by
Moots (1921) was subsequently considered to be
an arrhenoblastoma rather than a disgerminoma
(Javert and Finn, 1951). In another four of his
cases Meyer considered that the contralateral
gonad was probably an ovary, but this opinion
was not based on histological evidence.
This illustrates a peculiar difficulty in analyzing
the cases reported in the literature. The nature
of the gonad bearing the tumour is often ob¬
scured by the tumour, and the structure of the
contralateral gonad is rarely described. For
example, Meyer could identify gonadal sex in
only 7 out of his 27 cases.
The application of nuclear sexing and chro¬
mosome analysis to this problem might be
expected to supplement gonadal sexing based on
histological evidence. We have, therefore, col¬
lected from the literature 36 cases of tumours of
the seminoma-disgerminoma type in intersex
patients in which one or more of the following
pieces of information was available—a histolo¬
gical report on one or both gonads, sex chro-
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Table I
Tumours of the Disgerminoma-Seminoma Type in Intersexes
Gonadal sex Genetic sex
Tumour
Author nomenclature Tumour side Contralateral Sex Chromosome
chromatin analysis
Unger (1905) Disgerminoma Testis Testis
Marion (1905) Disgerminoma Testis
Zacharia:; (1909) Disgerminoma Testis
Skajaa (1919) Disgerminoma Testis
Polano (1921) Disgerminoma Ovotestis Ovotestis
Menetrier et al. (1922)
Case 1 Seminoma Testis Testis
Reverdin (1923) Disgerminoma Ovotestis
Weyeneth (1936) Disgerminoma Ovotestis
Essenberg and Feinberg (1937) Seminoma Ovotestis Ovary
(Carcinoma)
Seegar (1938) Disgerminoma Testis Testis
Long et al. (1941) Disgerminoma ? Ovary
Moehlig (1942) Seminoma Testis Testis
Corriden (1949) Disgerminoma
Lafferty and Pendergrass (1950) Seminoma Testis Testis
Huddleston-Slater (1953) Disgerminoma Negative
Morris (1953) Seminoma Testis
(Disgerminoma)
Plate (1953) Disgerminoma Negative1 46/XY2
Spielman and Motyloff (1955) Disgerminoma Testis
Melicow and Uson (1959)
Case 3 Seminoma Testis Testis Negative
Case 4 Disgerminoma Negative
Stirling (1959) Seminoma Testis Ovary Negative
Teter and Tarlowski (1960) Disgerminoma Negative
Case 1 (Seminoma)
Case 2 Disgerminoma Positive
Botella-Llusia (1960) Disgerminoma3 Ovotestis Ovotestis Positive 46/XX
Miller et al. (1960) Seminoma Testis Negative XO/XY
Seminoma Testis Negative XO/XY
Philipp and Stange (1960) Disgerminoma Positive
Dominguez and
Greenblatt (1962) Disgerminoma Negative 45/XO
Goodlin (1962) Seminoma Testis Negative XO/XY
or
(XO/XY
Reddy and Vittal (1963)
Case 3 Seminoma Testis Testis Negative
Hauser (1963) Seminoma Testis Testis
Halley (1963) Seminoma Testis Negative
Lewis et al. (1963) Seminoma Testis Negative XO/XY
Teter et al. (1964) Disgerminoma Negative 46/XY
Sohval (1964) Disgerminoma Negative
Bain and Scott (1965) Disgerminoma Negative XX/XY
1. Sex chromatin after Carpentier (1956).
2. Chromosome analysis after Scott (1965).
3. Tumour nomenclature after Overzier (1963).
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matin analysis, or chromosome analysis of the
patient. Fourteen of these tumours were de¬
scribed as seminomas and the other 22 as dis-
germinomas. Cases reported as embryonal
carcinoma, teratocarcinoma and gonadoblast-
oma have been excluded. A summary of these
cases is presented in Table I. This provides
information on four specific points.
1. Nature of the gonad which contained the tumour
This was reported as follows:
Testis 15 cases
Ovotestis 3 cases
? Ovary 1 case
Not identified 17 cases
The one case where the site of the tumour was
identified as an ovary was described by Long
et a/. (1941). This diagnosis was apparently based
on the finding of ovarian stroma. However,
this cortical type of tissue is not specific to the
ovary as it can also be found in ectopic testes
(Morris and Mahesh, 1963). Two other features
of this case suggest a testicular origin for this
tumour. The findings of a deep voice, hirsutism
and penile erections suggest that the patient was
a male, unless it is assumed that the tumour was
actively androgenic. Secondly, calcified con¬
cretions were present in the tumour. These are
practically unknown in ovarian disgerminomas
but are common in the tumours of dysgenetic
testes (Teter et ah, 1964).
The three cases in which the tumour was
found in an ovotestis need further comment.
In the case described by Essenberg and Feinberg
(1937), the tumour was situated in the testicular
part of an ovotestis. In the case originally de¬
scribed by Polano (1921) and reviewed by Meyer
(1925 and 1931a), one gonad was replaced by
the tumour, while in the contralateral gonad, an
ovotestis, Meyer found a focus of disgerminoma
cells in the ovarian component. Meyer con¬
sidered that this was a separate primary disger¬
minoma arising in ovarian tissue, but it is
difficulty to exclude the possibility that it may
have been a metastatic deposit from the other
gonad. In the case of Botella-Llusia (1960) an
early focus of what were apparently disgermin¬
oma cells was found between the testicular and
ovarian components of one ovotestis. In this
case, the origin of the tumour cannot be definitely
ascribed to either testis or ovary. One can con¬
clude from this data that no case of intersex with
a disgerminoma has been reported where the
tumour has been proven to have arisen in ovar¬
ian tissue. Undoubtedly, the vast majority have
arisen in testicular tissue.
2. Nature of the other gonad.
The nature of the gonad on the side opposite




Not identified 18 cases
The two cases in which the other gonad was
described as an ovary were those of Essenberg
and Feinberg (1937) and Stirling (1959). In both
cases the patient was a true hermaphrodite and
the tumour developed in a testis.
Two of the cases in which the nature of the
gonad was not identified deserve comment. In
the case of Corriden (1949) both gonads were
replaced by tumour tissue. The gonad contained
a disgerminoma, and the author describes an
epididymis attached to this tumour. The other
gonad was replaced by a typically ovarian type
of tumour, a mucinous cystadenoma, and this
suggests that this gonad was an ovary. This is
most probably an example of true hermaphro¬
ditism (Melicow and Uson, 1959). Moehlig's
case (1942) was unusual. One gonad, a testis, con¬
tained a disgerminoma, and there were two other
separate gonads in the pelvis. One of these was
removed and found to be a hypoplastic testis.
The other gonad was thought to be an ovary, but
it was neither removed nor was a biopsy taken.
One can conclude that in many intersex cases
with a disgerminoma, the contralateral gonad is
a testis. In cases in which the contralateral gonad
proved to be either a normal ovary or an ovo¬
testis it is likely that the gonad which was the
site of the tumour was either wholly or partly
testicular—i.e. all of these patients were probably
true hermaphrodites.
3. Sex chromatin studies.
There is information about sex chromatin in
19 patients of whom 16 were chromatin negative
and 3 were chromatin positive.
The three chromatin positive cases require
further comment. In one case (Philipp and Stange,
1960) only 23 per cent of nuclei from a buccal
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smear were chromatin positive. This low count is
suggestive of some form of chromosomal
mosaicism rather than a simple XX sex chromo¬
some complement. Furthermore, the contra¬
lateral gonad in this case was rudimentary. In
the second case (Teter and Tarlowski, 1960) the
tumour replaced one gonad while the contra¬
lateral gonad was again rudimentary. The pre¬
sence of calcification in this tumour suggests
that it was testicular in origin. In neither of these
two cases was chromosome analysis performed.
The third case (Botella-Llusia, 1960) was a true
hermaphrodite with bilateral ovotestis. This
patient was found to have a normal female
karyotype, 46/XX.
One can conclude that the majority of intersex
patients with a disgerminoma have been chro¬
matin negative. The three chromatin positive
patients which have been reported were probably
either true hermaphrodites with testicular tissue
or chromosome mosaics in association with
dysgenetic gonads. One feature common to all of
these patients is likely to have been the presence
of testicular tissue.
4. Chromosome analysis.
Chromosome analysis was carried out in 9







The one case with an apparently normal female
karyotype has already been discussed (Botella-
Llusia, I960) and shown to be an example of a
true hermaphrodite with a 46/XX karyotype.
The presence of testicular tissue despite the ap¬
parent absence of a Y chromosome has already
been well documented (Harnden and Armstrong,
1959). With this exception, no intersex case with
a disgerminoma and a normal female karyotype
has yet been described. Furthermore, every case
has had an XY cell line, with the further excep¬
tion of one patient with a 45/XO karyotype.
These four observations lead to the conclu¬
sion that in patients with an intersex state there
has been no clearly documented example in
which a disgerminoma has originated in ovarian
tissue. Undoubtedly, in the majority of cases it
was shown to derive from testicular tissue. As a
corollary to this statement, there is no well-
established case of a female pseudohermaphro¬
dite with a disgerminoma, the patients reported
being either male pseudohermaphrodites or
true hermaphrodites. The liability of a female
pseudohermaphrodite or a true hermaphrodite
to develop an ovarian disgerminoma is probably
the same as in women with normal sex develop¬
ment.
However, tumours other than disgerminoma
have occasionally been found in the ovaries of
intersex patients. Examples of mucinous cyst-
adenomas (Corriden, 1949; Bani, 1956; Grecham
and Fairgrieve, 1960), Brenner tumour (Weed et
al., 1947; Stange, 1957), thecoma (Vaughn and
Gonzales-Angulo, 1961), granulosa-theca cell
tumour (Hauser et al., 1960), and dermoid cyst
(Claret and Mcintosh, 1954), have been re¬
ported. The small number of such case reports,
however, suggests that the risks of any type of
neoplastic transformation in the ovary may not
be increased by the existence of an intersex state.
On the other hand, the incidence of testicular
tumours is undoubtedly increased in patients
with an intersex state. Cryptorchidism is com¬
mon in these cases, and the liability of ectopic
testes to neoplasia is well documented (Dixon
and Moore, 1953). It is significant that in these
cases the tumour, although commonly a semino¬
ma, is not infrequently a teratoma, embryonal
carcinoma, teratocarcinoma or chorionepitheli-
oma. For instance, in one series of 61 testicular
tumours in male pseudohermaphrodites, there
were 38 seminomas, 14 teratomas, and 9 mis¬
cellaneous tumours (Gilbert, 1942).
The remarkably close association between the
gonadoblastoma and intersex states is now well
documented. Of the cases described so far, all
were associated with abnormal sex development,
all proved to be chromatin negative, and in all
the cases in which chromosome analysis is avail¬
able an XY cell line was reported (Philip and
Teter, 1964). It seems likely that the gonado¬
blastoma is a variant of the testicular seminoma
rather than the ovarian disgerminoma, being a
tumour of dysgenetic testes.
The age distribution of seminomas and dis-
germinomas is relevant to this argument. Testi¬
cular seminomas are relatively rare in younger
age groups, only 12 per cent being found in males
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under the age of 30 (Fergusson, 1962). By con¬
trast, 80 per cent of ovarian disgerminomas, in
patients with normal sex development, occur
before the age of 30 years (Santesson, 1947).
However, many of the disgerminomas which
have been reported in intersex cases were found
in older age groups, and the age distribution in
these is more comparable to that of testicular
seminomas rather than ovarian disgerminomas
(Willis, 1953). This may support the belief that
these tumours in intersex cases are closely re¬
lated to the seminoma type of tumour.
A simple concept of the relation of the disger-
minoma-seminoma type of tumour to intersex
states emerge from this review. These tumours
undoubtedly occur most commonly in the testes
or ovaries of patients with normal sex develop¬
ment. However, the risk ofdeveloping a seminoma
is increased in ectopic testes whether or not there
is an associated intersex state. The incidence of
other forms of neoplasms is also increased in
ectopic testes, but probably to a lesser extent
(Fergusson, 1962). This implies that the signifi¬
cant aetiological factor is possibly the site of the
testis rather than the abnormal sex development.
Furthermore, there is no evidence that the inci¬
dence of neoplasia is increased in the ovaries of
intersex patients.
This argument has a clinical application. In
intersex states there is an increased risk of gona¬
dal neoplasia only if testicular tissue is present.
This may be indicated by the presence of an XY
cell line which is strong presumptive evidence of
testicular tissue. However, it may occasionally
arise in chromatin negative X monosomies with
dysgenetic gonads. Furthermore, it is important
to realize that the findings of a normal female
karyotype does not exclude the presence of
testicular tissue, for, as we have shown, a true
hermaphrodite possessing both ovarian and
testicular tissue may have have an XX sex chro¬
mosome complement. As a corollary to this, the
finding of a tumour of the seminoma-disger-
minoma type in an intersex patient is strong
evidence for the presence of testicular tissue.
B. Arrhenoblastomas and Intersex States.
Pick (1905) reported the first description of an
extremely well-differentiated arrhenoblastoma in
a female patient. He remarked on its close re¬
semblance to the typical tubular adenoma of the
undescended testis, and suggested that his case
may in fact have been a testicular tumour arising
from an ovotestis. However, Meyer (1931) later
included Pick's tumour and similar cases as
examples ofwell-differentiated arrhenoblastomas,
and the status of the tubular adenoma of Pick
as an ovarian tumour has been generally ac¬
cepted. However, with the recognition of the
testicular feminization syndrome (Morris, 1953),
it is now appreciated that the presence of bilateral
cryptorchidism is compatible with a female
phenotype. Moreover, in this syndrome the
undescended testes are commonly the site of
tubular adenomas which may replace the whole
testis. In these cases, if the opposite gonad is not
examined, or if it is also replaced by the tumour,
an erroneous diagnosis of ovarian arrhenoblas¬
toma may be made. This risk is increased by the
common finding of an ovarian-like stroma in the
capsule of these testes (Morris and Mahesh,
1963).
It is impossible to know how frequently this
error has been made. In two of our cases in
which an arrhenoblastoma was initially re¬
ported, the correct diagnosis proved to be testi¬
cular tubular adenomas in genetic males. In an
incomplete review of the literature, we have en¬
countered nine cases reported as ovarian
tumours in females where the true diagnosis may
be testicular feminization (Behrend and Levine,
1936; Anderson, 1937; Dudman, 1939; Novak,
1943—2 cases; Jolles and Gleave, 1945; Gold¬
berg and Maxwell, 1947; Javert and Finn, 1951;
Langley, 1954). The features common to these
cases are primary amenorrhoea, absence of
masculinization, and an absent or rudimentary
uterus.
Sex chromatin analysis will clarify the diagno¬
sis in most of these cases. As we have shown,
ovarian arrhenoblastomas are chromatin posi¬
tive, while testicular tubular adenomas are
chromatin negative. It should be emphasized
that the histological appearance of a testicular
tubular adenoma and a well-differentiated
ovarian arrhenoblastoma may be indistinguish¬
able. Not all of this type of tumour occur in male
testes, and a number of cases have been described
in parous women (Javert and Finn, 1951). This
emphasises the value of routine sex chromatin
analysis as an adjunct to histological examina¬
tion in elucidating the nature of these tumours.
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Summary
1. A study of five cases of ovarian disger-
minoma and five cases of arrhenoblastoma is
reported.
2. All five patients with a disgerminoma were
phenotypically normal females and had a normal
female sex chromatin pattern, while three of them
had a normal female karyotype. Of the five
tumours originally reported as arrhenoblasto-
mas, two proved to be testicular tubular adeno¬
mas replacing the undescended testes of genetic
males with the testicular feminization syndrome.
3. A review is presented of 36 reported cases
of intersex with tumours of the seminoma-
disgerminoma type, with special reference to the
nature of the ipsilateral and contralateral gonads,
and the sex chromatin and chromosome analy¬
sis of the patient. It is concluded that no dis¬
germinoma occurring in an intersex patient has
been proven to have arisen in ovarian tissue,
while in the majority of cases it has been shown
to have originated in testicular tissue.
4. There is probably no increased risk of any
type of neoplastic change in the ovaries of inter¬
sex patients. By contrast, there is an increased
risk of testicular tumours, including the semi¬
noma, in male intersexes. This is thought to be
a function of the ectopic position of the testes
rather than the abnormal sex development per se.
5. The histological similarity of the well-
differentiated arrhenoblastoma and the testicular
tubular adenoma may lead to errors in diagnosis.
Sex chromatin analysis is invaluable in these
cases.
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